RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-related disorder
Accession: DOID:303
browse the term
Definition: A disease of mental health involving the abuse or dependence on a substance that is ingested in order to produce a high, alter one's senses, or otherwise affect functioning. (DO)
Synonyms: exact_synonym: PSAB; organic mental disorders, substance induced; substance addiction; substance use disorder; substance use disorders; substance-related disorders
broad_synonym: psychiatric toxicity
related_synonym: dopamine receptor d2, reduced brain density of; polysubstance abuse, susceptibility to
xref: EFO:0011059 ; MESH:D019966 ; MIM:606581 ; MONDO:0002494 ; NCI:C92203
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcc4
ATP binding cassette subfamily C member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
G
Ablim1
actin-binding LIM protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:256,084,297...256,371,969
G
Adarb2
adenosine deaminase RNA specific B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr17:66,660,586...67,211,104
Ensembl chr17:61,756,067...62,300,831
G
Aff3
ALF transcription elongation factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:40,404,375...40,857,247
G
Agbl4
AGBL carboxypeptidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:130,483,551...131,762,906
Ensembl chr 5:125,254,956...126,534,367
G
Akap7
A-kinase anchoring protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:20,087,373...20,217,797
G
Ano4
anoctamin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 7:25,216,389...25,625,811
Ensembl chr 7:23,329,070...23,738,434
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:20,135,375...20,184,754
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:76,786,578...76,807,459
G
Bcar3
BCAR3 adaptor protein, NSP family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:210,525,260...210,638,798
G
Bpifa2
BPI fold containing family A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:162,953,538...162,961,497
Ensembl chr 3:142,493,379...142,501,337
G
C18h5orf63
similar to human chromosome 5 open reading frame 63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr18:50,424,079...50,442,172
Ensembl chr18:50,424,079...50,441,973
G
C1h19orf18
similar to human chromosome 19 open reading frame 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:82,094,513...82,122,109
Ensembl chr 1:73,025,988...73,049,736
G
Cadps2
calcium dependent secretion activator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:52,746,054...53,275,252
Ensembl chr 4:51,781,053...52,309,829
G
Ccdc91
coiled-coil domain containing 91
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:182,132,931...182,304,948
Ensembl chr 4:180,402,376...180,574,364
G
Cd274
CD274 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:227,116,649...227,134,450
G
Cdcp1
CUB domain containing protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:122,828,685...122,865,388
G
Cdh13
cadherin 13
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20098672 PMID:28387990
RGD:13503340
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:46,349,430...47,387,459
G
Cdh13em1Mcwi
cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin
IMP
knock-out compared to wild-type rats
RGD
PMID:28387990
RGD:13503340
G
Cers6
ceramide synthase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:53,630,959...53,876,848
G
Cftr
CF transmembrane conductance regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Chchd3
coiled-coil-helix-coiled-coil-helix domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:62,327,574...62,584,085
Ensembl chr 4:61,360,353...61,616,847
G
Chd1l
chromodomain helicase DNA binding protein 1-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 2:187,819,869...187,906,359
Ensembl chr 2:185,139,308...185,217,595
G
Chrm2
cholinergic receptor, muscarinic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20393457
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,014,144...65,149,103
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20438829
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9888857 PMID:18690112 PMID:21513772
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Colec12
collectin sub-family member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr18:1,005,787...1,193,455
Ensembl chr18:732,950...920,618
G
Csmd1
CUB and Sushi multiple domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr16:78,920,549...80,520,710
Ensembl chr16:72,218,503...73,817,614
G
Csmd3
CUB and Sushi multiple domains 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 7:80,637,341...81,956,469
Ensembl chr 7:78,748,480...80,066,369
G
Csrnp3
cysteine and serine rich nuclear protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:70,906,587...71,102,596
Ensembl chr 3:50,498,633...50,685,950
G
Csrp3
cysteine and glycine rich protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:98,528,068...98,546,653
G
Ctnna3
catenin alpha 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr20:23,613,016...25,198,699
Ensembl chr20:23,623,560...25,199,978
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,317,933...8,324,839
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17089107
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Ddx1
DEAD-box helicase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:35,996,469...36,027,365
G
Disc1
DISC1 scaffold protein
severity
ISO
protein:altered expression:orbitofrontal cortex
RGD
PMID:15657124
RGD:5509834
NCBI chr19:69,911,548...70,120,970
Ensembl chr19:53,014,616...53,219,778
G
Dnah8
dynein, axonemal, heavy chain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,692,963...8,946,772
G
Dock1
dedicator of cyto-kinesis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:198,897,021...199,413,636
Ensembl chr 1:189,467,143...189,983,768
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16901644
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Dscam
DS cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr11:49,391,385...49,976,861
Ensembl chr11:35,926,896...36,507,415
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr11:92,746,409...92,779,647
Ensembl chr11:79,241,938...79,275,188
G
Eipr1
EARP complex and GARP complex interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:51,116,827...51,230,453
Ensembl chr 6:45,388,376...45,502,083
G
Etv6
ETS variant transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:168,580,405...168,819,817
Ensembl chr 4:166,847,686...167,084,992
G
Faah
fatty acid amide hydrolase
susceptibility
ISO
ClinVar Annotator: match by term: Polysubstance abuse, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.P129T (human)
ClinVar OMIM CTD RGD
PMID:12060782 PMID:15254019 PMID:16972078 PMID:19103437 PMID:23556448 PMID:25741868 PMID:16972078 PMID:12060782 More...
RGD:1625741 , RGD:1300311
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:129,479,824...129,498,677
G
Fam184a
family with sequence similarity 184, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr20:33,477,089...33,599,296
Ensembl chr20:32,934,636...33,056,652
G
Fam184b
family with sequence similarity 184, member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr14:69,688,031...69,803,922
Ensembl chr14:65,475,489...65,591,388
G
Farp1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:104,531,196...104,770,148
Ensembl chr15:98,182,329...98,363,299
G
Faslg
Fas ligand
IDA
RGD
PMID:15644446
RGD:1358616
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fhit
fragile histidine triad diadenosine triphosphatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:16,365,401...17,872,901
Ensembl chr15:13,934,995...15,442,340
G
Fhod3
formin homology 2 domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:15,993,324...16,425,796
G
Fkbp15
FKBP prolyl isomerase family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:80,766,356...80,830,622
Ensembl chr 5:75,750,787...75,814,990
G
Frmd4a
FERM domain containing 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr17:78,577,062...79,167,924
Ensembl chr17:73,667,789...74,258,687
G
Gba3
glucosylceramidase beta 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr14:64,787,601...64,934,043
Ensembl chr14:60,574,976...60,721,653
G
Gria4
glutamate ionotropic receptor AMPA type subunit 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:1,562,119...2,034,979
G
Grik2
glutamate ionotropic receptor kainate type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:52,133,851...52,838,375
G
Grm5
glutamate metabotropic receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:141,312,368...141,882,274
G
Grm7
glutamate metabotropic receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:145,286,714...146,169,099
Ensembl chr 4:143,731,259...144,612,344
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IMP
RGD
PMID:30188517
RGD:13792724
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Hspa12a
heat shock protein family A (Hsp70) member 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:257,935,644...258,096,846
G
Htr2c
5-hydroxytryptamine receptor 2C
IMP
RGD
PMID:16474401
RGD:2292548
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Hycc1
hyccin PI4KA lipid kinase complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:12,024,692...12,131,504
Ensembl chr 4:11,132,385...11,239,113
G
Insr
insulin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
G
Klf12
KLF transcription factor 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:76,637,654...77,062,056
G
Ldlrad3
low density lipoprotein receptor class A domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:108,694,528...108,936,330
Ensembl chr 3:88,239,622...88,481,267
G
Limch1
LIM and calponin homology domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,114,803...41,425,191
G
Lrmda
leucine rich melanocyte differentiation associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:1,275,139...2,334,153
Ensembl chr15:1,225,710...2,284,749
G
Macrod2
mono-ADP ribosylhydrolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:127,720,181...129,734,492
G
Mknk1
MAPK interacting serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:134,554,881...134,594,392
Ensembl chr 5:129,318,170...129,357,639
G
Mpc1
mitochondrial pyruvate carrier 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:54,985,305...54,996,979
Ensembl chr 1:52,437,741...52,449,400
G
Mpp7
MAGUK p55 scaffold protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr17:60,135,096...60,401,814
Ensembl chr17:55,442,696...55,706,748
G
Msra
methionine sulfoxide reductase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:38,351,445...38,676,585
G
Myo5c
myosin VC
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 8:84,870,031...84,946,996
Ensembl chr 8:75,989,528...76,066,483
G
Myo6
myosin VI
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:81,087,139...81,239,292
G
Nme7
NME/NM23 family member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr13:79,190,462...79,319,890
Ensembl chr13:76,657,367...76,786,765
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19063928
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Nrcam
neuronal cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123759
NCBI chr 6:67,129,723...67,425,510
Ensembl chr 6:61,329,863...61,702,992
G
Nrxn3
neurexin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:107,641,780...109,272,044
G
Oprd1
opioid receptor, delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17622222 PMID:20098672
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27192616
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Or51e1
olfactory receptor family 51 subfamily E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:166,554,112...166,564,147
Ensembl chr 1:157,142,352...157,149,671
G
Pacs1
phosphofurin acidic cluster sorting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:211,866,872...211,998,828
Ensembl chr 1:202,437,505...202,569,473
G
Parva
parvin, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:175,981,725...176,139,523
Ensembl chr 1:166,547,132...166,704,950
G
Patj
PATJ, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:118,177,557...118,480,301
Ensembl chr 5:113,062,118...113,364,807
G
Pbx1
PBX homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:80,278,770...80,588,594
G
Pcdh15
protocadherin related 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr20:13,996,383...15,495,206
Ensembl chr20:13,963,565...15,494,719
G
Pde1c
phosphodiesterase 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 4:86,629,074...87,108,147
Ensembl chr 4:85,300,858...85,863,219
G
Piwil1
piwi-like RNA-mediated gene silencing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr12:33,585,747...33,606,715
Ensembl chr12:27,949,744...27,970,580
G
Pla2r1
phospholipase A2 receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:65,292,629...65,422,462
Ensembl chr 3:44,883,943...45,013,660
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
G
Polr1d
RNA polymerase I and III subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr12:13,084,505...13,118,069
Ensembl chr12:7,970,595...8,005,624
G
Prkce
protein kinase C, epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkch
protein kinase C, eta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:92,292,000...92,490,654
G
Prpf4
pre-mRNA splicing tri-snRNP complex factor PRPF4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:80,875,511...80,889,501
Ensembl chr 5:75,859,924...75,873,919
G
Pten
phosphatase and tensin homolog
IMP
RGD
PMID:16474401
RGD:2292548
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Qsox1
quiescin sulfhydryl oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:67,949,780...67,987,459
G
Rad51b
RAD51 paralog B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 6:103,829,390...104,373,923
Ensembl chr 6:98,098,868...98,640,979
G
Rhbdd3
rhomboid domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr14:84,208,155...84,214,334
Ensembl chr14:79,994,158...80,000,175
G
Rtl6
retrotransposon Gag like 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 7:115,684,812...115,689,897
Ensembl chr 7:115,684,739...115,690,052
G
Samd4a
sterile alpha motif domain containing 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:22,616,200...22,831,872
Ensembl chr15:20,134,377...20,348,380
G
Sema6d
semaphorin 6D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:131,801,680...132,394,578
Ensembl chr 3:111,883,872...111,941,094
G
Slc10a2
solute carrier family 10 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr16:91,088,089...91,111,025
Ensembl chr16:84,374,862...84,409,475
G
Slc18a2
solute carrier family 18 member A2
IEP
protein:increased cysteine nitrosylation:striatum, vesicle (rat)
RGD
PMID:17683483
RGD:5131179
NCBI chr 1:268,399,815...268,435,229
Ensembl chr 1:258,413,959...258,448,325
G
Slc22a3
solute carrier family 22 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17010131
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:48,235,476...48,324,612
G
Slc2a13
solute carrier family 2 member 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 7:124,278,881...124,606,146
Ensembl chr 7:122,399,330...122,726,605
G
Slc45a2
solute carrier family 45, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 2:61,690,828...61,723,437
Ensembl chr 2:59,963,706...59,996,317
G
Slc6a4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19272758
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Slk
STE20-like kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:256,415,013...256,470,942
Ensembl chr 1:246,473,712...246,526,530
G
Spmip5
sperm microtubule inner protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:267,912,696...267,919,413
Ensembl chr 1:257,926,388...257,934,399
G
Syne1
spectrin repeat containing nuclear envelope protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:41,512,030...41,983,322
G
Tenm2
teneurin transmembrane protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr10:20,984,710...22,121,001
Ensembl chr10:20,481,854...21,705,597
G
Thsd4
thrombospondin type 1 domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 8:69,280,397...69,880,144
Ensembl chr 8:60,386,875...61,024,995
G
Tiam2
TIAM Rac1 associated GEF 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:46,323,450...46,524,769
Ensembl chr 1:43,918,174...44,119,493
G
Tmprss7
transmembrane serine protease 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr11:68,583,710...68,629,200
Ensembl chr11:55,128,998...55,164,882
G
Ttc21b
tetratricopeptide repeat domain 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:71,269,425...71,343,936
Ensembl chr 3:50,861,367...50,935,903
G
Wdr11
WD repeat domain 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:193,595,606...193,641,149
Ensembl chr 1:184,165,571...184,210,846
G
Xkr4
XK related 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 5:20,694,433...21,095,350
Ensembl chr 5:15,895,863...16,282,962
G
Xpo6
exportin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:190,102,719...190,192,138
Ensembl chr 1:180,672,119...180,761,543
G
Xylt1
xylosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:181,078,222...181,361,047
Ensembl chr 1:171,643,925...171,926,783
G
Zfp366
zinc finger protein 366
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 2:32,312,712...32,376,996
Ensembl chr 2:30,578,715...30,642,182
G
Zfp385d
zinc finger protein 385D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr15:7,473,431...7,854,364
Ensembl chr15:5,042,572...5,423,367
G
Zfp606
zinc finger protein 606
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 1:72,981,920...73,022,423
Ensembl chr 1:72,981,989...73,008,072
G
Zfp804a
zinc finger protein 804A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20098672
NCBI chr 3:87,440,496...87,670,872
Ensembl chr 3:67,034,170...67,263,607
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
ClinVar Annotator: match by term: ALDH2-related condition | ClinVar Annotator: match by term: Alcohol sensitivity, acute | ClinVar Annotator: match by term: Susceptibility to hangover
ClinVar
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:25741868 PMID:28492532 PMID:33355142 More...
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Adcyap1
adenylate cyclase activating polypeptide 1
susceptibility
ISO
DNA:SNP:: (rs2856966) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:113,103,718...113,109,773
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
ISO
associated with other drug dependencies; DNA:SNPs:CDS: (rs904096) ClinVar Annotator: match by term: Alcohol dependence
OMIM ClinVar RGD
PMID:3397059 PMID:3758060 PMID:10090900 PMID:15863807 PMID:17718394 PMID:17923853 PMID:25741868 PMID:27151647 More...
RGD:405650603
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:226,797,303...226,808,892
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
RGD
PMID:20077761
RGD:401827938
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591
G
Adra2a
adrenoceptor alpha 2A
susceptibility
ISO IEP
DNA:SNP:promoter: C-1291G (rs1800544) (human) associated with stress-related disorder; mRNA:decreased expression:hypothalamus (rat)
RGD
PMID:21070505 PMID:26121187
RGD:401976462 , RGD:401976544
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Ago1
argonaute RISC component 1
susceptibility
ISO
DNA:SNP:intron:A>G(rs595961)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:138,722,111...138,773,546
G
Ago2
argonaute RISC catalytic component 2
susceptibility
ISO
DNA:SNP:promoter:A>C(rs4961280)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Ahr
aryl hydrocarbon receptor
ISO
mRNA:decreased expression:duodenum:
RGD
PMID:34454169
RGD:405866377
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akr1c3
aldo-keto reductase family 1, member C3
ISO
DNA:SNP:cds:rs12529 (p.H5Q)(human)
RGD
PMID:21323680
RGD:597621634
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:66,110,963...66,127,873
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
ClinVar Annotator: match by term: Alcohol dependence DNA:SNP: :1510G>A (human)
ClinVar RGD
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 PMID:20077761 PMID:16679777 More...
RGD:401827938 , RGD:401827936
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Alk
ALK receptor tyrosine kinase
ISO
DNA:SNP:CDS: (rs7592571)
RGD
PMID:21703634
RGD:597830064
NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:22,880,625...23,598,034
G
Angpt1
angiopoietin 1
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10090742)
RGD
PMID:27151647
RGD:405650603
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Ankk1
ankyrin repeat and kinase domain containing 1
susceptibility
ISO
DNA:polymorphism:exon: DNA:SNP,haplotype:exon:rs1800497(human)
RGD
PMID:28574012 PMID:23443985
RGD:401959222 , RGD:401959307
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Ar
androgen receptor
severity
ISO
DNA:repeats:N-terminal DNA:repeat, haplotype:exon
RGD
PMID:19231085 PMID:24271034
RGD:407424612 , RGD:407550222
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arrb2
arrestin, beta 2
IEP
mRNA:decreased expression:nucleus accumbens
RGD
PMID:34919270
RGD:401938593
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Avp
arginine vasopressin
ISO IEP
protein:decreased expression:cerebrospinal fluid protein:decreased expression:blood plasma mRNA:increased expression:paraventricular nucleus of hypothalamus
RGD
PMID:7106059 PMID:15608610 PMID:9622448
RGD:408426006 , RGD:596933105 , RGD:529435544
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Avpr1b
arginine vasopressin receptor 1B
IEP
RGD
PMID:21309953
RGD:14700679
NCBI chr13:45,598,116...45,611,680
Ensembl chr13:43,046,267...43,057,792
G
Bdnf
brain-derived neurotrophic factor
treatment disease_progression sexual_dimorphism
IDA ISO IEP
DNA:SNP: :66V>M protein:altered expression:hippocampus
RGD
PMID:34453945 PMID:19170664 PMID:37303582 PMID:32579730
RGD:401959604 , RGD:597830066 , RGD:596936394 , RGD:401959610
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bmal1
basic helix-loop-helix ARNT like 1
susceptibility
ISO
DNA:SNP::(rs6486120) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Bmal2
basic helix-loop-helix ARNT like 2
susceptibility
ISO
DNA:SNPs, haplotype:: (rs7958822,rs4964057) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 4:181,429,097...181,478,384
Ensembl chr 4:179,699,502...179,746,949
G
Bptf
bromodomain PHD finger transcription factor
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs11870068)
RGD
PMID:27151647
RGD:405650603
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:91,982,758...92,082,769
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
IEP
mRNA, protein:increased expression:amygdala, hippocampus (rat) protein:increased expression:inferior colliculus (human)
RGD
PMID:27905406 PMID:25556199
RGD:152985537 , RGD:152985539
NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:151,764,138...152,379,648
G
Cartpt
CART prepropeptide
susceptibility
ISO
DNA:polymorphism: : DNA:SNP: : rs16871471
RGD
PMID:15234472 PMID:20362026
RGD:597805890 , RGD:597805891
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:9622381
RGD:407419865
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:121,153,500...121,160,084
G
Cdk20
cyclin-dependent kinase 20
susceptibility
ISO
DNA:SNP:: (rs560019) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr17:706,863...717,828
Ensembl chr17:701,124...707,826
G
Ces1d
carboxylesterase 1D
ISO
protein:decreased expression:white blood cell
RGD
PMID:8730217
RGD:597621688
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:13,796,623...13,912,035
G
Chat
choline O-acetyltransferase
ISO
protein:decreased expression:hippocampus,septum,striatum
RGD
PMID:8436061
RGD:401976285
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility
ISO
DNA:missense:exons:p.R37H,p.E363D(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrnb3
cholinergic receptor nicotinic beta 3 subunit
susceptibility
ISO
DNA:missense:exons:multiple(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:64,714,169...64,751,360
G
Clock
clock circadian regulator
exacerbates
ISO
RGD
PMID:23722243
RGD:401976471
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Comt
catechol-O-methyltransferase
susceptibility sexual_dimorphism onset disease_progression
ISO
associated with Alzheimer's disease; DNA:SNP:cd: P.V158M G>A (rs4680) (human) DNA:SNPs,haplotypes:: (rs165774,rs4680) (human) DNA:SNPs,haplotype:exon 4: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (rs4680) (human) DNA:SNP:cd: p.V158M (human) associated with major depressive disorder; DNA:SNP:cd: p.V158M (human) DNA:polymorphism:exon 4: p.V158M (rs4680)(human) associated with schizophrenia; DNA:promoter:Hypermethylation associated with Trauma and Stressor Related Disorders ; DNA:polymorphism:exon: p.V158M (human)
RGD
PMID:25491588 PMID:22208661 PMID:16499480 PMID:24390676 PMID:16648777 PMID:20860878 PMID:25035107 PMID:16984965 PMID:20517217 PMID:11244495 PMID:31150143 PMID:10698363 More...
RGD:11073926 , RGD:401959747 , RGD:401959300 , RGD:401940156 , RGD:401940155 , RGD:401940149 , RGD:401940148 , RGD:401940146 , RGD:401940133 , RGD:401940131 , RGD:401940120 , RGD:401940118
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Cpe
carboxypeptidase E
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs10517844) DNA:SNP:CDS: (rs13706874) (human)
RGD
PMID:27151647 PMID:20201924
RGD:405650603 , RGD:405650609
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:25,030,276...25,142,233
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO IEP IDA
DNA:SNP:exon:rs35349697 protein:increased phosphorylation:prefrontal cortex (rat) mRNA,protein:decreased expression:hippocampus
RGD
PMID:24704376 PMID:19324071 PMID:21951632 PMID:32579730 PMID:34453945 PMID:37031608 More...
RGD:401938627 , RGD:401901600 , RGD:401959743 , RGD:401959610 , RGD:401959604 , RGD:401959603
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
protein:increased expression:brain
RGD
PMID:12354285
RGD:401901262
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IDA
RGD
PMID:9927612
RGD:405650696
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
IDA
RGD
PMID:9927612
RGD:405650696
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
IDA
RGD
PMID:9927612
RGD:405650696
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Dbi
diazepam binding inhibitor
susceptibility no_association
ISO
DNA:SNP:: +529A>T (rs8192503) (human) DNA:SNP:: +529A>T (human) DNA:SNP:: (rs2276596) (human)
RGD
PMID:18240651 PMID:21226341 PMID:24818357
RGD:408346758 , RGD:408361841 , RGD:408346759
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Dgcr8
DGCR8 microprocessor complex subunit
susceptibility
ISO
DNA:SNP:3���-UTR:G>T(rs1640299)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr11:96,208,959...96,241,560
Ensembl chr11:82,704,729...82,737,242
G
Drd1
dopamine receptor D1
IMP
RGD
PMID:17360123
RGD:405100958
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
onset susceptibility
ISO
DNA:insertion, deletion:promoter: DNA:SNP: :rs1800498(human)
RGD
PMID:23238469 PMID:36825486
RGD:401959213 , RGD:401959301
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd4
dopamine receptor D4
no_association
ISO
DNA:repeats:exon:
RGD
PMID:9342196
RGD:401959738
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Fkbp5
FKBP prolyl isomerase 5
susceptibility
ISO IEP
associated with stress-related disorder;DNA:SNP:: (rs1360780) (human) associated with stress-related disorder;mRNA:affects expression:ventral tegmental area,cingulate cortex, nucleus accumbens( rat) DNA:SNPs:intron,3'utr: (rs1360780, rs3800373)
RGD
PMID:27527158 PMID:27709495 PMID:27709495 PMID:27527158
RGD:401976484 , RGD:401976487 , RGD:401976487 , RGD:401976484
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Fmn1
formin 1
ISO
associated with other drug dependencies; DNA:SNPs:CDS: (rs3910705)
RGD
PMID:27151647
RGD:405650603
NCBI chr 3:120,555,445...120,939,978
Ensembl chr 3:100,134,549...100,479,220
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IDA IEP
protein:increased expression:granular insular cortex, paraventricular nucleus of thalamus, prefrontal cortex
RGD
PMID:29926762 PMID:17723286 PMID:14574439 PMID:17360123
RGD:405100722 , RGD:405295497 , RGD:405101697 , RGD:405100958
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
protein:increased expression:nucleus accumbens (rat) associated with Sleep Deprivation;protein:increased expression:brain
RGD
PMID:20626732 PMID:19324071 PMID:33662520
RGD:401851075 , RGD:401901600 , RGD:401900733
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
susceptibility severity
ISO
DNA:SNP:5'utr: -93A>G (rs45490695) (human) DNA:SNP:5'utr: T137346C (human)
RGD
PMID:18849153 PMID:14675807
RGD:408345238 , RGD:408345249
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility treatment
ISO IMP HEP
DNA:SNP, haplotype:intron: C>G (rs29220) (human) DNA:SNP:Exon 11: T1974C (Human) mRNA:decreased expression:hippocampus (rat) DNA:SNP:intron: (rs29220) (human) DNA:SNP:intron: (rs29253) (human)
RGD
PMID:26727527 PMID:36095322 PMID:36095322 PMID:10412185 PMID:22253714 PMID:29968397 PMID:25191505 More...
RGD:11552767 , RGD:401976442 , RGD:401976442 , RGD:401959601 , RGD:401900163 , RGD:401940102 , RGD:401940100
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
HEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:22253714
RGD:401900163
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:60,947,526...61,288,104
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
ISO
ClinVar Annotator: match by term: Alcohol dependence
ClinVar OMIM
PMID:25741868 PMID:28492532
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:SNPs: :
RGD
PMID:14745296
RGD:405866351
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO HEP
DNA:SNPs, haplotype:introns:IVS9+99C>A, IVS10+3145A>G (rs211014, rs211013) (human) mRNA:decreased expression:hippocampus (human) mRNA:increased expression:hippocampus (rat)
RGD
PMID:15630072 PMID:22253714 PMID:22253714
RGD:402463959 , RGD:401900163 , RGD:401900163
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gad1
glutamate decarboxylase 1
susceptibility onset
ISO
DNA:SNPs, haplotype:5'UTR,IVS:Rs3749034,Rs2270335,Rs10439259(human) DNA:SNPs: haplotype:multiple:rs1978340(human)
RGD
PMID:17067345 PMID:19111404
RGD:401900127 , RGD:401900129
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
susceptibility
ISO
DNA:SNP::-243A>G (rs2236418)
RGD
PMID:17034009
RGD:401900120
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gdnf
glial cell derived neurotrophic factor
treatment
IMP IDA ISO
protein:decreased expression:serum
RGD
PMID:15659598 PMID:19232578 PMID:20553781 PMID:24801661
RGD:405820207 , RGD:405850246 , RGD:405849399 , RGD:405849388
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gemin4
gem (nuclear organelle) associated protein 4
susceptibility
ISO
DNA:SNP:Promoter:C>T(rs910924)(human)
RGD
PMID:25495208
RGD:401900681
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
G
Ggt1
gamma-glutamyltransferase 1
IEP
protein:increased activity:plasma,liver,intestine:
RGD
PMID:6113606
RGD:14701046
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Gpsm1
G-protein signaling modulator 1
ameliorates
IMP
RGD
PMID:18719114
RGD:597830124
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:9,128,636...9,167,827
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ameliorates
ISO
RGD
PMID:33955100
RGD:405649731
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
susceptibility ameliorates
ISO
DNA:repeats:promoter:(GT)n DNA:mutation:cds:A825W(mouse)
RGD
PMID:21507155 PMID:33052417 PMID:29953905
RGD:401938633 , RGD:401938638 , RGD:401938635
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grm8
glutamate metabotropic receptor 8
susceptibility
ISO
DNA:SNPs:intron 1: (rs886003, rs17862325) (human)
RGD
PMID:25978827
RGD:11070870
NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:55,805,955...56,730,831
G
Gstt1
glutathione S-transferase theta 1
ISO
RGD
PMID:29582627
RGD:14700988
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:orbitofrontal cortex
RGD
PMID:23206318
RGD:7175526
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
mRNA:increased expression:Brodmann (1909) area 9 associated with nicotine dependence;DNA:SNPs:enhancer:multiple DNA:SNP: :140G>C
RGD
PMID:22176604 PMID:23216389 PMID:19060480
RGD:401900608 , RGD:405849412 , RGD:401900293
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
susceptibility onset sexual_dimorphism no_association
ISO
DNA:SNP:5'UTR:-161A>T (human) DNA:SNP: :861G>C (human) DNA:SNP: :861G>C(human) DNA:SNP,haplotype:promoter:161A>T (human) DNA:SNP:promoter:rs11568817 (human)
RGD
PMID:12022963 PMID:21906503 PMID:11104852 PMID:11827742 PMID:21172311 PMID:22005095 More...
RGD:405650693 , RGD:405847406 , RGD:405847401 , RGD:405818273 , RGD:405650698 , RGD:405650694
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
disease_progression treatment no_association
ISO IMP IEP
DNA:SNP: :102T>C (rs6313) protein:decreased expression:agranular insular cortex, cingulate cortex, frontal cortex DNA:SNP:promoter:-1438G>A (rs6311)
RGD
PMID:23321485 PMID:8822536 PMID:15080502 PMID:19328219 PMID:19060480 PMID:21930285 More...
RGD:401900291 , RGD:401900739 , RGD:401900737 , RGD:401900304 , RGD:401900293 , RGD:401900297
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr3a
5-hydroxytryptamine receptor 3A
exacerbates treatment susceptibility
ISO IEP
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:SNPs:enhancer, exon: (rs1150226, rs1176713) (human) DNA:SNPs, haplotype:multiple (human) mRNA:increased expression:prefrontal cortex (rat) DNA:SNP:exon 1: (rs33940208) (human)
RGD
PMID:27144979 PMID:23897038 PMID:24590108 PMID:25722691 PMID:23757001
RGD:404976874 , RGD:405096433 , RGD:404976878 , RGD:404976876 , RGD:404976875
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased expression:blood
RGD
PMID:14634483
RGD:405878079
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Kcnb2
potassium voltage-gated channel subfamily B member 2
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2251898)
RGD
PMID:27151647
RGD:405650603
NCBI chr 5:8,340,085...8,811,184
Ensembl chr 5:3,569,685...4,028,599
G
Lep
leptin
severity
IDA ISO IEP
DNA:hypermethylation:promoter DNA:hypomethylation:promoter protein:decreased expression:serum
RGD
PMID:29912265 PMID:30650427 PMID:19884906 PMID:29912265
RGD:21201248 , RGD:407572512 , RGD:407424613 , RGD:21201248
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:34453945
RGD:401959604
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:34453945
RGD:401959604
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mc4r
melanocortin 4 receptor
treatment
IMP
RGD
PMID:24635847
RGD:407572518
NCBI chr18:62,689,798...62,691,685
Ensembl chr18:60,419,832...60,421,719
G
Ncam1
neural cell adhesion molecule 1
susceptibility
ISO
DNA:SNPs:exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ngf
nerve growth factor
ISO IEP
protein:increased expression:serum protein:decreased expression:sciatic nerve protein:decreased expression:plasma
RGD
PMID:17434673 PMID:8733743 PMID:16737466
RGD:401965399 , RGD:401976493 , RGD:401965409
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
IEP
protein:altered expression:brain,neuron
RGD
PMID:7609866
RGD:401976553
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nkain2
sodium/potassium transporting ATPase interacting 2
susceptibility
ISO
DNA:SNP: :rs637547 (human)
RGD
PMID:21445666
RGD:596938167
NCBI chr 1:26,488,381...27,696,134
Ensembl chr 1:24,669,462...25,877,064
G
Npy
neuropeptide Y
susceptibility
ISO
DNA:SNP:cd: p.L7P (rs16139) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IMP ISO
RGD
PMID:25886852 PMID:26121746
RGD:408345235 , RGD:408345252
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
IEP
mRNA:altered expression:central amygdaloid nucleus (rat)
RGD
PMID:28461696
RGD:401960064
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Nrm
nurim
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs2269705)
RGD
PMID:27151647
RGD:405650603
NCBI chr20:2,893,126...2,897,725
Ensembl chr20:2,877,567...2,891,802
G
Nrxn3
neurexin 3
susceptibility
ISO
DNA:SNP,haplotype:Chr14:rs8019381, rs760288|rs8019381|2rs2293847 (human)
RGD
PMID:17804423
RGD:405096431
NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:107,641,780...109,272,044
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
onset
ISO
DNA:SNPs: :rs993315, rs10780691 DNA:SNP: :rs1439047
RGD
PMID:17200667 PMID:28512340
RGD:408395149 , RGD:596933091
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Ntsr1
neurotensin receptor 1
susceptibility
ISO
DNA:SNPs,haplotype::rs6011914,rs2427422(human)
RGD
PMID:23743782
RGD:596948429
NCBI chr 3:187,983,778...188,033,934
Ensembl chr 3:167,606,215...167,656,377
G
Nucb2
nucleobindin 2
IEP
mRNA,protein:decreased expression:hippocampus
RGD
PMID:37031608
RGD:401959603
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:170,750,877...170,787,353
G
Oprd1
opioid receptor, delta 1
ISO
DNA:SNP,haplotype:intron 1 (rs2298896|rs421300), multiple GCAAT (human)
RGD
PMID:17622222
RGD:401976552
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
no_association
ISO
DNA:SNPs:intron:multiple DNA:SNP,haplotype:multiple (multiple GGCTTCT) (human) mRNA:increased expression:orbitofrontal cortex DNA:SNP: :rs6473797 (human)
RGD
PMID:16924269 PMID:17622222 PMID:21955155 PMID:24035285
RGD:401850571 , RGD:401976552 , RGD:401850584 , RGD:401850579
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
no_association treatment sexual_dimorphism
ISO
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:SNP: :rs1799971 (human)
RGD
PMID:16679777 PMID:24035285 PMID:30748046 PMID:11424981 PMID:35992511 PMID:17374034 PMID:18250251 PMID:20077761 PMID:20077761 More...
RGD:401827936 , RGD:401850579 , RGD:401831038 , RGD:401827953 , RGD:401827952 , RGD:401827944 , RGD:11097488 , RGD:401827938 , RGD:401827938
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Oxtr
oxytocin receptor
treatment susceptibility ameliorates
ISO IMP
associated with anxiety disorder; DNA:SNP:intron: (rs2254298) (human) rat gene in mouse model
RGD
PMID:28150062 PMID:37520225 PMID:25449413 PMID:27306084
RGD:597538533 , RGD:597538604 , RGD:597538598 , RGD:597015745
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:145,599,561...145,614,674
G
Pde4b
phosphodiesterase 4B
susceptibility
ISO
DNA:SNP:: (rs1937443) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pdyn
prodynorphin
no_association disease_progression
ISO
DNA:SNP, hypermethylation:promoter:rs2235751 (human) mRNA, protein:increased expression:dorsolateral prefrontal cortex, orbitofrontal cortex DNA:SNP: :rs1997794 (human) DNA:SNP, hypermethylation:dorsolateral prefrontal cortex:rs2281285 (human) DNA:SNP: :rs2281285 (human) DNA:SNPs: :multiple DNA:SNPs, haplotypes:multiple
RGD
PMID:28336495 PMID:21955155 PMID:24035285 PMID:21521424 PMID:26502829 PMID:16924269 PMID:24223163 PMID:23101464 More...
RGD:401850551 , RGD:401850584 , RGD:401850579 , RGD:401850575 , RGD:11535796 , RGD:401850571 , RGD:401850565 , RGD:401850560
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Per2
period circadian regulator 2
ISO
DNA, mRNA:hypermethylation, decreased expression:blood DNA:hypermethylation:blood, promoter
RGD
PMID:30597578 PMID:31329297
RGD:405878075 , RGD:405878078
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pknox2
PBX/knotted 1 homeobox 2
ISO
associated with other drug dependencies; DNA:SNPs:CDS:intron (rs750338)
RGD
PMID:27151647
RGD:405650603
NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:36,600,636...36,790,940
G
Pomc
proopiomelanocortin
no_association
ISO IDA IEP
DNA:SNP: :rs934778 (human) DNA:hypermethylation:promoter:blood mRNA:decreased expression:hypothalamus mRNA:increased expression:pituitary gland mRNA:increased expression:blood, lymphocyte DNA:hypermethylation:blood, promoter DNA, mRNA:hypermethylation, decreased expression:blood mRNA:increased expression:blood, lymphocytes
RGD
PMID:24035285 PMID:24635847 PMID:20191296 PMID:11981131 PMID:7662043 PMID:14634483 PMID:31329297 PMID:30597578 PMID:9426836 More...
RGD:401850579 , RGD:407572518 , RGD:407431644 , RGD:407424597 , RGD:406179436 , RGD:405878079 , RGD:405878078 , RGD:405878075 , RGD:405878074
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
treatment
ISO
RGD
PMID:11418230
RGD:401959332
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Rgs4
regulator of G-protein signaling 4
susceptibility
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:20430014
RGD:597830074
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:81,936,775...81,943,068
G
Rgs6
regulator of G-protein signaling 6
ISO
associated with other drug dependencies; DNA:SNPs:CDS: (rs11621871)
RGD
PMID:27151647
RGD:405650603
NCBI chr 6:107,875,883...108,527,472
Ensembl chr 6:102,264,447...102,824,753
G
Slc29a1
solute carrier family 29 member 1
ISS
OMIM:103780
MouseDO
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc6a1
solute carrier family 6 member 1
susceptibility
ISO
DNA:insertion:promoter:: (human)
RGD
PMID:26727527
RGD:11552767
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:147,466,965...147,482,293
G
Slc6a2
solute carrier family 6 member 2
susceptibility
ISO
DNA:SNPs,haplotypes:intron: (rs36020,rs36029) (human)
RGD
PMID:21070505
RGD:401976462
NCBI chr19:30,183,289...30,228,292
Ensembl chr19:14,010,386...14,050,357
G
Slc6a4
solute carrier family 6 member 4
disease_progression
ISO
DNA:VNTR
RGD
PMID:18552399
RGD:401900298
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Srd5a1
steroid 5 alpha-reductase 1
ISO
DNA:SNP:exon:rs248793(human)
RGD
PMID:21323680
RGD:597621634
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:33,686,391...33,720,461
G
Tas2r118
taste receptor, type 2, member 118
susceptibility
ISO
OMIM
NCBI chr 4:53,414,815...53,415,714
Ensembl chr 4:52,449,208...52,450,107
G
Tbx19
T-box transcription factor 19
susceptibility
ISO
DNA:SNP:: (rs1003502) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr13:79,983,935...80,016,219
Ensembl chr13:77,450,849...77,504,163
G
Tlr2
toll-like receptor 2
ISO
protein:increased expression:orbitofrontal cortex
RGD
PMID:23206318
RGD:7175526
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
protein:increased expression:orbitofrontal cortex
RGD
PMID:23206318
RGD:7175526
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
ISO
protein:increased expression:orbitofrontal cortex
RGD
PMID:23206318
RGD:7175526
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tph2
tryptophan hydroxylase 2
no_association
ISO
DNA:SNP, haplotypes: :multiple DNA:SNP:promoter:-703G>T associated with alcohol dependence;DNA:SNPs, haplotypes: :multiple
RGD
PMID:26232682 PMID:18405071 PMID:17251907
RGD:597621681 , RGD:597830065 , RGD:597621693
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Ttc12
tetratricopeptide repeat domain 12
susceptibility
ISO
DNA:SNPs:introns,exon:
RGD
PMID:17761687
RGD:405866369
NCBI chr 8:58,696,381...58,743,857
Ensembl chr 8:49,799,920...49,847,087
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
IEP
RGD
PMID:14506614
RGD:1581765
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:181,026,608...181,044,838
G
Acads
acyl-CoA dehydrogenase short chain
susceptibility
ISO
DNA:SNP:: (rs1799958) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:41,493,626...41,502,898
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16404797
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:226,797,303...226,808,892
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
IMP
RGD
PMID:8462548
RGD:5129091
NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:226,947,466...226,987,591
G
Ager
advanced glycosylation end product-specific receptor
treatment onset
IEP ISO
protein:increased expression:frontal cortex neuron protein:increased expression:orbitofrontal cortex mRNA, protein:increased expression:orbitofrontal cortex, neurons
RGD
PMID:33716687 PMID:32664441 PMID:23867237 PMID:23867237 PMID:23867237
RGD:597538457 , RGD:597805903 , RGD:597538460 , RGD:597538460 , RGD:597538460
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16404797 PMID:17590986 PMID:10780266
RGD:734551
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Ankk1
ankyrin repeat and kinase domain containing 1
severity
ISO
DNA:polymorphism: :rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human)
RGD
PMID:32889058 PMID:21936764
RGD:401940151 , RGD:401959296
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Apc2
APC regulator of WNT signaling pathway 2
ISO
DNA, mRNA, protein:hypermethylation, decreased expression:brain
RGD
PMID:31239533
RGD:407987270
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:9,392,336...9,414,310
G
App
amyloid beta precursor protein
IEP
protein:increased expression:liver
RGD
PMID:36187787
RGD:597830170
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Arc
activity-regulated cytoskeleton-associated protein
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Avp
arginine vasopressin
IEP
mRNA:altered expression:central amygdaloid nucleus, medial amygdaloid nucleus, medial zone of hypothalamus protein:decreased expression:suprachiasmatic nucleus
RGD
PMID:21575018 PMID:11709626
RGD:408364978 , RGD:596933084
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP ISO
protein:decreased expression:plasma mRNA, protein:altered expression:brain protein:decreased expression:cerebellum, hippocampus mRNA,protein:decreased expression:hippocampus, plasma (rat) protein:decreased expression:plasma (human)
RGD
PMID:32135570 PMID:32330588 PMID:33919862 PMID:19100286 PMID:15307153 PMID:30277635 PMID:30277635 More...
RGD:35673317 , RGD:596936412 , RGD:596933362 , RGD:401976492 , RGD:401965482 , RGD:401938665 , RGD:401938665
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Calb1
calbindin 1
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 5:34,172,612...34,199,555
Ensembl chr 5:29,375,642...29,402,431
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
mRNA:increased expression:prefrontal cortex
RGD
PMID:28714806
RGD:18337277
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:150,673,507...150,676,600
G
Camk4
calcium/calmodulin-dependent protein kinase IV
IEP
protein:decreased expression:brain, cingulate gyrus
RGD
PMID:11181917
RGD:401959326
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Cartpt
CART prepropeptide
susceptibility
ISO
DNA:SNPs: : rs11575893,rs16871471
RGD
PMID:20362026
RGD:597805891
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cast
calpastatin
IEP
protein:increased expression:gastrocnemius (rat)
RGD
PMID:28800153
RGD:405100967
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
treatment
IEP
associated with diabetes; protein:decreased activity;testis, epididymis (rat) associated with cardiomyopathy associated with cognitive disorder; protein:altered activity:hippocampus (rat) associated with diabetes;protein:decreased activity:liver, kidney (rat)
RGD
PMID:22596042 PMID:25541261 PMID:7195942 PMID:27367870 PMID:21713042
RGD:405255659 , RGD:405255664 , RGD:405255663 , RGD:405255662 , RGD:405255660
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cckar
cholecystokinin A receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr14:61,505,270...61,513,618
Ensembl chr14:57,292,397...57,300,747
G
Cdk20
cyclin-dependent kinase 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr17:706,863...717,828
Ensembl chr17:701,124...707,826
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414406
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
severity
ISO
DNA:haplotypes: :
RGD
PMID:19698703
RGD:405849410
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441
G
Clock
clock circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2412648) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Cnr1
cannabinoid receptor 1
sexual_dimorphism
IEP
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :rs4680(human) DNA:polymorphism::
CTD RGD
PMID:10395222 PMID:32889058 PMID:10395222
RGD:401940151 , RGD:401940114
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
sexual_dimorphism
IEP IDA
mRNA, protein:decreased expression:amygdala protein:increased phosphorylation:liver protein:altered expression, altered phosphorylation:liver, nucleus
RGD
PMID:29991681 PMID:31262967 PMID:22269225
RGD:401938626 , RGD:401959334 , RGD:401959317
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
IEP
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Crh
corticotropin releasing hormone
IEP
mRNA:increased expression:central amygdaloid nucleus (rat)
RGD
PMID:20060104
RGD:5508173
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:11988580
RGD:734822
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma, extracellular exosome
CTD RGD
PMID:20843640 PMID:23819932 PMID:29404485 PMID:29404485
RGD:14700915 , RGD:14700911 , RGD:14700911
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dbh
dopamine beta-hydroxylase
no_association
ISO
DNA:polymorphism:5' utr:g.-1021C>T (human) DNA:polymorphism:cds:g.444G>A (human)
RGD
PMID:16133787 PMID:16252068
RGD:1625572 , RGD:1625571
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:10,488,260...10,505,248
G
Dbi
diazepam binding inhibitor
ISO
mRNA,protein:increased expression:cerebral cortex (mouse)
RGD
PMID:9526063
RGD:408346747
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Dcx
doublecortin
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:107,430,767...107,507,476
G
Dlg4
discs large MAGUK scaffold protein 4
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:mRNA,protein:decreased expression:brain (mouse)
RGD
PMID:30016666
RGD:401959614
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:54,739,470...54,767,153
G
Drd2
dopamine receptor D2
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd4
dopamine receptor D4
treatment susceptibility
ISO
DNA:repeats:exon: associated with peer pressure;DNA:repeats:exon:
RGD
PMID:25640830 PMID:26307243
RGD:11064848 , RGD:401959598
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Ep300
E1A binding protein p300
IEP
mRNA, protein:decreased expression:amygdala
RGD
PMID:29991681
RGD:401938626
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
IEP
RGD
PMID:23095216
RGD:10045658
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Fgf2
fibroblast growth factor 2
IMP
RGD
PMID:28821667 PMID:31375540
RGD:405855870 , RGD:405855874
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA:increased expression:cerebellum
RGD
PMID:34453331
RGD:401938639
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:147,240,301...147,278,050
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP IDA ISO
protein:increased expression:brain protein:increased expression:parvocellular oculomotor nucleus
RGD
PMID:14741756 PMID:29210146 PMID:11164784
RGD:405255650 , RGD:405295495 , RGD:405255652
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
treatment
IEP ISO
protein:increased expression:dorsal striatum (mouse) protein:increased expression:brain (mouse)
RGD
PMID:22792289 PMID:27380261 PMID:9835277
RGD:401851082 , RGD:401901287 , RGD:401901184
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Fshb
follicle stimulating hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
ISO
DNA:SNP:intron: (rs2900512) (human)
RGD
PMID:28118741
RGD:401940105
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:60,947,526...61,288,104
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
susceptibility
ISO
DNA:SNPs:multiple: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22253714 PMID:15024690
RGD:6480257
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:CA repeats: :(human)
RGD
PMID:9858031
RGD:405866342
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20585342
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:37,459,601...37,505,636
G
Gdnf
glial cell derived neurotrophic factor
treatment
ISO IEP IDA
protein:increased expression:serum associated with Tobacco Use Disorder;mRNA:decreased expression:ventral tegmental area DNA:hypomethylation:nucleus accumbens
RGD
PMID:25623403 PMID:28559549 PMID:22238721 PMID:31710958
RGD:401965480 , RGD:405850249 , RGD:405849387 , RGD:405820205
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12747453
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Ghsr
growth hormone secretagogue receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23977009
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:110,268,489...110,271,865
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO IEP
protein:increased phosphorylation:lumbar spinal cord (mouse) protein:decreased expression:neocortex (rat) protein:increased expression, increased phosphorylation:cingulate cortex (rat) protein:increased expression:nucleus accumbens (mouse) protein:increased expression:nucleus accumbens (rat)
RGD
PMID:28585190 PMID:12036520 PMID:34280506 PMID:21041654 PMID:21041654
RGD:405100727 , RGD:405820203 , RGD:405818275 , RGD:405650686 , RGD:405650686
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IEP
protein:decreased expression:neocortex (rat) protein:increased expression:ventral CA1 field of hippocampus (rat)
RGD
PMID:12036520 PMID:30481568
RGD:405820203 , RGD:596933081
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
RGD
PMID:14573320
RGD:1642372
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO IEP
RGD
PMID:14573320 PMID:32664441 PMID:16911840
RGD:1642372 , RGD:597805903 , RGD:1642200
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Grm5
glutamate metabotropic receptor 5
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:141,312,368...141,882,274
G
Gstp1
glutathione S-transferase pi 1
ISO
DNA:SNP:: rs1695(human)
RGD
PMID:31886888
RGD:597621684
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Hdac2
histone deacetylase 2
IMP
RGD
PMID:23485013
RGD:9590265
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hmgb1
high mobility group box 1
onset treatment
ISO IEP
protein:increased expression:orbitofrontal cortex protein:increased expression:frontal cortex neuron
RGD
PMID:23867237 PMID:32664441 PMID:23867237
RGD:597538460 , RGD:597805903 , RGD:597538460
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Htr1a
5-hydroxytryptamine receptor 1A
treatment
IMP
RGD
PMID:9631953
RGD:401900760
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
sexual_dimorphism onset no_association
ISO
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs11568817(human) DNA:SNP: :rs13212041 (human) DNA:SNPs: :multiples (human)
RGD
PMID:28923721 PMID:30774345 PMID:11496363
RGD:405650695 , RGD:405847403 , RGD:405818272
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
IEP IMP
mRNA, protein:decreased expression:cerebral cortex, liver protein:increased expression:dorsal raphe, nucleus accumbens
RGD
PMID:20501057 PMID:9631953 PMID:9347073 PMID:9347075
RGD:401900301 , RGD:401900760 , RGD:401900742 , RGD:401900740
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
treatment
IDA
RGD
PMID:24041931
RGD:401900761
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
DNA:hypermethylation, hypomethylation:promoter: (mouse)
RGD
PMID:22834954
RGD:404976877
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Htr3b
5-hydroxytryptamine receptor 3B
susceptibility
ISO
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr 8:58,175,785...58,204,939
Ensembl chr 8:49,279,173...49,308,444
G
Htr7
5-hydroxytryptamine receptor 7
ISO
DNA:SNP:intron: (rs7916403) (human)
RGD
PMID:21184583
RGD:150429835
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:233,636,452...233,760,626
G
Igf2
insulin-like growth factor 2
ISO
protein:decreased expression:plasma (human)
RGD
PMID:30277635
RGD:401938665
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Il10
interleukin 10
IEP
mRNA:increased expression:liver
RGD
PMID:22269225
RGD:401959317
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il6
interleukin 6
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:26208141
RGD:11342768
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
ISO
DNA:SNP:promoter:rs2836016 (human)
RGD
PMID:21307845
RGD:6483053
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:34,061,708...34,308,758
G
Kcnn2
potassium calcium-activated channel subfamily N member 2
IEP
protein:decreased expression:ventral CA1 field of hippocampus (rat)
RGD
PMID:30481568
RGD:596933081
NCBI chr18:40,004,693...40,445,043
Ensembl chr18:37,817,957...38,258,347
G
Lhb
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lrp1
LDL receptor related protein 1
IEP
protein:decreased expression:liver
RGD
PMID:36187787
RGD:597830170
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Maoa
monoamine oxidase A
susceptibility
ISO
RGD
PMID:15900229
RGD:1600720
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:6,030,795...6,099,593
G
Mapk1
mitogen activated protein kinase 1
IEP
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
ISO
protein:increased expression, increased phosphorylation:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
IEP
protein:increased expression:liver
RGD
PMID:31262967
RGD:401959334
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
IDA
RGD
PMID:31262967
RGD:401959334
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mb
myoglobin
ISO
protein:decreased expression:serum
RGD
PMID:3766421
RGD:458925288
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mcm5
minichromosome maintenance complex component 5
IEP
RGD
PMID:23095216
RGD:10045658
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389
G
Mir191
microRNA 191
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 8:118,142,627...118,142,717
G
Mir195
microRNA 195
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:54,951,838...54,951,924
G
Mir206
microRNA 206
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:30,590,697...30,590,780
Ensembl chr 9:23,094,249...23,094,332
G
Mir30a
microRNA 30a
onset
IEP
RGD
PMID:32135570
RGD:35673317
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:25,737,600...25,737,670
G
Mki67
marker of proliferation Ki-67
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mmp2
matrix metallopeptidase 2
IEP
RGD
PMID:24966898
RGD:13207311
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
IEP
RGD
PMID:24966898
RGD:13207311
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ncam1
neural cell adhesion molecule 1
sexual_dimorphism treatment
IEP
mRNA:decreased expression:hippocampus (rat) associated with chronic stress in female rats
RGD
PMID:30277635 PMID:27894930 PMID:16207289
RGD:401938665 , RGD:401959751 , RGD:401959613
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ngf
nerve growth factor
ISO IEP
protein:increased expression:serum protein:decreased expression:cerebral cortex, hippocampus protein:decreased expression:brain
RGD
PMID:25623403 PMID:19100286 PMID:15307153
RGD:401965480 , RGD:401976492 , RGD:401965482
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy
neuropeptide Y
IAGP ISO
DNA:deletion:intron:g.4666_4674del (rat) CTD Direct Evidence: marker/mechanism DNA:missense mutation: :p.L7P (human)
CTD RGD
PMID:17572454 PMID:15749341 PMID:12215082
RGD:1357412 , RGD:10430830
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:167,903,879...167,905,024
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IDA IEP IMP
protein:decreased expression, decreased DNA binding:brain mRNA, protein:decreased expression:placenta
RGD
PMID:11961084 PMID:21143252 PMID:31756338 PMID:33920737
RGD:408345232 , RGD:408345244 , RGD:408345241 , RGD:408345239
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment sexual_dimorphism
IMP
RGD
PMID:29437012 PMID:30171933 PMID:33007359
RGD:401965466 , RGD:401976281 , RGD:401966865
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Nrg1
neuregulin 1
sexual_dimorphism
ISO
in female, associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntf3
neurotrophin 3
ISO IEP
protein:decreased expression:plasma (human) protein:increased expression:brain mRNA,protein:decreased expression:hippocampus, plasma (rat)
RGD
PMID:30277635 PMID:15307153 PMID:30277635
RGD:401938665 , RGD:401965482 , RGD:401938665
NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:158,914,957...158,984,596
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO IEP IDA
associated with Prenatal Exposure Delayed Effects and anxiety disorder:protein:decreased acetylation:brain
RGD
PMID:30016666 PMID:33919862 PMID:32206827 PMID:8840027
RGD:401959614 , RGD:596933362 , RGD:596933095 , RGD:401965407
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
IEP ISO IMP
associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNPs, haplotype:intron 1:multiple (human)
RGD
PMID:28511993 PMID:24533225 PMID:7501658
RGD:401976432 , RGD:402525443 , RGD:401976439
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
severity susceptibility no_association
ISO IEP
DNA:SNP, haplotype: :rs6473797 (human) associated with stress-related disorder; mRNA:decreased expression:dorsal striatum (rat) DNA:SNP: :rs6473797 (human) DNA:SNP: :rs997917 (human)
RGD
PMID:31004399 PMID:28511993 PMID:37177778 PMID:37177778
RGD:401831037 , RGD:401976432 , RGD:401850581 , RGD:401850581
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
IMP
RGD
PMID:11814626
RGD:9835016
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
treatment no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:missense mutations, SNP:exon, intron:p.A6V, p.S147C, p.N40D (118A>G) (rs 1799971), IVS2+691G>C (human) DNA:SNP: :rs510769
CTD RGD
PMID:12815747 PMID:32772383 PMID:9399694 PMID:26042510
RGD:401827947 , RGD:401827934 , RGD:401827930
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Oxt
oxytocin/neurophysin I prepropeptide
disease_progression
ISO
mRNA:increased expression:prefrontal cortex, brain (human)
RGD
PMID:28787642
RGD:597621697
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
Oxtr
oxytocin receptor
sexual_dimorphism
ISO
DNA:SNP:intron: (rs53576) (human) DNA:hypomethylation
RGD
PMID:27716573 PMID:35146961
RGD:597538589 , RGD:597538605
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:145,599,561...145,614,674
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pdyn
prodynorphin
no_association susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:decreased expression:hippocampus, granule cell DNA:SNPs: :rs2281285, rs2225749, rs910080 (human) DNA:SNP: :rs2281285 (human) DNA, mRNA:SNP, decreased expression:promoter, dorsolateral prefrontal cortex:rs1997794 (human) associated with cocaine dependence;DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human)
CTD RGD
PMID:17559549 PMID:18923396 PMID:1589146 PMID:37177778 PMID:36099111 PMID:29925858 PMID:18923396 More...
RGD:401851059 , RGD:401850581 , RGD:401850566 , RGD:401850559 , RGD:401850550
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
IEP
mRNA:increased expression:frontal lobe:
RGD
PMID:22703995
RGD:10003152
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
G
Per1
period circadian regulator 1
IEP
mRNA:altered expression: arcuate nucleus of hypothalamus
RGD
PMID:15009656
RGD:407572515
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
IEP
mRNA:altered expression: arcuate nucleus of hypothalamus, suprachiasmatic nucleus
RGD
PMID:15009656
RGD:407572515
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
IEP
mRNA:altered expression:suprachiasmatic nucleus
RGD
PMID:15009656
RGD:407572515
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607
G
Pomc
proopiomelanocortin
sexual_dimorphism
IEP ISO
protein:decreased expression:brain (rat) mRNA:altered expression: arcuate nucleus of hypothalamus associated with Prenatal Exposure Delayed Effects;mRNA:altered expression:adenohypophysis protein:increased expression:plasma mRNA, protein:increased expression:arcuate nucleus, hypothalamus, septum DNA, mRNA:deletion, decreased expression:enhancer, hypothalamus mRNA:increased expression: hypothalamus, pituitary gland, shell of nucleus accumbens
RGD
PMID:18162070 PMID:15009656 PMID:19912941 PMID:19912941 PMID:7925590 PMID:31339663 PMID:22724395 More...
RGD:401976284 , RGD:407572515 , RGD:407572513 , RGD:407572513 , RGD:407571692 , RGD:407550221 , RGD:405878072
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rbfox1
RNA binding fox-1 homolog 1
sexual_dimorphism
ISO
DNA:SNPs:intron 1, 3: (rs8062784, rs12921846) (human)
RGD
PMID:33329073
RGD:597830062
NCBI chr10:8,658,809...10,754,648
Ensembl chr10:8,152,198...9,686,659
G
Rest
RE1-silencing transcription factor
ISO
protein:increased expression:basal forebrain
RGD
PMID:37402853
RGD:597538603
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:30,862,553...30,894,354
G
Rpl18a
ribosomal protein L18A
IEP
mRNA:decreased expression:parietal cortex
RGD
PMID:11244494
RGD:11038708
NCBI chr16:18,576,467...18,578,653
Ensembl chr16:18,542,566...18,545,546 Ensembl chr 1:18,542,566...18,545,546
G
Sell
selectin L
ISO
protein:decreased expression:Tcell
RGD
PMID:7573774
RGD:597015763
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Shbg
sex hormone binding globulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8590623
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,332,941...54,351,057
G
Slc1a2
solute carrier family 1 member 2
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
susceptibility
ISO
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15520362 PMID:17000009 PMID:20838391
RGD:6480660
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18055133
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sod1
superoxide dismutase 1
IEP
associated with diabetes; protein:decreased activity;testis, epididymis (rat)
RGD
PMID:25541261
RGD:405255664
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sox2
SRY-box transcription factor 2
IEP
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:30277635
RGD:401938665
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:117,536,929...117,539,338
G
Spi1
Spi-1 proto-oncogene
treatment
IEP IDA
protein:decreased expression:alveolar macrophage
RGD
PMID:16272341 PMID:21447000
RGD:9586723 , RGD:9586725
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:77,073,012...77,092,393
G
Spn
sialophorin
ISO
associated with Prenatal Exposure Delayed Effects and anxiety disorder:DNA:Hypermthylation:promoter
RGD
PMID:30016666
RGD:401959614
NCBI chr 1:191,177,449...191,190,115
Ensembl chr 1:181,746,429...181,759,628
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
severity
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:17697868
RGD:10043133
NCBI chr11:91,031,481...91,158,111
Ensembl chr11:77,526,837...77,653,310
G
Syp
synaptophysin
sexual_dimorphism
IEP
associated with chronic stress in female rats
RGD
PMID:27894930
RGD:401959751
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19204064
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733
G
Tacr3
tachykinin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:223,266,536...223,363,791
G
Tas2r118
taste receptor, type 2, member 118
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16385453 PMID:17250611
NCBI chr 4:53,414,815...53,415,714
Ensembl chr 4:52,449,208...52,450,107
G
Tas2r138
taste receptor, type 2, member 138
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17250611
NCBI chr 4:70,395,042...70,396,037
Ensembl chr 4:69,428,344...69,429,339
G
Tbx19
T-box transcription factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr13:79,983,935...80,016,219
Ensembl chr13:77,450,849...77,504,163
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11000917 PMID:21792595
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Timeless
timeless circadian regulator
susceptibility
ISO
DNA:SNP:: (rs2291738) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 7:1,239,388...1,263,344
Ensembl chr 7:654,822...678,738
G
Tlr2
toll-like receptor 2
IEP ISO
protein:decreased expression:alveolar macrophage mRNA:increased expression:orbitofrontal cortex mRNA:increased expression:liver protein:decreased expression:blood, monocyte mRNA:increased expression:respiratory system fluid/secretion
RGD
PMID:36281822 PMID:34415075 PMID:30756376 PMID:27256567 PMID:26208141
RGD:597538461 , RGD:597538499 , RGD:597538493 , RGD:597538485 , RGD:11342768
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
onset
ISO IEP
mRNA:decreased expression:respiratory system fluid/secretion protein:increased expression:frontal cortex neuron protein:increased expression:orbitofrontal cortex mRNA:increased expression:orbitofrontal cortex mRNA:increased expression:liver protein:increased expression:liver protein:decreased expression:blood, monocyte
RGD
PMID:26208141 PMID:23867237 PMID:23867237 PMID:34415075 PMID:30756376 PMID:21276439 PMID:27256567 More...
RGD:11342768 , RGD:597538460 , RGD:597538460 , RGD:597538499 , RGD:597538493 , RGD:150540306 , RGD:597538485
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tlr5
toll-like receptor 5
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr13:97,166,430...97,190,642
Ensembl chr13:94,634,801...94,657,738
G
Tlr6
toll-like receptor 6
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
G
Tlr7
toll-like receptor 7
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:27,027,425...27,054,754
G
Tlr8
toll-like receptor 8
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr X:30,708,714...30,733,104
Ensembl chr X:27,091,778...27,116,549
G
Tlr9
toll-like receptor 9
ISO
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:34415075
RGD:597538499
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
Tnf
tumor necrosis factor
treatment
IEP
RGD
PMID:32664441
RGD:597805903
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tph1
tryptophan hydroxylase 1
ISO
RGD
PMID:15654285
RGD:1580464
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:97,157,409...97,178,344
G
Tph2
tryptophan hydroxylase 2
ISO IEP
mRNA, protein:increase3d expression:dorsal raphe nucleus, median raphe nucleus protein:decreased expression:midbrain protein:decreased expression:hippocampus protein:decreased expression, increased activity:raphe nuclei associated with temporal lobe epilepsy;DNA:SNP: :rs17110747
RGD
PMID:24942188 PMID:27647531 PMID:26747301 PMID:32330588 PMID:24491795
RGD:597621679 , RGD:597830173 , RGD:597805906 , RGD:596936412 , RGD:597621680
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Vip
vasoactive intestinal peptide
susceptibility
ISO
DNA:SNPs, haplotype:: (rs3823082,rs688136) (human)
RGD
PMID:20554694
RGD:401976551
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:10235270
RGD:406351024
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:121,153,500...121,160,084
G
Cnr1
cannabinoid receptor 1
ISO
RGD
PMID:11841893
RGD:1626329
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Ngf
nerve growth factor
ISO
protein:increased expression:serum
RGD
PMID:17434673
RGD:401965399
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16318954
RGD:5688289
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
susceptibility
IEP
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,228,306...5,668,215
G
Drd2
dopamine receptor D2
susceptibility
ISO
DNA:SNP:exon:A>G(human)
RGD
PMID:23238469
RGD:401959213
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Pdyn
prodynorphin
ISO
mRNA:increased expression:brain
RGD
PMID:15869750
RGD:401850576
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Slc29a1
solute carrier family 29 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Avp
arginine vasopressin
IEP ISO
protein:decreased expression:suprachiasmatic nucleus DNA:hypermethylation:promoter
RGD
PMID:11709626 PMID:24356727
RGD:596933084 , RGD:596933307
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bdnf
brain-derived neurotrophic factor
severity
ISO IEP
protein:increased expression:hippocampus, prefrontal cortex
RGD
PMID:20553781 PMID:26659122
RGD:405849399 , RGD:596936245
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bmal1
basic helix-loop-helix ARNT like 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Clock
clock circadian regulator
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Cry1
cryptochrome circadian regulator 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:18,529,823...18,594,091
G
Cry2
cryptochrome circadian regulator 2
ISO
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:78,374,995...78,404,965
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
no_association treatment
ISO
DNA:SNPs::CYP2C19*2 (681G>A,rs4244285), CYP2C19*3 (636G>A, rs4986893),CYP2C19*17 (-806C>T, rs12248560) (human) DNA:SNP:promoter:CYP2C19*17 (-806C>T,rs12248560)(human) DNA:SNP:cds:CYP2C19*2 (681G>A,rs4244285)(human)
RGD
PMID:27099220 PMID:30325732 PMID:31957548
RGD:401960863 , RGD:401960882 , RGD:401960880
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Dbi
diazepam binding inhibitor
ISO
mRNA,protein:increased expression:cerebral cortex (mouse)
RGD
PMID:9526063
RGD:408346747
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Drd4
dopamine receptor D4
severity
ISO
DNA:repeats:exon:
RGD
PMID:20359751
RGD:401959612
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Fkbp5
FKBP prolyl isomerase 5
severity
ISO
DNA:SNPs,haplotypes:multiple
RGD
PMID:24603855
RGD:401976481
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
protein:altered expression:brain
RGD
PMID:26727528 PMID:31778691
RGD:405101372 , RGD:405255665
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
disease_progression
ISO
protein:increased expression:primary motor cortex, secondary motor cortex, ventral tegmental area (mouse)
RGD
PMID:24355551
RGD:401851085
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
IEP
mRNA, protein:increased expression:hippocampus (rat)
RGD
PMID:12488536
RGD:402528882
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gdnf
glial cell derived neurotrophic factor
IDA
mRNA, DNA:altered expression, hypomethylation:brain
RGD
PMID:31710958
RGD:405820205
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
IEP
protein:increased phosphorylation:lateral habenular nucleus (rat)
RGD
PMID:28865912
RGD:405650672
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Ngf
nerve growth factor
ISO
protein:increased expression:plasma
RGD
PMID:8727238
RGD:401976550
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy1r
neuropeptide Y receptor Y1
IEP
mRNA:decreased expression:hippocampus, cerebral cortex (rat)
RGD
PMID:20028355
RGD:10448926
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IDA ISO IEP
protein:decreased phosphorylation:prefrontal cortex protein:decreased expression:cingulate gyrus
RGD
PMID:25732140 PMID:18801418 PMID:11961084
RGD:408345231 , RGD:408345247 , RGD:408345232
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IDA IEP
associated with Binge Drinking protein:increased phopsphorylation, increased expression:hippocampus, prefrontal cortex
RGD
PMID:24076087 PMID:26659122 PMID:37366469
RGD:596933360 , RGD:596936245 , RGD:596933361
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Per1
period circadian regulator 1
severity
ISO
mRNA:decreased expression:peripheral blood mononuclear cells (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
severity
ISO
mRNA:decreased expression:Peripheral blood mononuclear cell (human)
RGD
PMID:20735373
RGD:401976556
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pomc
proopiomelanocortin
IEP ISO
mRNA:increased expression:hypothalamus protein:decreased expression:plasma
RGD
PMID:11981131 PMID:11704624 PMID:9406908 PMID:31117084
RGD:407424597 , RGD:407550224 , RGD:407550223 , RGD:407431638
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
treatment
ISO
RGD
PMID:3816539
RGD:401960110
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Tat
tyrosine aminotransferase
IEP
RGD
PMID:11022015
RGD:597621660
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
G
Tdo2
tryptophan 2,3-dioxygenase
IEP
RGD
PMID:11022015
RGD:597621660
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:167,269,579...167,287,511
G
Tlr2
toll-like receptor 2
ISO
mRNA:increased expression:blood, monocyte
RGD
PMID:37058088
RGD:597538488
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Aif1
allograft inflammatory factor 1
IEP
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,646,777...3,652,668
G
Cirbp
cold inducible RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr 7:10,184,515...10,189,623
Ensembl chr 7:9,424,178...9,538,818
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Foxo4
forkhead box O4
IEP
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:70,425,218...70,432,120
Ensembl chr X:66,385,558...66,392,115
G
Gsr
glutathione-disulfide reductase
treatment
IEP
RGD
PMID:24972622
RGD:10401897
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:40,800,232...40,991,584
Ensembl chr12:35,182,154...35,330,987
G
Ppa2
inorganic pyrophosphatase 2
ISO
ClinVar Annotator: match by term: PPA2-related condition | ClinVar Annotator: match by term: Sudden cardiac failure, alcohol-induced
OMIM ClinVar
PMID:24033266 PMID:25741868 PMID:27523597 PMID:27523598 PMID:28492532 PMID:30384889 PMID:31705601 PMID:33028643 PMID:34400813 More...
NCBI chr 2:224,472,738...224,552,101
Ensembl chr 2:221,800,842...221,878,081
G
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,602,786...19,086,300
G
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr16:81,349,429...81,440,439
Ensembl chr16:74,647,153...74,738,173
G
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:146,079,021...146,118,272
G
Bdnf
brain-derived neurotrophic factor
sexual_dimorphism
IEP
protein:altered expression:brain protein:altered expression:frontal cortex,hippocampus,occipital cortex protein:altered expression:cerebral cortex
RGD
PMID:10837897 PMID:18652597 PMID:14604765
RGD:401965408 , RGD:401976540 , RGD:401976539
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cartpt
CART prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22823101
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:30118883
RGD:13782287
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Cd4
Cd4 molecule
sexual_dimorphism
IEP
associated with Mycobacterium Infections;protein:decreased expression:spleen (rat) protein:increases expression:spleen (rat)
RGD
PMID:9744851 PMID:8214423
RGD:407446372 , RGD:407446376
NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:157,668,878...157,695,191
G
Crh
corticotropin releasing hormone
sexual_dimorphism
IEP
mRNA:increased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
IEP
protein:increased expression:liver
RGD
PMID:9731567
RGD:405101375
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Ngf
nerve growth factor
IEP ISO
protein:altered expression:brain protein:decreased expression:entorhinal cortex protein:increased expression:frontal cortex,cerebellar vermis protein:increased expression:cerebral cortex protein:increased expression:thalamus
RGD
PMID:10837897 PMID:10440485 PMID:18652597 PMID:14604765 PMID:21277941
RGD:401965408 , RGD:401976542 , RGD:401976540 , RGD:401976539 , RGD:401976494
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ngfr
nerve growth factor receptor
IEP
protein:decreased expression:brain protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:16325017
RGD:408345251
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntf3
neurotrophin 3
IEP
protein:increased expression:hippocampus,cerebellar vermis
RGD
PMID:18652597
RGD:401976540
NCBI chr 4:160,601,161...160,670,623
Ensembl chr 4:158,914,957...158,984,596
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
protein:altered expression:brain protein:decreased expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
IEP
protein:altered expression:brain
RGD
PMID:15188276 PMID:15188277
RGD:401976554 , RGD:401976555
NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:132,132,849...132,503,286
G
Oprk1
opioid receptor, kappa 1
treatment
IDA
RGD
PMID:20962231
RGD:401850591
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Pomc
proopiomelanocortin
sexual_dimorphism
IEP
mRNA:decreased expression:fetus, thymus
RGD
PMID:8977428
RGD:405878076
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:26226164
RGD:597538484
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:26226164
RGD:597538484
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tph2
tryptophan hydroxylase 2
no_association
ISO
DNA:SNP: :rs4570625
RGD
PMID:18782386
RGD:597621690
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Ace
angiotensin I converting enzyme
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22497828
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Atg3
autophagy related 3
treatment
ISO
RGD
PMID:29039471
RGD:407532638
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:55,624,917...55,653,224
G
Atg7
autophagy related 7
treatment
ISO
RGD
PMID:29039471
RGD:407532638
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Becn1
beclin 1
treatment
ISO
RGD
PMID:29039471
RGD:407532638
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Nos1
nitric oxide synthase 1
IEP
protein:decreased expression:skeletal muscle, membrane
RGD
PMID:17607508
RGD:1642138
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Pparg
peroxisome proliferator-activated receptor gamma
IEP
protein:increased expression:heart myocardium
RGD
PMID:18783396
RGD:2301868
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Rxra
retinoid X receptor alpha
IEP
RGD
PMID:19791468
RGD:2317465
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Slc25a4
solute carrier family 25 member 4
IEP
mRNA, protein:decreased expression:myocardium
RGD
PMID:21169901
RGD:9681464
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:46,072,939...46,076,733
G
Smad3
SMAD family member 3
IEP
protein:increased expression:heart
RGD
PMID:19080654
RGD:597830061
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Tnxb
tenascin XB
IEP
protein:increased expression:heart
RGD
PMID:19080654
RGD:597830061
G
Abcb11
ATP binding cassette subfamily B member 11
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
G
Agt
angiotensinogen
ISO
mRNA:decreased expression:liver
RGD
PMID:17258719
RGD:1601135
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
ISO
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
ISO
protein:increased expression:liver
RGD
PMID:28089901
RGD:407987426
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
severity
ISO
protein:increased expression, modification:urine
RGD
PMID:29369844
RGD:14694842
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
App
amyloid beta precursor protein
IEP
protein:increased expression:liver
RGD
PMID:36187787
RGD:597830170
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Atg3
autophagy related 3
treatment
ISO
RGD
PMID:36308627
RGD:407532639
NCBI chr11:69,130,948...69,159,280
Ensembl chr11:55,624,917...55,653,224
G
Atg7
autophagy related 7
treatment
ISO
protein:increased expression:liver
RGD
PMID:31090940 PMID:36308627
RGD:407445926 , RGD:407532639
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Becn1
beclin 1
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Ccl2
C-C motif chemokine ligand 2
severity
ISO
RNA:increased expression:liver:
RGD
PMID:24429361 PMID:21826694 PMID:10446112
RGD:14975280 , RGD:14995491 , RGD:14995467
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
severity
ISO
RGD
PMID:10446112
RGD:14995467
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:31258651
RGD:14995304
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Col1a1
collagen type I alpha 1 chain
ISO
RGD
PMID:1670041
RGD:5688335
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Cpt1a
carnitine palmitoyltransferase 1A
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Ddr1
discoidin domain receptor tyrosine kinase 1
disease_progression severity
ISO
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (human)
RGD
PMID:33173221 PMID:33173221
RGD:151347691 , RGD:151347691
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,044,320...3,064,468
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fgf19
fibroblast growth factor 19
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:200,056,644...200,060,287
G
Icam1
intercellular adhesion molecule 1
severity
ISO
protein:increased expression:hepatocyte
RGD
PMID:1347281
RGD:14402038
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Il13
interleukin 13
IEP
mRNA:increased expression:liver
RGD
PMID:16698589
RGD:1581860
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il18
interleukin 18
severity
ISO
associated alcoholic liver cirrhosis; protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Lrp1
LDL receptor related protein 1
IEP
protein:decreased expression:liver
RGD
PMID:36187787
RGD:597830170
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Mir155
microRNA 155
ameliorates
IEP ISO
RNA:increased expression:liver
RGD
PMID:32317960 PMID:31090940
RGD:151347420 , RGD:407445926
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mtor
mechanistic target of rapamycin kinase
ISO
protein:decreased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Nfkb1
nuclear factor kappa B subunit 1
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nlrp3
NLR family, pyrin domain containing 3
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
protein:altered expression:hepatocyte
RGD
PMID:34082111
RGD:405866379
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Ppara
peroxisome proliferator activated receptor alpha
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Sell
selectin L
treatment
ISO IEP
mRNA:increased expression:liver
RGD
PMID:10782906 PMID:9835285
RGD:597015742 , RGD:597015743
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Slc10a1
solute carrier family 10 member 1
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:100,613,045...100,626,670
G
Socs1
suppressor of cytokine signaling 1
IEP
mRNA:decreased expression:liver
RGD
PMID:32317960
RGD:151347420
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Sqstm1
sequestosome 1
treatment
ISO
protein:increased expression:liver
RGD
PMID:31090940 PMID:36308627
RGD:407445926 , RGD:407532639
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
treatment
IEP
RGD
PMID:27939985
RGD:15036816
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr X:46,102,524...46,110,868
Ensembl chr X:42,225,372...42,233,402
G
Sult1e1
sulfotransferase family 1E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26220752
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,422,324...20,439,275
G
Tnf
tumor necrosis factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12586603 PMID:27939985
RGD:15036816
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Arc
activity-regulated cytoskeleton-associated protein
disease_progression
ISO
mRNA:altered expression:brain (mouse)
RGD
PMID:26708208
RGD:401853772
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Bdnf
brain-derived neurotrophic factor
ISO
mRNA,protein:decreased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Drd2
dopamine receptor D2
treatment
IDA
RGD
PMID:28300818
RGD:13506954
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:altered expression:brain mRNA:decreased expression:adrenal gland
RGD
PMID:26727528 PMID:12351928
RGD:405101372 , RGD:405255666
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gdnf
glial cell derived neurotrophic factor
ISO
mRNA:decreased expression:basal nucleus
RGD
PMID:24061482
RGD:405850213
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:9514301
RGD:10755766
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ngf
nerve growth factor
ISO
mRNA,protein:increased expression:cerebellum protein:increased expression:plasma
RGD
PMID:19861148 PMID:18639986
RGD:401965398 , RGD:401965411
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nps
neuropeptide S
IDA
RGD
PMID:19860802
RGD:9831199
NCBI chr 1:199,505,772...199,510,915
Ensembl chr 1:190,077,040...190,080,821
G
Npsr1
neuropeptide S receptor 1
IEP
mRNA:increased expression:brain
RGD
PMID:19860802
RGD:9831199
NCBI chr 8:30,882,830...31,107,425
Ensembl chr 8:22,606,946...22,831,558
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
sexual_dimorphism
ISO
DNA:SNP: :rs244465
RGD
PMID:20731635
RGD:408345194
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA,protein:increased expression:cerebellum
RGD
PMID:19861148
RGD:401965398
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA:increased expression:basal nucleus, cerebral cortex
RGD
PMID:24061482
RGD:405850213
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Per2
period circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15608650
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility
ISO
DNA:missense mutation:cds:p.E504K (human) DNA:missense mutation:cds: (rs671) (human) associated with alcohol dependence;DNA:missense mutation:exon 12:p.E487K (human)
RGD
PMID:29779728 PMID:23550892 PMID:11051375
RGD:14696777 , RGD:15042864 , RGD:15042858
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Bcl2
BCL2, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
C3
complement C3
ISO
RGD
PMID:9176087
RGD:408418722
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
protein:decreased expression:brain
RGD
PMID:16205370
RGD:6483345
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:85,511,160...85,517,720
G
Col3a1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Crp
C-reactive protein
severity
ISO
RGD
PMID:22441510
RGD:6482305
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20843640 PMID:29404441
RGD:14700873
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Ddr1
discoidin domain receptor tyrosine kinase 1
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221
RGD:151347691
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,044,320...3,064,468
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression ameliorates
IEP IMP
RGD
PMID:21199726 PMID:23409069
RGD:150429766 , RGD:150517731
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:82,195,463...82,317,363
G
Fabp2
fatty acid binding protein 2
onset
ISO
DNA:polymorphism:CDS:amino acid A54T, homozygosity of the T allele associated with later onset
RGD
PMID:16289894 PMID:16289894
RGD:1578455 , RGD:1578455
NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:211,040,032...211,044,089
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
susceptibility
ISO
DNA:SNP:intron 8:84435G>A (human)
RGD
PMID:19428381
RGD:402463950
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Il18bp
interleukin 18 binding protein
ISO
protein:increased expression:plasma:
RGD
PMID:15566508
RGD:14696666
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:156,372,883...156,374,963
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23274713 PMID:21236309
RGD:597538491
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Jak2
Janus kinase 2
ISO
mRNA, protein:increased expression, increased tyrosine phosphorylation:liver
RGD
PMID:24619965
RGD:10403061
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Lep
leptin
IDA
DNA:hypomethylation:promoter (human)
RGD
PMID:29912265
RGD:21201248
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Mboat7
membrane bound O-acyltransferase domain containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:65,525,213...65,539,538
G
Mir122
microRNA 122
ISO
miRNA:decreased expression:liver
RGD
PMID:28987423
RGD:14401600
NCBI chr18:61,028,817...61,028,901
G
Mir141
microRNA 141
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 4:159,209,525...159,209,618
Ensembl chr 4:157,523,239...157,523,332
G
Mir17
microRNA 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:92,180,629...92,180,712
G
Mir193b
microRNA 193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:1,824,944...1,825,026
Ensembl chr10:1,317,742...1,317,824
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:62,412,272...62,412,350
Ensembl chr10:61,914,133...61,914,226
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:1,394,905...1,394,981
Ensembl chr10:887,684...887,760
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:15,247,315...15,247,393
G
Mir93
microRNA 93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:22,156,844...22,156,930
Ensembl chr12:17,043,135...17,043,221
G
Mmp13
matrix metallopeptidase 13
IEP
RGD
PMID:16286264
RGD:10043176
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19731237 PMID:23274713
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP: :677C>T(human)
RGD
PMID:25987440
RGD:14696749
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:158,465,296...158,483,797
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr10:84,224,599...84,231,812
Ensembl chr10:83,728,318...83,735,705
G
Plau
plasminogen activator, urokinase
IDA
RGD
PMID:19615318
RGD:7241800
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271 PMID:26482880
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:
RGD
PMID:25987440
RGD:14696749
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
ISO
protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Smad3
SMAD family member 3
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23274713 PMID:18180699
RGD:597830076
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Sod2
superoxide dismutase 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: : 47T>C(human)
CTD RGD
PMID:19731237 PMID:26873981
RGD:11060603
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Tg
thyroglobulin
ISO
RGD
PMID:6883738
RGD:401976502
NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:98,418,293...98,603,210
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tlr2
toll-like receptor 2
ISO
protein:increased expression:blood, neutrophil
RGD
PMID:18433921
RGD:5130706
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
ISO
RGD
PMID:18433921
RGD:5130706
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tlr9
toll-like receptor 9
ISO
protein:increased expression:blood, neutrophil
RGD
PMID:18433921
RGD:5130706
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26482880
NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,344,222...19,351,431
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23274713
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ace
angiotensin I converting enzyme
severity treatment
ISO
protein:increased activity:serum (human)
RGD
PMID:3028446 PMID:28691216
RGD:19165343 , RGD:40400719
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adipor2
adiponectin receptor 2
treatment
IEP
RGD
PMID:24797033
RGD:25824940
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Ager
advanced glycosylation end product-specific receptor
ISO
mRNA, protein:increased expression:serum
RGD
PMID:36502724
RGD:597538595
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Ahr
aryl hydrocarbon receptor
exacerbates ameliorates
ISO
RGD
PMID:34454169 PMID:36871955
RGD:405866377 , RGD:405866378
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:35926779
RGD:408345226
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility severity
ISO
DNA:missense mutation:cds, exon 12:p.E487K (human) DNA:polymorphism:exon 12: (human) DNA:deletion:cds: (mouse)
RGD
PMID:1916152 PMID:12198368 PMID:26173414 PMID:3189338
RGD:14696699 , RGD:14981580 , RGD:11076022 , RGD:14696790
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Angpt2
angiopoietin 2
severity
ISO
RGD
PMID:24959006
RGD:15014784
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:71,088,364...71,138,804
G
Atg7
autophagy related 7
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Becn1
beclin 1
ISO
protein:increased expression:liver
RGD
PMID:31090940
RGD:407445926
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bhmt
betaine-homocysteine S-methyltransferase
IEP
protein:increased expression:cytosol
RGD
PMID:25684186
RGD:408418736
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
C6
complement C6
resistance
IAGP
RGD
PMID:15351314
RGD:1600673
NCBI chr 2:55,573,596...55,648,857
Ensembl chr 2:53,851,985...53,921,275
G
Car3
carbonic anhydrase 3
IEP
protein:decreased expression:cytosol
RGD
PMID:25684186
RGD:408418736
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Cat
catalase
treatment
IEP
RGD
PMID:8370342 PMID:28898587
RGD:405255646 , RGD:405255658
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
treatment
IEP
RGD
PMID:23764359
RGD:8662277
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Cd27
CD27 molecule
IEP
RGD
PMID:16698589
RGD:1581860
NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:158,030,703...158,035,592
G
Cd59b
CD59b molecule
IEP
protein:decreased expression:liver
RGD
PMID:12483994
RGD:1600486
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:90,459,162...90,478,847
G
Cldn1
claudin 1
treatment
IEP
RGD
PMID:31116255
RGD:407424600
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:74,421,569...74,436,724
G
Cps1
carbamoyl-phosphate synthase 1
IEP
protein:increased expression:cytosol
RGD
PMID:25684186
RGD:408418736
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:68,614,153...68,737,033
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP::-318 T>C(rs5742909)(human)
RGD
PMID:15208156
RGD:14398728
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:62,319,312...62,324,963
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
IEP
mRNA:increased expression:liver
RGD
PMID:10498645
RGD:5135271
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,310,426...17,313,093
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
treatment
ISO IEP
RGD
PMID:29401608 PMID:9927612 PMID:30192013 PMID:25592162 PMID:29902864
RGD:14700887 , RGD:405650696 , RGD:14700906 , RGD:14700894 , RGD:14700893
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
ISO
RGD
PMID:9927612
RGD:405650696
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Egfr
epidermal growth factor receptor
ISO
RGD
PMID:30502657
RGD:38599215
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
IDA
RGD
PMID:21059295
RGD:10395351
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:lymphocyte:
RGD
PMID:26429926
RGD:14700711
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fkbp5
FKBP prolyl isomerase 5
ameliorates
ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653 PMID:33710653
RGD:401976495 , RGD:401976495
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Gdnf
glial cell derived neurotrophic factor
ISO
protein:increased expression:serum mRNA,protein:increased expression:liver
RGD
PMID:35338490 PMID:35338490
RGD:405849393 , RGD:405849393
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gstm1
glutathione S-transferase mu 1
ISO
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
ISO
RGD
PMID:15932176 PMID:26937962
RGD:14700973 , RGD:11060494
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Hfe
homeostatic iron regulator
IEP
mRNA:increased expression:liver, Kupffer cell (rat)
RGD
PMID:18599584
RGD:8694397
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,413,451...41,421,502
G
Hif1a
hypoxia inducible factor 1 subunit alpha
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:17085342
RGD:9068897
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Igf2
insulin-like growth factor 2
IEP
mRNA:increased expression:liver
RGD
PMID:18505416
RGD:5510002
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Il1b
interleukin 1 beta
IEP
protein:increased expression:serum (rat)
RGD
PMID:23009062
RGD:7204488
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
treatment
IEP
RGD
PMID:31116255
RGD:407424600
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Keap1
Kelch-like ECH-associated protein 1
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:22459801
RGD:6892954
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lpl
lipoprotein lipase
treatment
IEP
RGD
PMID:28442378
RGD:13794376
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Mif
macrophage migration inhibitory factor
IEP
protein:increased expression:liver
RGD
PMID:11798463
RGD:1642007
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir122
microRNA 122
ISO
miRNA:decreased expression:hepatocyte
RGD
PMID:28987423
RGD:14401600
NCBI chr18:61,028,817...61,028,901
G
Mir155
microRNA 155
ameliorates
ISO
RNA:increased expression:liver
RGD
PMID:28492308 PMID:31090940 PMID:31090940
RGD:25314298 , RGD:407445926 , RGD:407445926
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir223
microRNA 223
severity
ISO
RGD
PMID:27679493
RGD:21408575
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mmp9
matrix metallopeptidase 9
IEP
protein:increased expression:liver
RGD
PMID:17374579
RGD:1642042
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mtor
mechanistic target of rapamycin kinase
ISO
protein:decreased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Myc
MYC proto-oncogene, bHLH transcription factor
disease_progression severity
ISO
mRNA:increased expression:liver
RGD
PMID:26576483 PMID:26576483
RGD:14695016 , RGD:14695016
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nedd8
NEDD8 ubiquitin like modifier
ISO
RGD
PMID:12533840
RGD:1549458
NCBI chr15:33,123,505...33,135,522
Ensembl chr15:29,153,556...29,166,160
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment severity
ISO
DNA:SNP:promoter:rs35652124(human)
RGD
PMID:31906014 PMID:31340446
RGD:21201307 , RGD:21201311
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ameliorates
ISO
RGD
PMID:34082111
RGD:405866379
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Otc
ornithine transcarbamylase
IEP
protein:increased expression:serum (rat)
RGD
PMID:19101528
RGD:4144059
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:12,453,834...12,566,918
G
Plaur
plasminogen activator, urokinase receptor
ISO
protein:increased expression:serum
RGD
PMID:22098627
RGD:6484116
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19946271
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:115,293,538...115,314,077
G
Ppara
peroxisome proliferator activated receptor alpha
severity
ISO
DNA:knockout::increased severity in knockouts (mouse)
RGD
PMID:15382117
RGD:5683636
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27765815
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Psmd14
proteasome 26S subunit, non-ATPase 14
IEP
protein:decreased expression:liver, cytosolic proteasome complex (rat)
RGD
PMID:19609968
RGD:9480236
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:46,254,330...46,347,076
G
Rbp4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16762690
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:235,893,917...235,901,399
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased phosphorylation:liver
RGD
PMID:35338490
RGD:405849393
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Slc39a13
solute carrier family 39 member 13
IEP
protein:increased expression:liver, endoplasmic reticulum (rat)
RGD
PMID:25767260
RGD:11553884
NCBI chr 3:97,495,229...97,504,279
Ensembl chr 3:77,037,565...77,049,226
G
Sod1
superoxide dismutase 1
treatment
ISO
human gene in a rat model
RGD
PMID:11266387
RGD:9587792
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment
ISO
RGD
PMID:32236798
RGD:27095880
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Sqstm1
sequestosome 1
ISO
protein:increased expression:liver
RGD
PMID:31090940 PMID:31090940
RGD:407445926 , RGD:407445926
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Tbxas1
thromboxane A synthase 1
IEP
mRNA,protein:increased expression:liver, Kupffer cell:
RGD
PMID:9262373
RGD:11059607
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:67,665,007...67,837,096
G
Tert
telomerase reverse transcriptase
ISO
mRNA,protein,activity:increased expression, increased activity:kupffer cell:
RGD
PMID:26725521
RGD:11574970
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tlr2
toll-like receptor 2
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:16628628 PMID:30353422
RGD:597538497 , RGD:597538498
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
treatment
ISO
RGD
PMID:23023014 PMID:30870678
RGD:21079426 , RGD:21079436
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:liver
RGD
PMID:16628628
RGD:597538497
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IMP IEP
mRNA:increased expression:liver (rat)
RGD
PMID:9397994 PMID:31116255 PMID:7556590 PMID:15670576
RGD:14398736 , RGD:407424600 , RGD:14995472 , RGD:14995456
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Uchl5
ubiquitin C-terminal hydrolase L5
IEP
protein:decreased expression:liver, cytosolic proteasome complex
RGD
PMID:19609968
RGD:9480236
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:55,520,729...55,556,502
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma
RGD
PMID:24959006
RGD:15014784
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Igf1
insulin-like growth factor 1
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
IEP
RGD
PMID:23016131
RGD:10402569
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IMP
RGD
PMID:18093169
RGD:408345248
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Car2
carbonic anhydrase 2
ISO
RGD
PMID:15831920
RGD:408425973
NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:86,741,626...86,756,818
G
Cck
cholecystokinin
disease_progression
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:11185710
RGD:407419866
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:121,153,500...121,160,084
G
Cftr
CF transmembrane conductance regulator
ISO
DNA:missense mutations: :p.L1156F, Q1352H (human)
RGD
PMID:26089335
RGD:11566036
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Pthlh
parathyroid hormone-like hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22280800
NCBI chr 4:181,919,400...181,930,454
Ensembl chr 4:180,188,792...180,199,847
G
Ugt1a7c
UDP glucuronosyltransferase 1 family, polypeptide A7C
ISO
DNA:polymorphisms: :p.N129K, p.R131K, p.W208R (human)
RGD
PMID:12806614
RGD:2317503
NCBI chr 9:96,187,382...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Ache
acetylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16470869
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Acsl6
acyl-CoA synthetase long-chain family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,440,080...38,498,757
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,853...13,333,386
G
Ak5
adenylate kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:241,397,297...241,581,458
G
Akt1
AKT serine/threonine kinase 1
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:introns: (rs2494743, 2498794) DNA:SNP:intron: (rs3730358)
CTD RGD
PMID:15982448 PMID:31654273 PMID:15982448
RGD:407419880 , RGD:407419878
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aoah
acyloxyacyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr17:48,503,812...48,745,161
Ensembl chr17:43,809,638...44,049,148
G
Arc
activity-regulated cytoskeleton-associated protein
disease_progression
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:25959066
RGD:401938592
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Arrb2
arrestin, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17233643
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Astn2
astrotactin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:78,758,142...79,748,273
G
Bdnf
brain-derived neurotrophic factor
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:frontal cortex, striatum protein:increased expression:nucleus accumbens, ventral tegmental area mRNA:increased expression:nucleus accumbens, dorsal striatum protein:decreased expression:hippocampus
CTD RGD
PMID:20736000 PMID:31693929 PMID:37904065 PMID:33961872 PMID:24407463
RGD:597015747 , RGD:596938173 , RGD:596936246 , RGD:401976437
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cartpt
CART prepropeptide
IEP
mRNA:increased expression:striatum
RGD
PMID:28827541
RGD:407984842
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cat
catalase
treatment
IEP
RGD
PMID:24445072
RGD:405255657
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cchcr1
coiled-coil alpha-helical rod protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,205,676...3,218,308
G
Cd4
Cd4 molecule
IEP
protein:decreased expression:spleen (rat)
RGD
PMID:25678251
RGD:407446373
NCBI chr 4:159,355,147...159,381,636
Ensembl chr 4:157,668,878...157,695,191
G
Cd55
CD55 molecule (Cromer blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:41,857,395...41,885,831
G
Cd8a
CD8 subunit alpha
IEP
protein:increased expression:spleen (rat)
RGD
PMID:25678251
RGD:407446373
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:103,365,804...103,370,040
G
Cdh13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:46,349,430...47,387,459
G
Cdk5
cyclin-dependent kinase 5
ISO
protein:increased expression:ventral tegmental area, nucleus accumbens (mouse)
RGD
PMID:28782589
RGD:401900303
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Cfh
complement factor H
ISO IEP
protein:increased expression:serum: protein:increased expression:serum, hippocampus:
RGD
PMID:22871478 PMID:22871478
RGD:7364944 , RGD:7364944
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:51,511,828...51,613,838
G
Col28a1
collagen type XXVIII alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 4:37,036,303...37,189,435
Ensembl chr 4:36,069,970...36,223,220
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:cd: p.V158M (human) DNA:SNPs,haplotypes:exon,3'utr: (rs4680, rs165599) (human) ClinVar Annotator: match by term: methamphetamine use disorder
CTD ClinVar RGD
PMID:15274053 PMID:25741868 PMID:33544778 PMID:21934638 PMID:17187009 PMID:15274053 More...
RGD:401959602 , RGD:401940147 , RGD:401940150 , RGD:401940124
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO IEP
protein:increases activity:ventral tegmental area, nucleus accumbens (mouse) mRNA:decreased expression:nucleus accumbens protein:increased expression, increased phosphorylation:nucleus accumbens, ventral tegmental area
RGD
PMID:28782589 PMID:33961872 PMID:31900897
RGD:401900303 , RGD:596936246 , RGD:401938636
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Csmd1
CUB and Sushi multiple domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr16:78,920,549...80,520,710
Ensembl chr16:72,218,503...73,817,614
G
Cubn
cubilin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr17:81,293,619...81,501,694
Ensembl chr17:76,385,060...76,593,231
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18280655
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Dcstamp
dendrocyte expressed seven transmembrane protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:70,807,581...70,822,078
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18363855 PMID:19444617
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18363855 PMID:18555060 PMID:19940168
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19940168
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15274053
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19598248
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
Fhit
fragile histidine triad diadenosine triphosphatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr15:16,365,401...17,872,901
Ensembl chr15:13,934,995...15,442,340
G
Fkbp15
FKBP prolyl isomerase family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:80,766,356...80,830,622
Ensembl chr 5:75,750,787...75,814,990
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus accumbens,striatum mRNA:increased expression:nucleus accumbens
CTD RGD
PMID:19689456 PMID:18834549 PMID:24183790
RGD:405255667 , RGD:405100720
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO IEP
protein:increased expression:ventral tegmental area, nucleus accumbens (mouse) associated with stress related disorder;protein:increased expression:brain (rat)
RGD
PMID:28782589 PMID:27672362 PMID:31373119
RGD:401900303 , RGD:401901183 , RGD:401900735
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility
ISO
DNA:SNPs, halotypes:intron (rs2076483,rs29221,rs715044) (human)
RGD
PMID:30143926
RGD:401940101
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
sexual_dimorphism
ISO
CTD Direct Evidence: marker/mechanism DNA:missense mutation:exon 8:p.K289M (rs4480617) (human)
CTD RGD
PMID:15772696 PMID:14569258
RGD:402528887
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gad1
glutamate decarboxylase 1
susceptibility
ISO
DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
susceptibility
ISO
DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gdnf
glial cell derived neurotrophic factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus accumbens, ventral tegmental area
CTD RGD
PMID:17356005 PMID:37904065 PMID:23432945
RGD:596938173 , RGD:405850210
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
IEP
methamphetamine abuse;protein:increased expression:hippocampal formation, striatum, prefrontal cortex (rat)
RGD
PMID:37778205
RGD:405100237
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IMP
RGD
PMID:16311338
RGD:596933067
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
Gstm1
glutathione S-transferase mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19254865
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18186040 PMID:19254865
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Hdac8
histone deacetylase 8
IEP
mRNA:decreased expression:striatum (rat)
RGD
PMID:25452209
RGD:9681719
NCBI chr X:71,425,240...71,632,865
Ensembl chr X:67,385,289...67,592,923
G
Hs3st4
heparan sulfate-glucosamine 3-sulfotransferase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 1:187,970,127...188,375,869
Ensembl chr 1:178,539,093...178,944,107
G
Htr1b
5-hydroxytryptamine receptor 1B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10780831
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19689456
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:151,296,662...151,311,912
G
Large1
LARGE xylosyl- and glucuronyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,603,129...12,048,930
G
Lingo2
leucine rich repeat and Ig domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:55,166,250...56,488,672
Ensembl chr 5:50,367,101...50,516,956
G
Map2k5
mitogen activated protein kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:63,625,221...63,851,983
G
Mb
myoglobin
ISO
RGD
PMID:12935649
RGD:458925289
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mtarc1
mitochondrial amidoxime reducing component 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:96,339,757...96,397,796
G
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr13:98,894,347...98,928,754
G
Myo5b
myosin Vb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr18:70,313,717...70,613,918
Ensembl chr18:68,038,759...68,338,745
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542708
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs7687423) (human)
CTD RGD
PMID:19566775 PMID:19566775
RGD:402463941
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP ISO
mRNA:increased expression:nucleus accumbens protein:increased expression:frontal cortex, striatum protein:altered expression:nucleus accumbens, ventral tegmental area
RGD
PMID:33961872 PMID:31693929 PMID:37904065 PMID:34273388
RGD:596936246 , RGD:597015747 , RGD:596938173 , RGD:596938171
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Oxt
oxytocin/neurophysin I prepropeptide
IEP
mRNA:increased expression:nucleus accumbens
RGD
PMID:28827541
RGD:407984842
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:117,782,650...117,783,490
G
Pcolce2
procollagen C-endopeptidase enhancer 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:96,193,461...96,251,114
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:116,799,971...117,367,696
G
Pde4d
phosphodiesterase 4D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:40,019,933...41,525,884
G
Pde6c
phosphodiesterase 6C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 1:245,322,015...245,377,874
Ensembl chr 1:235,909,775...235,965,315
G
Pdyn
prodynorphin
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:nucleus acccumbens mRNA:increased expression:nucleus accumbens mRNA:increased expression:central amygdaloid nucleus mRNA:altered expression:brain DNA:repeat:promoter:rs35286251 (human)
CTD RGD
PMID:16529859 PMID:27989838 PMID:22390687 PMID:12523490 PMID:16289352 PMID:16529859 More...
RGD:401851910 , RGD:401851043 , RGD:401850585 , RGD:401850564 , RGD:401850552
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:110,797,117...110,816,848
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15659235
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Pou5f1
POU class 5 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,223,129...3,227,891
G
Prdm2
PR/SET domain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:160,704,396...160,815,184
Ensembl chr 5:155,422,134...155,531,825
G
Prkaca
protein kinase cAMP-activated catalytic subunit alpha
treatment
IEP
protein:increased expression, increased phosphorylation:nucleus accumbens, ventral tegmental area
RGD
PMID:31900897
RGD:401938636
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:24,155,090...24,178,430
G
Prkg1
protein kinase cGMP-dependent 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:228,408,947...229,639,080
G
Prokr2
prokineticin receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20576534
NCBI chr 3:140,077,629...140,092,327
Ensembl chr 3:119,627,601...119,635,718
G
Psd3
pleckstrin and Sec7 domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr16:26,238,595...26,802,535
Ensembl chr16:21,465,639...22,034,547
G
Raly
RALY heterogeneous nuclear ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 3:163,766,183...163,830,726
Ensembl chr 3:143,306,300...143,370,539
G
Rapgef5
Rap guanine nucleotide exchange factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 6:144,588,162...144,822,908
Ensembl chr 6:138,437,991...138,679,936
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19689456
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rgs17
regulator of G-protein signaling 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 1:44,627,583...44,729,957
Ensembl chr 1:42,227,070...42,324,609
G
Serpina5
serpin family A member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 6:128,774,006...128,793,187
Ensembl chr 6:123,023,306...123,028,407
G
Sgcz
sarcoglycan zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr16:60,363,718...61,444,256
Ensembl chr16:53,660,502...54,735,193
G
Sh3rf3
SH3 domain containing ring finger 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr20:27,306,937...27,642,315
Ensembl chr20:26,765,015...27,099,257
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19689456
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Slc6a9
solute carrier family 6 member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17582620
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:131,374,542...131,408,728
G
Smyd3
SET and MYND domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr13:93,241,274...93,798,221
Ensembl chr13:90,709,270...91,266,253
G
Snca
synuclein alpha
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15542733 PMID:32278788 PMID:20551914
RGD:13506280
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Tph2
tryptophan hydroxylase 2
ISO
protein:decreased expression:hippocampus
RGD
PMID:26747301
RGD:597805906
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Trpm3
transient receptor potential cation channel, subfamily M, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 1:229,099,741...229,984,172
Ensembl chr 1:219,672,892...220,560,717
G
Usp48
ubiquitin specific peptidase 48
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr 5:155,083,520...155,151,208
Ensembl chr 5:149,800,179...149,867,719
G
Zfp385d
zinc finger protein 385D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr15:7,473,431...7,854,364
Ensembl chr15:5,042,572...5,423,367
G
Zfp423
zinc finger protein 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18316681
NCBI chr19:35,282,149...35,580,775
Ensembl chr19:19,110,238...19,407,373
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
mRNA:increased expression:hippocampal formation (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Clock
clock circadian regulator
ISO
mRNA:increased expression:hippocampal formation (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Cry1
cryptochrome circadian regulator 1
ISO
mRNA:increased expression:hippocampal formation (mouse)
RGD
PMID:15994025
RGD:405866347
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:18,529,823...18,594,091
G
Per1
period circadian regulator 1
ISO
mRNA:decreased expression: hippocampal formation, caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
ISO
mRNA:increased expression, decreased expression:hippocampal formation, caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Ache
acetylcholinesterase
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
IEP
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:226,797,303...226,808,892
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
IEP
mRNA:altered exxpression:liver (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591
G
Bdnf
brain-derived neurotrophic factor
IEP
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23588198
RGD:405849391
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Car3
carbonic anhydrase 3
IEP
associated with Alcoholic Liver Diseases;protein:decreased expression:liver
RGD
PMID:22545783
RGD:7495839
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Ccl2
C-C motif chemokine ligand 2
IEP
mRNA:increased expression:frontal cortex mRNA:increased expression:basal forebrain cholinergic neurons
RGD
PMID:23867237 PMID:37402853
RGD:597538460 , RGD:597538603
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Chat
choline O-acetyltransferase
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Crhr1
corticotropin releasing hormone receptor 1
IEP
mRNA:decreased expression:adenohypophysis
RGD
PMID:11045867
RGD:407431640
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
Cybb
cytochrome b-245 beta chain
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:13,359,430...13,392,586
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO IEP
associated with Alcoholic Liver Diseases;protein:increased expression:liver mRNA:altered exxpression:liver (rat) protein:increased expression, increased nitration
RGD
PMID:25236742 PMID:22545783 PMID:23413777 PMID:29404485 PMID:25236742
RGD:14700891 , RGD:7495839 , RGD:405100715 , RGD:14700911 , RGD:14700891
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dnmt1
DNA methyltransferase 1
ISO
protein:increased expression:nucleus accumbens:
RGD
PMID:23423140
RGD:9588287
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Drd1
dopamine receptor D1
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IEP
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
susceptibility
ISO IEP
DNA:repeats:exon: mRNA:altered exxpression:spleen (rat)
RGD
PMID:19393859 PMID:23413777
RGD:401960068 , RGD:405100715
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Efhd2
EF-hand domain family, member D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28397836
NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:154,160,946...154,176,980
G
Ehmt2
euchromatic histone lysine methyltransferase 2
IEP
mRNA:increased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547
G
Fn1
fibronectin 1
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
protein:increased expression:prefrontal cortex
RGD
PMID:29407478
RGD:405295494
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gabra1
gamma-aminobutyric acid type A receptor subunit alpha 1
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:26,595,160...26,650,864
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr X:155,301,979...155,543,870
Ensembl chr X:150,261,607...150,501,559
G
Gabra6
gamma-aminobutyric acid type A receptor subunit alpha6
IEP
mRNA:altered exxpression:spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr10:27,311,965...27,327,337
Ensembl chr10:26,810,423...26,825,769
G
Gdnf
glial cell derived neurotrophic factor
IMP IEP
protein:altered expression:amygdala, pyriform cortex, bed nucleus of stria terminalis
RGD
PMID:23298382 PMID:23588198
RGD:405849390 , RGD:405849391
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gpx1
glutathione peroxidase 1
IEP
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx3
glutathione peroxidase 3
IEP
protein:decreased expression:serum
RGD
PMID:25864381
RGD:401827870
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Gpx4
glutathione peroxidase 4
IEP
protein:decreased expression:liver
RGD
PMID:25864381
RGD:401827870
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Grm2
glutamate metabotropic receptor 2
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
Grm5
glutamate metabotropic receptor 5
IEP
associated with human immunodeficiency virus infectious disease;mRNA:altered expression:liver,spleen (rat)
RGD
PMID:23413777
RGD:405100715
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:141,312,368...141,882,274
G
Hmgb1
high mobility group box 1
ISO IEP
mRNA, protein:increased expression:brain mRNA:increased expression:basal forebrain cholinergic neurons
RGD
PMID:23206318 PMID:37402853
RGD:7175526 , RGD:597538603
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Il1b
interleukin 1 beta
IEP
mRNA:increased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Lhx8
LIM homeobox 8
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr 2:245,904,712...245,929,376
Ensembl chr 2:243,244,961...243,269,416
G
Mir125a
microRNA 125a
IEP
RNA:decreased expression:neuron
RGD
PMID:27085842
RGD:26884454
NCBI chr 1:67,350,675...67,350,759
Ensembl chr 1:58,677,626...58,677,710
G
Mir223
microRNA 223
ISO
RNA:increased expression:serum RNA:increased expression:serum, neutrophil,liver
RGD
PMID:27679493 PMID:27679493
RGD:21408575 , RGD:21408575
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:61,141,887...61,141,996
G
Mt-co2
mitochondrially encoded cytochrome c oxidase II
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
G
Myd88
MYD88, innate immune signal transduction adaptor
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Ngfr
nerve growth factor receptor
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:80,515,299...80,533,518
G
Npy1r
neuropeptide Y receptor Y1
ameliorates
ISO
protein:decreased expression:central amygdaloid nucleus (mouse)
RGD
PMID:30647448 PMID:22218088
RGD:402463940 , RGD:405096664
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IMP
RGD
PMID:22500955
RGD:408361838
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntsr2
neurotensin receptor 2
IEP
mRNA,protein:altered expression:anterior paraventricular nucleus of thalamus
RGD
PMID:32623746
RGD:596948426
NCBI chr 6:45,153,095...45,159,783
Ensembl chr 6:39,424,324...39,431,014
G
Oprl1
opioid related nociceptin receptor 1
ISO
RGD
PMID:29197086
RGD:14348965
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Per2
period circadian regulator 2
ISO
DNA, mRNA:hypermethylation, decreased expression:blood
RGD
PMID:30597578
RGD:405878075
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pomc
proopiomelanocortin
ISO IEP
DNA, mRNA:hypermethylation, decreased expression:blood protein:decreased expression:central amygdaloid nucleus, arcuate and paraventricular nucleus of hypothalamus mRNA:decreased expression:hypothalamus
RGD
PMID:30597578 PMID:23792540 PMID:11045867
RGD:405878075 , RGD:407571694 , RGD:407431640
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rest
RE1-silencing transcription factor
IEP
mRNA:increased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:30,862,553...30,894,354
G
S100b
S100 calcium binding protein B
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Sirt1
sirtuin 1
IEP
RGD
PMID:24416161
RGD:9495933
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Slc18a3
solute carrier family 18 member A3
IEP
mRNA:decreased expression:basal forebrain cholinergic neurons
RGD
PMID:37402853
RGD:597538603
NCBI chr16:7,719,953...7,722,814
G
Slc23a2
solute carrier family 23 member 2
IEP
RGD
PMID:27085842
RGD:26884454
NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:119,302,666...119,460,343
G
Tlr2
toll-like receptor 2
sexual_dimorphism
ISO
mRNA, protein:increased expression:brain mRNA:increased expression:adipose tissue
RGD
PMID:23206318 PMID:27711160
RGD:7175526 , RGD:407424601
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr3
toll-like receptor 3
ISO
mRNA, protein:increased expression:brain
RGD
PMID:23206318
RGD:7175526
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
ISO
mRNA, protein:increased expression:brain
RGD
PMID:23206318
RGD:7175526
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:23867237
RGD:597538460
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tph2
tryptophan hydroxylase 2
susceptibility
ISO
DNA:SNPs: :rs7963717, rs11178999, rs17110451
RGD
PMID:29697747
RGD:597621695
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19625010
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Apol2
apolipoprotein L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:109,331,392...109,338,558
G
Bche
butyrylcholinesterase
ISO
protein:increased activity:blood plasma (human)
RGD
PMID:30707402
RGD:401960085
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bdnf
brain-derived neurotrophic factor
IEP
protein:decreased expression:frontal cortex, hippocampus
RGD
PMID:22083592
RGD:597015776
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Calm1
calmodulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:12,845,170...12,857,830
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Cnr1
cannabinoid receptor 1
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19016476 PMID:21187978
RGD:596933102
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
susceptibility onset
ISO
DNA:SNP:cd: p.V158M (human) associated with alcohol use disorder; DNA:hypermethylation:promoter
RGD
PMID:19259017 PMID:33781176 PMID:30790675
RGD:401959590 , RGD:401959741 , RGD:401959592
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Drd4
dopamine receptor D4
susceptibility
ISO
DNA:duplication:promoter: 120bp repeat
RGD
PMID:33544778
RGD:401959602
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:37,412,146...37,440,287
G
Gcc1
GRIP and coiled-coil domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,032,314...57,042,663
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IMP
RGD
PMID:21187978
RGD:596933102
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IMP
RGD
PMID:21187978
RGD:596933102
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Ngf
nerve growth factor
ISO
protein:decreased expression:serum
RGD
PMID:18774699
RGD:401965396
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nrg1
neuregulin 1
ISO
associated with schizophrenia;protein:increased expression:blood:
RGD
PMID:30799217
RGD:405112241
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP
protein:decreased expression:hippocampus
RGD
PMID:22083592
RGD:597015776
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:31,296,156...31,362,647
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
DNA:SNP: :3435C>T (rs1045642) (human)
RGD
PMID:19625010
RGD:401901192
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Ache
acetylcholinesterase
susceptibility
ISO
protein:increased activity:blood DNA:SNP:3'UTR:rs17228602 (human)
RGD
PMID:31129131 PMID:31129131
RGD:405855848 , RGD:405855848
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Comt
catechol-O-methyltransferase
ISO
DNA:hypermethylation:promoter
RGD
PMID:24902721
RGD:401940112
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Hcrt
hypocretin neuropeptide precursor
ISO
mRNA:increased expression:blood (human)
RGD
PMID:22846875
RGD:401960066
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Nrg1
neuregulin 1
susceptibility
ISO
DNA:SNP: :rs17664708(human)
RGD
PMID:22520967
RGD:405115756
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Bche
butyrylcholinesterase
severity
ISO
RGD
PMID:21540357
RGD:401960084
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bdnf
brain-derived neurotrophic factor
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:31280332
RGD:596948400
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
mRNA:decreased expression:caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:167,331,633...167,430,231
G
Cartpt
CART prepropeptide
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:15009677
RGD:597805894
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Ccl5
C-C motif chemokine ligand 5
severity
ISO
RGD
PMID:21806491
RGD:401794583
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Cd40lg
CD40 ligand
severity
ISO
RGD
PMID:21806491
RGD:401794583
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:135,126,969...135,138,306
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
onset
ISO
DNA:SNP:exon:rs16969968(human)
RGD
PMID:32841724
RGD:150530292
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
susceptibility
ISO
DNA:SNP::rs892413(human)
RGD
PMID:24675634
RGD:405849277
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
onset
ISO
DNA:SNP::rs950776(human)
RGD
PMID:32841724
RGD:150530292
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027
G
Clock
clock circadian regulator
ISO
mRNA:increased expression:caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:31,908,566...31,990,400
G
Creb1
cAMP responsive element binding protein 1
ISO IDA
protein:increased expression, increased phosphorylation:prefrontal cortex
RGD
PMID:24205196 PMID:18001273
RGD:401940185 , RGD:401959587
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Cry1
cryptochrome circadian regulator 1
ISO
mRNA:decreased expression:caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866347
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:18,529,823...18,594,091
G
Fgf2
fibroblast growth factor 2
IEP
mRNA:increased expression:nucleus accumbens (rat)
RGD
PMID:27114539
RGD:405855871
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fkbp5
FKBP prolyl isomerase 5
sexual_dimorphism
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:31029877
RGD:401976486
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
RGD
PMID:28366798
RGD:405100962
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
IEP ISO
associated with alcohol dependence;protein:increased expression: caudate-putamen (rat)
RGD
PMID:17572394 PMID:9294222
RGD:401900302 , RGD:407446380
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
sexual_dimorphism
ISO IEP
protein:increased expression:prefrontal cortex (mouse) protein:increased expression:nucleus accumbens (rat) protein:decreased expression:nucleus accumbens (mouse)
RGD
PMID:33497752 PMID:11801363 PMID:22197517
RGD:401976469 , RGD:405650201 , RGD:405650197
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Hcrt
hypocretin neuropeptide precursor
treatment
ISO
RGD
PMID:29454841
RGD:401960065
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Htr1a
5-hydroxytryptamine receptor 1A
IEP
protein:decreased expression:dentate gyrus, hypothalamus
RGD
PMID:9723786
RGD:401900605
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
IEP IMP
mRNA:increased expression:orbitofrontal cortex
RGD
PMID:27733540 PMID:20814782 PMID:11259563
RGD:401900753 , RGD:401901179 , RGD:401900755
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
treatment
IMP
RGD
PMID:20814782
RGD:401901179
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Mapk1
mitogen activated protein kinase 1
IDA
protein:increased phosphorylation:nucleus accumbens
RGD
PMID:25522720
RGD:401851063
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
IDA
protein:increased phosphorylation:nucleus accumbens
RGD
PMID:25522720
RGD:401851063
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mb
myoglobin
ISO
protein:increased expression:umbilical cord blood
RGD
PMID:8989474
RGD:458925290
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Npas2
neuronal PAS domain protein 2
ISO
mRNA:decreased expression:hippocampal formation,caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866347
NCBI chr 9:48,959,225...49,138,036
Ensembl chr 9:41,463,830...41,642,320
G
Npy1r
neuropeptide Y receptor Y1
susceptibility
ISO
DNA:SNP:intron: (rs4518200) (human)
RGD
PMID:33242852
RGD:402463938
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IMP ISO
mRNA:decreased expression:blood
RGD
PMID:12805318 PMID:29761890 PMID:9765324
RGD:401976288 , RGD:407987269 , RGD:401976376
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:27576164 PMID:31280332
RGD:596948399 , RGD:596948400
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Pdyn
prodynorphin
IEP
mRNA:increased expression:caudate putamen mRNA:increased expression:central amygdaloid nucleus, dentate gyrus of hippocampal formation
RGD
PMID:7694032 PMID:12523490
RGD:401850578 , RGD:401850585
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Per1
period circadian regulator 1
ISO
mRNA:increased expression:hippocampal formation, caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
ISO
mRNA:increased expression, decreased expression:hippocampal formation, caudate-putamen (mouse)
RGD
PMID:15994025
RGD:405866348
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Prl
prolactin
treatment
ISO
RGD
PMID:17391744
RGD:401960113
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Tlr2
toll-like receptor 2
ISO
protein:increased expression:striatum, microglial cell
RGD
PMID:26860188
RGD:597538483
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Acvr2a
activin A receptor type 2A
ameliorates
IMP
RGD
PMID:26030849
RGD:597830060
NCBI chr 3:53,614,143...53,701,933
Ensembl chr 3:33,205,523...33,289,968
G
Ankk1
ankyrin repeat and kinase domain containing 1
treatment
ISO
DNA:SNP: :rs1800497(human)
RGD
PMID:23635803
RGD:401959203
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Arc
activity-regulated cytoskeleton-associated protein
ISO
protein:increased expression:dorsal striatum, shell of nucleus accumbens (mouse)
RGD
PMID:27567310
RGD:401901591
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Avp
arginine vasopressin
IEP
protein:increased expression:nucleus accumbens
RGD
PMID:19596360
RGD:408426004
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bdnf
brain-derived neurotrophic factor
ISO IMP
RGD
PMID:14973246 PMID:18990365
RGD:401965389 , RGD:596933098
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Camk4
calcium/calmodulin-dependent protein kinase IV
no_association
ISO
DNA:SNP: :rs919334 DNA:SNPs: :rs1457115, rs9285875
RGD
PMID:19001277 PMID:19001277
RGD:401938643 , RGD:401938643
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Ccser1
coiled-coil serine-rich protein 1
susceptibility
ISO
DNA:SNP:: (rs1381355) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 4:91,483,896...92,720,439
Ensembl chr 4:90,292,780...91,388,786
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility
ISO
DNA:missense:exons:p.R37H,p.E363D(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrnb3
cholinergic receptor nicotinic beta 3 subunit
susceptibility
ISO
DNA:missense:exons:multiple(human)
RGD
PMID:24057674
RGD:405849397
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:64,714,169...64,751,360
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
DNA:SNPs,haplotypes:exon: p.V158M (rs4680, rs737865, rs165688) (human)
RGD
PMID:18704099
RGD:401959302
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment sexual_dimorphism no_association
IEP IDA ISO
protein:increased phosphorylation:nucleus accumbens protein:increased phosphorylation:nucleus accumbens, prefrontal cortex DNA:SNPs: :rs10876469, rs2177000
RGD
PMID:27664298 PMID:25522720 PMID:23665060 PMID:19001277
RGD:401900166 , RGD:401851063 , RGD:401851078 , RGD:401938643
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Drd2
dopamine receptor D2
sexual_dimorphism treatment
IMP ISO
female only;DNA:SNP: :rs2283265(human)
RGD
PMID:29454035 PMID:30367264 PMID:23635803
RGD:13506950 , RGD:401959597 , RGD:401959203
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Egr1
early growth response 1
treatment
IEP
RGD
PMID:26674058
RGD:405100964
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment severity
IEP
protein:increased expression:habenula mRNA:increased expression:brain protein:increased expression:brain
RGD
PMID:26674058 PMID:29139213 PMID:18488248 PMID:18310906 PMID:24633559
RGD:405100964 , RGD:401900161 , RGD:401959615 , RGD:405101699 , RGD:405100965
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
treatment ameliorates
IEP ISO
protein:increased expression:Nucleus Accumbens, Caudate Putamen (rat) protein:increased expression:dorsal striatum, nucelus accumbens (mouse) mRNA,protein:increased expression:Nucleus Accumbens, Caudate Putamen (rat) protein:increased expression:Brain (rat)
RGD
PMID:25522720 PMID:27380261 PMID:20633205 PMID:27664298 PMID:22403532 PMID:23665060 More...
RGD:401851063 , RGD:401901287 , RGD:401900126 , RGD:401900166 , RGD:401851084 , RGD:401851078
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility
ISO
DNA:SNP:intron: C>G (rs29220) (human) mRNA:decreased expression:hippocampus (human)
RGD
PMID:22253714 PMID:26727527
RGD:401900163 , RGD:11552767
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO
mRNA:decreased expression:hippocampus (human)
RGD
PMID:22253714
RGD:401900163
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gad1
glutamate decarboxylase 1
ISO
mRNA:decreased expression:hippocampus
RGD
PMID:22253714
RGD:401900163
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
ISO
mRNA:decreased expression:hippocampus
RGD
PMID:22253714
RGD:401900163
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
treatment exacerbates
IMP IEP ISO
protein:increased expression:nucleus accumbens (rat) protein:increased expression, increased phosphorylation:hippocampal formation, postsynaptic density (mouse) protein:increased expression:nucleus accumbens cell surface (rat) protein:increased phosphorylation:prefrontal cortex, premotor cortex (rat) protein:increased phosphorylation:hippocampal formation (mouse) protein:increased expression:ventral tegmental area (rat)
RGD
PMID:18430032 PMID:18500330 PMID:22127928 PMID:16794574 PMID:29089442 PMID:16207873 PMID:28495973 PMID:17439498 PMID:18554320 PMID:29196318 PMID:25539504 PMID:21613507 More...
RGD:405096666 , RGD:408364954 , RGD:405820210 , RGD:405820206 , RGD:405818277 , RGD:405818274 , RGD:405650670 , RGD:405650586 , RGD:405649734 , RGD:405649733 , RGD:405649730 , RGD:405100712
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
treatment
IMP
RGD
PMID:20555310
RGD:408364961
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:CDS:p.Ile105Val
RGD
PMID:16272961
RGD:597621685
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
ISO IMP
DNA:SNP: :rs6561333
RGD
PMID:23241418 PMID:15849375 PMID:23336050
RGD:401900299 , RGD:401900756 , RGD:401900743
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
treatment
IMP
RGD
PMID:23336050
RGD:401900743
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
DNA:SNPs, haplotype:exon, intron: (rs1985242, rs2276302, rs4938066) (human) DSNA:SNP:intron:g.113985089A>G (rs897687) (human)
RGD
PMID:24590108 PMID:26227246
RGD:404976878 , RGD:405096480
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Klhl5
kelch-like family member 5
susceptibility
ISO
DNA:SNP:: (rs1046655) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,144,257...43,184,238
G
Lrrc7
leucine rich repeat containing 7
susceptibility
ISO
DNA:SNP: (rs1938584) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr 2:249,792,441...250,294,267
Ensembl chr 2:247,147,752...247,634,547
G
Manea
mannosidase, endo-alpha
susceptibility
ISO
DNA:SNPs:multiple
RGD
PMID:19255376
RGD:401851915
NCBI chr 5:44,992,937...45,015,084
Ensembl chr 5:40,196,396...40,218,459
G
Mapk1
mitogen activated protein kinase 1
IDA
protein:increased phosphorylation:brain
RGD
PMID:23665060
RGD:401851078
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
IDA
protein:increased phosphorylation:brain
RGD
PMID:23665060
RGD:401851078
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Ngf
nerve growth factor
ISO
protein:decreased expression:serum
RGD
PMID:17715210
RGD:401976440
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP
mRNA:decreased expression:adenohypophysis
RGD
PMID:12892653
RGD:408345227
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IMP
RGD
PMID:18990365 PMID:31417375 PMID:27488635
RGD:596933098 , RGD:596933359 , RGD:596933099
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
susceptibility treatment
ISO
DNA:SNP,haplotype:intron 1 (rs2298896|rs421300), multiple GCAAT (human) DNA:SNPs, haplotype:intron 1 (rs2298896|rs421300) (human) associated with alcohol use disorder; DNA:SNP:intron (rs678849) (human) associated with opiate dependence;DNA:SNP:intron (rs678849) (human) DNA:SNP:intron,cds (rs678849,rs2234918) (human)
RGD
PMID:17622222 PMID:24533225 PMID:27449273 PMID:33953123 PMID:22795689
RGD:401976552 , RGD:402525443 , RGD:402463960 , RGD:402463937 , RGD:401976559
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
ISO
DNA:SNPs:intron:rs6473797, rs10111937
RGD
PMID:34843875
RGD:401851040
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29992335
RGD:401831041
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
susceptibility
ISO
DNA, mRNA:SNPs, haplotype:3' utr:rs910080, rs910079, rs2235749 (human) mRNA:increased expression:nucleus accumbens mRNA:increased expression:caudate-putamen DNA:VNTR:Promoter
RGD
PMID:18923396 PMID:22390687 PMID:23164614 PMID:16184603
RGD:401850550 , RGD:401851043 , RGD:401850589 , RGD:401850583
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Per2
period circadian regulator 2
susceptibility
ISO
DNA:repeats::
RGD
PMID:22832851
RGD:401976513
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Ppbp
pro-platelet basic protein
ISO
protein:increased expression:plasma
RGD
PMID:21806491
RGD:401794583
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,302,326...17,303,130
G
Prl
prolactin
severity
ISO
protein:decreased expression:blood serum (human) protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human)
RGD
PMID:16915581 PMID:2243892 PMID:15064918
RGD:401959377 , RGD:401960099 , RGD:401959381
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
IEP
protein:increased expression:brain
RGD
PMID:9789813
RGD:405255653
NCBI chr 1:190,433,501...190,457,241
Ensembl chr 1:181,010,305...181,026,648
G
Sirt1
sirtuin 1
IEP
protein:increased expression:brain, nucleus accumbens (rat)
RGD
PMID:27664298
RGD:401900166
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Sirt2
sirtuin 2
treatment
IEP
RGD
PMID:27664298
RGD:401900166
NCBI chr 1:93,181,472...93,204,499
Ensembl chr 1:84,052,903...84,076,975
G
Smad3
SMAD family member 3
ameliorates
IMP
RGD
PMID:27422367 PMID:26030849
RGD:597830063 , RGD:597830060
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
ameliorates
IMP
RGD
PMID:27422367
RGD:597830063
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975
G
Tenm3
teneurin transmembrane protein 3
susceptibility
ISO
DNA:SNP:: (rs1514483) (human)
RGD
PMID:18438686
RGD:401851917
NCBI chr16:47,984,732...50,711,352
Ensembl chr16:41,252,182...43,978,594
G
Tph2
tryptophan hydroxylase 2
treatment
ISO
DNA:SNP: :rs4290270
RGD
PMID:22925276
RGD:597805898
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Abat
4-aminobutyrate aminotransferase
treatment
IMP
RGD
PMID:22128851
RGD:9588542
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:6,999,819...7,092,835
G
Ago2
argonaute RISC catalytic component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Apol2
apolipoprotein L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:109,331,392...109,338,558
G
Arc
activity-regulated cytoskeleton-associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18311559
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Atp9b
ATPase phospholipid transporting 9B (putative)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr18:76,451,821...76,643,931
Ensembl chr18:74,176,863...74,368,953
G
Avp
arginine vasopressin
susceptibility
ISO
DNA:SNP:intron: (rs2282018) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18292872 PMID:18514640 PMID:20060817 PMID:20971807 PMID:22935511 PMID:22960160 PMID:23000451 PMID:25814464 More...
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bdnf
brain-derived neurotrophic factor
severity susceptibility
ISO IMP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:14973246 PMID:17618281 PMID:17651427 PMID:18311559 PMID:19321768 PMID:20711185 PMID:20810894 PMID:23583595 PMID:23583595 More...
RGD:38501054 , RGD:38501054
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bdnfem1Sage
brain-derived neurotrophic factor; ZFN induced mutant 1, Sage
severity
IMP
RGD
PMID:23583595
RGD:38501054
G
Calm1
calmodulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:12,845,170...12,857,830
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14725635
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Camk4
calcium/calmodulin-dependent protein kinase IV
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19001277
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Cartpt
CART prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20886038
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cckbr
cholecystokinin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9922984
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:159,771,733...159,814,881
G
Ccser1
coiled-coil serine-rich protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 4:91,483,896...92,720,439
Ensembl chr 4:90,292,780...91,388,786
G
Cdk5
cyclin-dependent kinase 5
ISO
RGD
PMID:11268215
RGD:734739
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:10,754,687...10,760,112
G
Ces1d
carboxylesterase 1D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12679808 PMID:12773168
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:13,796,623...13,912,035
G
Ces2h
carboxylesterase 2H
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19710369
NCBI chr19:49,884,164...49,898,764
Ensembl chr19:32,974,242...32,988,830
G
Cfl1
cofilin 1
IEP
protein:altered expression:striatum (rat)
RGD
PMID:27018876
RGD:11568696
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:202,786,627...202,817,587
G
Chrm5
cholinergic receptor, muscarinic 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:13130510
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:99,284,846...99,337,252
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16314880 PMID:17596442 PMID:19052543
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18704099
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11717377 PMID:16359811 PMID:18596687
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP ISO
mRNA:decreased expression:hypothalamus (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7796157 PMID:10516337 PMID:11797056 PMID:18596687 PMID:19349312 PMID:12782395 More...
RGD:5508177
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Crhbp
corticotropin releasing hormone binding protein
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:3'UTR: (rs1875999) (HUMAN)
CTD RGD
PMID:17437087 PMID:24766650
RGD:401976505
NCBI chr 2:28,427,139...28,439,446
Ensembl chr 2:26,692,403...26,704,710
G
Crhr1
corticotropin releasing hormone receptor 1
IEP ISO
mRNA:increased expression:anterior pituitary (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19339610 PMID:12576179
RGD:5508175
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17437087
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:84,224,002...84,265,904
G
Dnah8
dynein, axonemal, heavy chain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr20:8,694,371...8,948,849
Ensembl chr20:8,692,963...8,946,772
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15295029 PMID:16014726 PMID:16541082 PMID:20456009
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IDA ISO
protein:increased activity:caudate putamen (rat) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10900248 PMID:11751029 PMID:11923462 PMID:15010698 PMID:15042275 PMID:16541082 PMID:16971900 PMID:17332411 PMID:18418874 PMID:20494958 PMID:18284941 More...
RGD:2311586
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:10523822 PMID:15100700 PMID:17332411 PMID:18566292 PMID:20494958
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Egr1
early growth response 1
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:16157275 PMID:16738229 PMID:18311559 PMID:25309368 PMID:21309948
RGD:10395309 , RGD:10400880
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20056891
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17133264
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:37,412,146...37,440,287
G
Fgf2
fibroblast growth factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19014962
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:brain
CTD RGD
PMID:17276011 PMID:18311559 PMID:19533625 PMID:14741756
RGD:405255650
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:12657709 PMID:17898221 PMID:18539927 PMID:19331462
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
ameliorates
ISO
RGD
PMID:35185557
RGD:408345254
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19833324 PMID:20133874
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gad1
glutamate decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Galr1
galanin receptor 1
susceptibility
ISO
DNA:SNP:intron: (rs2717162) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:75,772,023...75,787,577
G
Gcc1
GRIP and coiled-coil domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,032,314...57,042,663
G
Gdnf
glial cell derived neurotrophic factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14622243 PMID:15899247
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17407494
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22253714
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
Gpsm1
G-protein signaling modulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15091342
NCBI chr 3:29,538,929...29,565,921
Ensembl chr 3:9,128,636...9,167,827
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14684464 PMID:15764012 PMID:16495937 PMID:18430032 PMID:18486119
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18945913
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16014726 PMID:20149346
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grk2
G protein-coupled receptor kinase 2
ISO
protein:decreased expression:prefrontal cortex (human)
RGD
PMID:23727505
RGD:13792719
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:201,581,480...201,601,582
G
Grk3
G protein-coupled receptor kinase 3
ISO
protein:decreased expression:prefrontal cortex (human)
RGD
PMID:23727505
RGD:13792719
NCBI chr12:49,285,228...49,395,803
Ensembl chr12:43,624,897...43,731,262
G
Grk5
G protein-coupled receptor kinase 5
ISO
protein:decreased expression:prefrontal cortex (human)
RGD
PMID:23727505
RGD:13792719
NCBI chr 1:270,014,314...270,208,294
Ensembl chr 1:260,028,242...260,218,701
G
Grm2
glutamate metabotropic receptor 2
IMP
knockout compared to wild type
RGD
PMID:28700935
RGD:38501064
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
Grm2em1
glutamate metabotropic receptor 2; endonuclease induced mutant 1
IMP
KO compared to wild-type rats
RGD
PMID:28700935
RGD:38501064
G
Grm5
glutamate metabotropic receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20826661
NCBI chr 1:150,722,711...151,297,585
Ensembl chr 1:141,312,368...141,882,274
G
Hcrt
hypocretin neuropeptide precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16357203
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Hcrtr1
hypocretin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16357203 PMID:19591850 PMID:19741128
NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:142,477,214...142,486,674
G
Hdac4
histone deacetylase 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17988634
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
G
Hdac5
histone deacetylase 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17988634
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
G
Homer1
homer scaffold protein 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16160706 PMID:16314758
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:24,543,093...24,644,785
G
Homer2
homer scaffold protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15545022
NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:135,567,414...135,659,772
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11853856
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9603521 PMID:17509084
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Cocaine-Related Disorders
CTD ClinVar
PMID:9635956 PMID:11259563 PMID:12476319 PMID:15364038 PMID:16300424 PMID:19212317 More...
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr3b
5-hydroxytryptamine receptor 3B
susceptibility
ISO
DNA:SNP:cds:rs1176744(human)
RGD
PMID:20838391
RGD:6480660
NCBI chr 8:58,175,785...58,204,939
Ensembl chr 8:49,279,173...49,308,444
G
Ice2
interactor of little elongation complex ELL subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 8:78,921,962...78,965,983
Ensembl chr 8:70,043,424...70,084,995
G
Ilk
integrin-linked kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18702665 PMID:19629758
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:160,088,897...160,095,140
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17898221
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Klhl5
kelch-like family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,144,257...43,184,238
G
Lhb
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12893845
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lrrc7
leucine rich repeat containing 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 2:249,792,441...250,294,267
Ensembl chr 2:247,147,752...247,634,547
G
Manea
mannosidase, endo-alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686 PMID:19255376
NCBI chr 5:44,992,937...45,015,084
Ensembl chr 5:40,196,396...40,218,459
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16407894 PMID:20692647
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20692647
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mecp2
methyl CpG binding protein 2
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20711185 PMID:20711185
RGD:12789445
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
Mir130a
microRNA 130a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 3:90,229,228...90,229,315
Ensembl chr 3:69,822,542...69,822,629
G
Mir136
microRNA 136
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 6:134,331,335...134,331,416
Ensembl chr 6:128,549,096...128,549,177
G
Mir137
microRNA 137
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 2:209,165,709...209,165,810
Ensembl chr 2:206,480,884...206,480,985
G
Mir138-1
microRNA 138-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 8:131,178,434...131,178,532
Ensembl chr 8:122,300,966...122,301,064
G
Mir148b
microRNA 148b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:134,421,398...134,421,494
G
Mir154
microRNA 154
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 6:134,574,352...134,574,435
Ensembl chr 6:128,752,947...128,753,030
G
Mir186
microRNA 186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:246,582,806...246,582,891
G
Mir212
microRNA 212
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20613834 PMID:20711185
NCBI chr10:60,521,740...60,521,850
Ensembl chr10:60,023,403...60,023,513
G
Mir301b
microRNA 301b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr11:97,384,033...97,384,110
Ensembl chr11:83,879,816...83,879,893
G
Mir324
microRNA 324
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr10:55,233,363...55,233,445
Ensembl chr10:54,734,678...54,734,766
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 6:134,321,142...134,321,238
Ensembl chr 6:128,538,902...128,538,998
G
Mir488
microRNA 488
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr13:73,216,541...73,216,619
Ensembl chr13:70,683,064...70,683,142
G
Mir500
microRNA 500
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr X:17,930,647...17,930,726
Ensembl chr X:15,258,768...15,258,859
G
Mir544
microRNA 544
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 6:134,564,935...134,565,012
Ensembl chr 6:128,743,530...128,743,607
G
Mir665
microRNA 665
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643829
NCBI chr 6:134,321,679...134,321,772
Ensembl chr 6:128,539,440...128,539,533
G
Ngf
nerve growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17715210
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nps
neuropeptide S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19339610 PMID:20974945 PMID:21466221
NCBI chr 1:199,505,772...199,510,915
Ensembl chr 1:190,077,040...190,080,821
G
Npsr1
neuropeptide S receptor 1
treatment
IMP
RGD
PMID:22982682
RGD:9831202
NCBI chr 8:30,882,830...31,107,425
Ensembl chr 8:22,606,946...22,831,558
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19063928
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:167,903,879...167,905,024
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12805318 PMID:19234455
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
susceptibility
ISO
DNA:SNP:intron: (rs1040288) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20826313 PMID:20947769
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprk1
opioid receptor, kappa 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18575850 PMID:20232055
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12815747 PMID:16893609 PMID:18762918
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
ISO IEP IMP
CTD Direct Evidence: marker/mechanism mRNA:altered expression:brain DNA:VNTR:promoter
CTD RGD
PMID:16184603 PMID:17559549 PMID:18575850 PMID:18923396 PMID:8840025 PMID:24816773 PMID:11992566 More...
RGD:401851906 , RGD:401850568 , RGD:401850567
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11750770 PMID:16520439 PMID:18201294 PMID:19279569
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15064918
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Prmt6
protein arginine methyltransferase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27506785
NCBI chr 2:200,615,780...200,620,790
Ensembl chr 2:197,927,220...197,933,648
G
Rhoa
ras homolog family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Rps6ka5
ribosomal protein S6 kinase A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16339038
NCBI chr 6:125,558,434...125,736,576
Ensembl chr 6:119,828,846...120,006,224
G
Runx2
RUNX family transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:31,296,156...31,362,647
G
Sigmar1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12736327 PMID:16132061
NCBI chr 5:61,700,021...61,702,799
Ensembl chr 5:56,904,159...56,907,017
G
Slc1a2
solute carrier family 1 member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19625514
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:11320258 PMID:11746736 PMID:16537431 PMID:19602552
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
susceptibility
ISO
protein:decreased activity: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11320258 PMID:20838391
RGD:6480660
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Smad1
SMAD family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr19:45,417,430...45,477,962
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27422367
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad5
SMAD family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,864,720...7,891,634
G
Smarca4
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27422367
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:20,167,717...20,258,975
G
Smurf1
SMAD specific E3 ubiquitin protein ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr12:14,748,717...14,840,273
Ensembl chr12:9,635,025...9,726,519
G
Snca
synuclein alpha
ISO
mRNA,protein:increased expression:dopamine neuron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18055133 PMID:12684441
RGD:6480198
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sncg
synuclein, gamma
IMP
RGD
PMID:20579003
RGD:6218958
NCBI chr16:9,706,765...9,712,072
Ensembl chr16:9,700,514...9,705,368
G
Srcin1
SRC kinase signaling inhibitor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27506785
NCBI chr10:82,999,295...83,066,359
Ensembl chr10:82,504,393...82,571,040
G
Syt13
synaptotagmin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 3:99,332,554...99,372,960
Ensembl chr 3:78,877,114...78,917,392
G
Tacr3
tachykinin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18422838
NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:223,266,536...223,363,791
G
Tenm3
teneurin transmembrane protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr16:47,984,732...50,711,352
Ensembl chr16:41,252,182...43,978,594
G
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 8:27,918,054...27,943,319
Ensembl chr 8:19,641,884...19,667,044
G
Abcb1a
ATP binding cassette subfamily B member 1A
treatment
ISO
DNA:polymorphisms: :2677G>T, ���1236C>T (human)
RGD
PMID:24455721
RGD:401901193
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Ache
acetylcholinesterase
susceptibility
ISO
DNA:SNP:3'UTR:rs17228602 (human)
RGD
PMID:31129131
RGD:405855848
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
associated with alcohol dependence;DNA:haplotype:exons:
RGD
PMID:18828801
RGD:401959320
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
associated with Trauma and Stressor Related Disorders;DNA:polymorphism:exon: p.V158M (human)
RGD
PMID:31150143
RGD:401940120
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP
ketamine
RGD
PMID:29476799
RGD:401938642
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
treatment
ISO
DNA:polymorphism: :785A>G (rs2279343), (human)
RGD
PMID:24455721
RGD:401901193
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Faah
fatty acid amide hydrolase
ISO
ClinVar Annotator: match by term: Drug addiction, susceptibility to
ClinVar
PMID:12060782 PMID:15254019 PMID:16972078 PMID:23556448 PMID:25741868
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:129,479,824...129,498,677
G
Ncam1
neural cell adhesion molecule 1
ISO
associated with alcohol dependence;DNA:haplotype:exon:
RGD
PMID:18828801
RGD:401959320
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Oprm1
opioid receptor, mu 1
ISO
DNA:SNP, haplotype:exon 1 (rs1799971) (human)
RGD
PMID:33402148
RGD:402528879
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Ttc12
tetratricopeptide repeat domain 12
ISO
associated with alcohol dependence;DNA:haplotype:exon:
RGD
PMID:18828801
RGD:401959320
NCBI chr 8:58,696,381...58,743,857
Ensembl chr 8:49,799,920...49,847,087
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
DNA:SNPs:exons :3435C>T (rs1045642), 1236C>T (rs1128503)(human)
RGD
PMID:23515680
RGD:401901187
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8527259
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11914425
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
susceptibility
ISO
DNA:SNPs:cds:rs3745274 (c.516G > T, Q172H), rs8192719 (21563 C > T) (human)
RGD
PMID:28184434
RGD:401901144
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
susceptibility
ISO
DNA:polymorphism: :CYP2D6*4(1846G>A)(human)
RGD
PMID:15349706
RGD:401901260
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Arrb2
arrestin, beta 2
IEP
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Drd2
dopamine receptor D2
IEP
RGD
PMID:26174132
RGD:11534754
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Gad1
glutamate decarboxylase 1
susceptibility
ISO IEP
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Oprm1
opioid receptor, mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,602,786...19,086,300
G
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Avp
arginine vasopressin
IEP
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bpifa1
BPI fold containing family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr 3:163,087,965...163,093,708
Ensembl chr 3:142,627,810...142,633,552
G
C3
complement C3
IEP
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
C5
complement C5
IEP
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
IEP
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,040,203...89,083,481
G
Dio3
iodothyronine deiodinase 3
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660
G
Dnmt1
DNA methyltransferase 1
IEP
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3b
DNA methyltransferase 3 beta
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:142,130,592...142,169,124
G
Drd2
dopamine receptor D2
IDA IEP
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Ehmt2
euchromatic histone lysine methyltransferase 2
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,919,624...3,941,547
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
treatment sexual_dimorphism
IEP ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
IEP
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
IMP IEP
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Hdac2
histone deacetylase 2
IEP
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:40,548,250...40,571,609
G
Hdac4
histone deacetylase 4
IEP
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:92,507,611...92,750,164
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
IEP
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
G
Igf1
insulin-like growth factor 1
IEP
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
IEP
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Mat2a
methionine adenosyltransferase 2A
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:104,488,466...104,495,493
G
Mecp2
methyl CpG binding protein 2
treatment
IEP
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
Mir326
microRNA 326
IEP
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 1:163,266,165...163,266,259
Ensembl chr 1:153,854,029...153,854,123
G
Mir9
microRNA 9
IEP
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr 9:1,167,436...1,167,545
Ensembl chr 9:1,080,274...1,080,383
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:58,220,071...58,304,822
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
sexual_dimorphism
IEP
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Oprk1
opioid receptor, kappa 1
IEP
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
IEP
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Pdyn
prodynorphin
IEP
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pnoc
prepronociceptin
IEP
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr15:43,800,240...43,827,841
Ensembl chr15:39,624,641...39,651,867
G
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Prl
prolactin
IEP
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Pten
phosphatase and tensin homolog
IEP
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:90,445,154...90,574,269
G
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:146,079,021...146,118,272
G
Setd7
SET domain containing 7, histone lysine methyltransferase
IEP
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:137,713,545...137,756,319
Ensembl chr 2:135,562,683...135,605,468
G
Slc25a12
solute carrier family 25 member 12
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:56,097,269...56,192,100
G
Slc6a4
solute carrier family 6 member 4
IEP
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Tlr4
toll-like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Ube3a
ubiquitin protein ligase E3A
treatment
IEP
RGD
PMID:23763370
RGD:13432044
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:110,070,480...110,157,250
G
Rhoa
ras homolog family member A
IEP
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Abat
4-aminobutyrate aminotransferase
IMP
RGD
PMID:10900239
RGD:10046064
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:6,999,819...7,092,835
G
Abcb1a
ATP binding cassette subfamily B member 1A
treatment
ISO
associated with methadone treatment;DNA:SNP:intron (rs1128503) (human)
RGD
PMID:29173032
RGD:401976557
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Ache
acetylcholinesterase
ISO
protein:increased activity:blood
RGD
PMID:31129131
RGD:405855848
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15717844
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adra1a
adrenoceptor alpha 1A
susceptibility
ISO
DNA:SNP:exon 4: p.R347C (rs1048101) (human)
RGD
PMID:33577997
RGD:401940110
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500
G
Akt1
AKT serine/threonine kinase 1
ameliorates
IMP
RGD
PMID:33619816
RGD:408346756
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh2
aldehyde dehydrogenase 2 family member
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:21723677
RGD:401959204
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Ankk1
ankyrin repeat and kinase domain containing 1
onset susceptibility
ISO
DNA:SNPS:exon:rs17115439, rs7118900, rs1800497 (human) DNA:SNPs:5'UTR,exon:rs877138, rs4938013(human) DNA:SNP:exon:rs1800497(human) DNA:SNPs, haplotypes:intron, 3'flanking:rs11214598, rs2859545(human)
RGD
PMID:28854834 PMID:23303482 PMID:23840506 PMID:29550268
RGD:401959202 , RGD:401959304 , RGD:401959223 , RGD:401959205
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Ap2m1
adaptor related protein complex 2 subunit mu 1
IEP
protein:increased expression:medial prefrontal cortex (rat)
RGD
PMID:19160503
RGD:529195970
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:80,328,041...80,364,140
G
Arrb2
arrestin, beta 2
treatment
ISO
DNA:polymorphism: :rs1045280(human) associated with methadone treatment;DNA:SNP:intron (rs1045280) (human)
RGD
PMID:33783060 PMID:29173032
RGD:401901593 , RGD:401976557
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
IEP
protein:decreased expression:medial prefrontal cortex (rat)
RGD
PMID:19160503
RGD:529195970
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:33,735,871...33,843,295
G
Bche
butyrylcholinesterase
ISO
protein:increased activity:blood plasma (human)
RGD
PMID:30707402
RGD:401960085
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bdnf
brain-derived neurotrophic factor
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:serum
CTD RGD
PMID:17715210 PMID:17715210
RGD:401976440
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Chrm2
cholinergic receptor, muscarinic 2
ISO
DNA:SNP:intron:rs2350780 (human)
RGD
PMID:19500151
RGD:5509583
NCBI chr 4:65,981,136...66,116,128
Ensembl chr 4:65,014,144...65,149,103
G
Cnr1
cannabinoid receptor 1
treatment
ISO
DNA:SNP: :rs806368
RGD
PMID:32481444
RGD:597805904
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
severity onset susceptibility
ISO
DNA:SNP:exon 5: (rs769224) (human) DNA:SNP:cd: p.V158M (human) DNA:SNP:: (rs737866) (Human) DNA:SNP:-287A>G (human) DNA:SNP:exon 1: (rs737866) (Human) DNA:SNP:exon 4: (rs4680) p.V158M (human)
RGD
PMID:33577997 PMID:33544778 PMID:23155402 PMID:12476424 PMID:21857968 PMID:20728009 More...
RGD:401940110 , RGD:401959602 , RGD:401959234 , RGD:401940154 , RGD:401940140 , RGD:401940113
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA ISO
DNA:SNP:exon:rs35349697
RGD
PMID:21362452 PMID:24704376 PMID:23062870
RGD:401901181 , RGD:401938627 , RGD:401901182
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Ctnnb1
catenin beta 1
IEP
protein:decreased expression:medial prefrontal cortex (rat)
RGD
PMID:19160503
RGD:529195970
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
treatment
ISO
DNA:polymorphisms: :785A>G (rs2279343), 516G>T (rs3745274)(human) DNA:SNP: :rs16974799
RGD
PMID:21790905 PMID:32481444
RGD:11097675 , RGD:597805904
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
treatment
ISO
DNA:SNP:exon:CYP2C19*2 (681G>A,rs4244285)(human) DNA:SNPs::CYP2C19*2, CYP2C19*3(human)
RGD
PMID:24016178 PMID:24956251
RGD:401960868 , RGD:401960881
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Drd1
dopamine receptor D1
IEP
RGD
PMID:28598964
RGD:13506959
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
susceptibility onset
ISO IEP
CTD Direct Evidence: marker/mechanism DNA:SNP:intron:rs1079597(human) DNA:SNPS:exon, intron:multiples(human)
CTD RGD
PMID:11751029 PMID:23840506 PMID:28854834 PMID:28598964
RGD:401959223 , RGD:401959202 , RGD:13506959
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
IEP
RGD
PMID:28598964
RGD:13506959
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
G
Drd4
dopamine receptor D4
susceptibility onset
ISO
DNA:SNPs:5promoter:rs1800955,rs936462(human) DNA:SNP,methylation::rs3758653(human) DNA:polymorphism:promoter:-521G>A(human)
RGD
PMID:23840506 PMID:34864042 PMID:18991844
RGD:401959223 , RGD:401959595 , RGD:401959594
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Fas
Fas cell surface death receptor
IEP
protein:increased expression:cerebral cortex (rat)
RGD
PMID:14530904
RGD:8686423
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fkbp5
FKBP prolyl isomerase 5
susceptibility
ISO
DNA:SNPs:intron,3'utr: (rs1360780,rs3800373) (human)
RGD
PMID:24845178
RGD:401976498
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ameliorates treatment
IDA IEP
RGD
PMID:21362452 PMID:17165513 PMID:23062870
RGD:401901181 , RGD:407571685 , RGD:401901182
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility
ISO
DNA:SNP:intron: C>G (rs29220) (human)
RGD
PMID:26727527
RGD:11552767
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabra2
gamma-aminobutyric acid type A receptor subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19833324
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,097,279...37,228,944
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
susceptibility
ISO
DNA:SNP:promoter:rs4906902(human) DNA:SNP::rs7165224(human)
RGD
PMID:25025424 PMID:19500151
RGD:405866341 , RGD:5509583
NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:108,296,124...108,698,961
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma 2
ISO
DNA:SNP:intron: (rs211014) (human)
RGD
PMID:17440936
RGD:402525444
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,374,694...26,464,346
G
Gad1
glutamate decarboxylase 1
treatment susceptibility
ISO
DNA:SNPs, haplotype:multiple: DNA:SNP,haplotype: :rs2058725(human) DNA:SNPs,haplotypes:promoter,exon:rs1978340, rs3791878, rs11542313 (human)
RGD
PMID:31866536 PMID:19500151 PMID:22564729
RGD:401900128 , RGD:5509583 , RGD:401900156
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
susceptibility
ISO
DNA:SNP: ::rs8190646(human)
RGD
PMID:19500151
RGD:5509583
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gdnf
glial cell derived neurotrophic factor
ISO
DNA:SNP: :rs2910709
RGD
PMID:24022000
RGD:405849398
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
treatment
ISO IEP
mRNA:increased expression:ventral striatum (human)
RGD
PMID:27863698 PMID:19940171
RGD:405096665 , RGD:4107717
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IEP
protein:decreased expression:medial prefrontal cortex (rat) protein:decreased expression:infralimbic area synaptosome (rat)
RGD
PMID:19160503 PMID:29134962
RGD:529195970 , RGD:596920311
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
IEP
protein:decreased expression:medial prefrontal cortex (rat)
RGD
PMID:19160503
RGD:529195970
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:120,238,534...120,504,096
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
susceptibility
ISO
DNA:repeats,SNPs,haplotype:introns:(GT)26, rs3219790,rs1102972,rs1650420,rs3104703 (human) DNA:repeats: :(GT)26 (human)
RGD
PMID:23940648 PMID:25366762
RGD:401938628 , RGD:401938629
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
IEP
protein:decreased expression:medial prefrontal cortex (rat)
RGD
PMID:19160503
RGD:529195970
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Grm2
glutamate metabotropic receptor 2
IMP
RGD
PMID:30283001
RGD:38501063
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
Grm2em1
glutamate metabotropic receptor 2; endonuclease induced mutant 1
IMP
KO compared to wild-type rats
RGD
PMID:30283001
RGD:38501063
G
Hcrt
hypocretin neuropeptide precursor
treatment
ISO
RGD
PMID:35984180
RGD:401960075
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
DSNA:SNPs:promoter, intron, CDS:g.113974819C>T, g.113985089A>G, g.113989703A>G (rs1150226, rs897687, rs1176713) (human) DNA:SNPs, haplotype:multiple (human)
RGD
PMID:26227246 PMID:19500151
RGD:405096480 , RGD:5509583
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
ISO
DNA:SNP: :rs2070995 (human)
RGD
PMID:20220551
RGD:6483055
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:34,061,708...34,308,758
G
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15717844
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Ngf
nerve growth factor
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:serum DNA:SNP:intron:rs2239622
CTD RGD
PMID:17715210 PMID:17715210 PMID:21358750
RGD:401976440 , RGD:401965390
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy1r
neuropeptide Y receptor Y1
susceptibility
ISO
DNA:SNP, haplotype:intron: (rs4234955) (human) DNA:SNP:intron: (rs4518200) (human)
RGD
PMID:29465008 PMID:24845178
RGD:402463944 , RGD:401976498
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
susceptibility
ISO
DNA:SNP, haplotype: :rs10482672
RGD
PMID:29465008
RGD:402463944
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
DNA:SNPs: :multiple
RGD
PMID:23651024
RGD:401938595
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
onset treatment
ISO
DNA:SNP: :rs508448 (human) associated with stress-related disorder;DNA:SNP:coding synonymous,intron (rs2234918, rs2236857) (human) associated with methadone treatment;DNA:SNP:intron (rs529520) (human) DNA:SNP, haplotype:intron 1 (multiple) (human) DNA:SNP, haplotype:multiple (multiple) (human) DNA:SNP:CDS:intron 1 (rs204047|rs797397) (human)
RGD
PMID:28692418 PMID:30171993 PMID:29173032 PMID:22500942 PMID:34031368 PMID:31907389 More...
RGD:401831045 , RGD:401977579 , RGD:401976557 , RGD:401976535 , RGD:401976533 , RGD:401976443
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
treatment
IMP ISO
DNA:SNP: :rs3802279, rs3802281, and rs963549 (human)
RGD
PMID:24725195 PMID:24305833 PMID:31940240
RGD:9831447 , RGD:401850592 , RGD:401827951
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
treatment
ISO
DNA:SNP: :rs2229205
RGD
PMID:32481444
RGD:597805904
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
susceptibility no_association severity
ISO
CTD Direct Evidence: marker/mechanism mRNA:splice variants:prefrontal cortex DNA:SNPs, haplotypes: :multiple DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:SNP, haplotype: :rs483481 (human) DNA:SNPs, haplotypes: :rs696522, rs1381376, rs3778151 (human)
CTD RGD
PMID:20201854 PMID:32506472 PMID:28692418 PMID:28976288 PMID:11424981 PMID:32189578 PMID:17157823 More...
RGD:401831047 , RGD:401831045 , RGD:401831044 , RGD:401827953 , RGD:401827950 , RGD:401827940
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
onset susceptibility no_association
ISO
DNA:repeat:promoter:rs35286251 (human) DNA:VNTR, SNPs:rs1022563, rs2235749, rs910080 (human) DNA:VNTR:promoter DNA:SNPs, repeat:promoter:rs2281285, rs2235749, rs35286251 (human) DNA:SNP: :rs910080 (human) mRNA:decreased expression:periamygdaloid cortex
RGD
PMID:30936032 PMID:21382455 PMID:30138645 PMID:29911117 PMID:29911117 PMID:35271823 PMID:24231353 More...
RGD:401850549 , RGD:401850577 , RGD:401850562 , RGD:401850561 , RGD:401850561 , RGD:401850556 , RGD:401850554
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
IMP
RGD
PMID:22683090
RGD:10003025
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
G
Pomc
proopiomelanocortin
treatment
ISO IDA IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18201294 PMID:6316060 PMID:23771528
RGD:407572514 , RGD:407431642
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15717844
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
Slc6a3
solute carrier family 6 member 3
IEP
RGD
PMID:28598964
RGD:13506959
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Th
tyrosine hydroxylase
onset
ISO
DNA:SNP:5'utr:(rs10770140) (human)
RGD
PMID:32736537
RGD:405866368
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Tph1
tryptophan hydroxylase 1
ISO
DNA:SNP: :rs1799913
RGD
PMID:18181017
RGD:597621691
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:97,157,409...97,178,344
G
Tph2
tryptophan hydroxylase 2
treatment
ISO
DNA:SNPs: :rs4290270, rs7963720 DNA:SNP: :rs1386493
RGD
PMID:18181017 PMID:32481444
RGD:597621691 , RGD:597805904
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Ttc12
tetratricopeptide repeat domain 12
susceptibility
ISO
DNA:SNP:5'UTR,intron:rs7130431(human)
RGD
PMID:23303482
RGD:401959304
NCBI chr 8:58,696,381...58,743,857
Ensembl chr 8:49,799,920...49,847,087
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
toluene
RGD
PMID:22074881
RGD:405101373
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Cnr1
cannabinoid receptor 1
ISO
RGD
PMID:9106242
RGD:1358448
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:plasma
RGD
PMID:16115302
RGD:5686674
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adipor2
adiponectin receptor 2
treatment
IEP ISO
RGD
PMID:26115886 PMID:18755807 PMID:27220557 PMID:22013387
RGD:25330099 , RGD:25824943 , RGD:25824939 , RGD:25440493
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Adra2a
adrenoceptor alpha 2A
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:28987868
RGD:407574728
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Aldh2
aldehyde dehydrogenase 2 family member
severity treatment susceptibility
IDA ISO
human transgene in mouse model protein:altered processing:liver (mouse) DNA:missense mutation:cds:p.E504K (human)
RGD
PMID:17058263 PMID:25457208 PMID:29156373 PMID:29063269
RGD:1599041 , RGD:15036811 , RGD:15036805 , RGD:14696776
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Ar
androgen receptor
severity
IEP
RGD
PMID:11447013
RGD:407424619
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arrb2
arrestin, beta 2
ameliorates
ISO
protein:increased expression:hepatocyte
RGD
PMID:33871024 PMID:33871024
RGD:401938594 , RGD:401938594
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Atg7
autophagy related 7
exacerbates ameliorates
ISO
RGD
PMID:31235522 PMID:34303881
RGD:407445921 , RGD:407445922
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:147,718,752...147,925,593
G
Bhmt
betaine-homocysteine S-methyltransferase
IEP
protein:increased expression:serum,liver
RGD
PMID:23083309
RGD:408425974
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Birc3
baculoviral IAP repeat-containing 3
ISO
protein:increased expression:liver (human)
RGD
PMID:29307797
RGD:153297819
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
C1qc
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35789393
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:149,127,415...149,131,017
G
C3
complement C3
severity ameliorates
IEP ISO
RGD
PMID:36653797 PMID:17321001
RGD:408395146 , RGD:408418721
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Car3
carbonic anhydrase 3
IEP
mRNA,protein:decreased expression:cytosol,liver
RGD
PMID:23083309
RGD:408425974
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:25557254 PMID:30611703
RGD:14995489 , RGD:407424594
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
treatment
ISO
RGD
PMID:25557254
RGD:14995489
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
disease_progression
ISO
RGD
PMID:27859576
RGD:14401742
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
treatment
IEP
RGD
PMID:23277536
RGD:407424596
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,335,340...28,337,261
G
Cd36
CD36 molecule
ISO
RGD
PMID:24280415
RGD:11041117
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd68
Cd68 molecule
treatment
IEP
RGD
PMID:23277536 PMID:29399060
RGD:407424596 , RGD:407424599
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697
G
Crp
C-reactive protein
IEP
protein:increased expression:serum:
RGD
PMID:21806828
RGD:9491781
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Ctsb
cathepsin B
IEP
protein:increased activity:liver, cytosol (rat)
RGD
PMID:17850215
RGD:2315516
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Cxcl1
C-X-C motif chemokine ligand 1
ameliorates
ISO
RGD
PMID:33710653
RGD:401976495
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26428356 PMID:25583360 PMID:24064383
RGD:14700884 , RGD:14700870
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Dnmt1
DNA methyltransferase 1
ISO
RGD
PMID:22905112
RGD:9588654
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Fkbp5
FKBP prolyl isomerase 5
ameliorates
ISO
mRNA,protein:incrased expression:liver (human)
RGD
PMID:33710653
RGD:401976495
NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,457,216...6,541,674
G
Foxo1
forkhead box O1
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA:decreased expression:liver
RGD
PMID:19253830
RGD:11041633
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Klf5
KLF transcription factor 5
severity
IEP
RGD
PMID:36653797
RGD:408395146
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:76,064,258...76,079,445
G
Lbp
lipopolysaccharide binding protein
treatment
IEP
RGD
PMID:23277536
RGD:407424596
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:146,954,015...146,981,586
G
Ldlr
low density lipoprotein receptor
IEP
protein:decreased expression: liver (rat)
RGD
PMID:20028367
RGD:21410185
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Mir155
microRNA 155
ISO
RGD
PMID:26867493
RGD:25671474
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Nlrc5
NLR family, CARD domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36708882
NCBI chr19:10,483,601...10,587,223
Ensembl chr19:10,477,628...10,562,121
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
treatment severity
IMP IEP
RGD
PMID:26256083 PMID:36653797
RGD:11522097 , RGD:408395146
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:77,158,808...77,168,722
G
Ocln
occludin
treatment
IEP
RGD
PMID:31116255
RGD:407424600
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Pemt
phosphatidylethanolamine N-methyltransferase
IEP
RGD
PMID:17156888
RGD:1642369
NCBI chr10:45,275,434...45,349,651
Ensembl chr10:44,775,911...44,850,013
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18703563
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:29399060 PMID:31116255
RGD:407424599 , RGD:407424600
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
severity
IEP
RGD
PMID:36653797
RGD:408395146
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Serpine1
serpin family E member 1
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:25561792
RGD:11075083
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
IEP
protein:decreased expression:liver
RGD
PMID:18996124
RGD:2312349
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19951287
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
IEP
RGD
PMID:11477087
RGD:1625694
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Stat4
signal transducer and activator of transcription 4
IEP
RGD
PMID:18296740
RGD:7207884
NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:49,419,340...49,588,540
G
Tead1
TEA domain transcription factor 1
ameliorates
ISO
RGD
PMID:33710653
RGD:401976495
NCBI chr 1:176,227,175...176,445,122
Ensembl chr 1:166,792,628...167,003,369
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:29399060
RGD:407424599
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tjp1
tight junction protein 1
treatment
IEP
RGD
PMID:23277536
RGD:407424596
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tlr2
toll-like receptor 2
treatment
IEP
RGD
PMID:23277536
RGD:407424596
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
severity treatment
ISO IEP
RGD
PMID:29884546 PMID:23277536 PMID:21463341
RGD:14697697 , RGD:407424596 , RGD:14700554
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
susceptibility treatment
ISO IEP
DNA:SNP:promoter:-238G>A (human)
RGD
PMID:9214463 PMID:29399060 PMID:20143470
RGD:14995434 , RGD:407424599 , RGD:38508901
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ubd
ubiquitin D
ISO
protein:increased expression:liver (human)
RGD
PMID:30009772
RGD:401976534
NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
G
Adra2a
adrenoceptor alpha 2A
IEP
mRNA:increases expression:cerebral cortex (rat)
RGD
PMID:9105684
RGD:401976538
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Ago2
argonaute RISC catalytic component 2
IEP
RGD
PMID:23927484
RGD:401900655
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Arc
activity-regulated cytoskeleton-associated protein
ameliorates
IMP
RGD
PMID:21549764 PMID:25746394
RGD:401851922 , RGD:11087075
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IDA
RGD
PMID:24906198
RGD:10054248
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:24906198
RGD:10054248
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdnf
brain-derived neurotrophic factor
treatment
ISO IEP
mRNA:increased expression:hippocampus protein:decreased expression:nucleus accumbens
RGD
PMID:27461790 PMID:32323150 PMID:21872672 PMID:32860885 PMID:28940732 PMID:32428531 More...
RGD:401940145 , RGD:596936415 , RGD:596936244 , RGD:596936242 , RGD:596936232 , RGD:401959372
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cartpt
CART prepropeptide
IEP
mRNA, protein:decreased expression:nucleus accumbens
RGD
PMID:26955782
RGD:597805883
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Cnr1
cannabinoid receptor 1
treatment
ISO
RGD
PMID:27461790
RGD:401940145
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
DNA:SNP:cd: (rs4680) p.V158M (human)
RGD
PMID:30211780
RGD:401940137
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO IEP IDA
CTD Direct Evidence: marker/mechanism associated with alcohol dependence; protein:decreased phosphorylation:prefrontal cortex (rat) protein:increased expression:neuron, brain protein:increased phosphorylation:central amygdaloid nucleus protein:increased phosphorylation:hypothalamus, ventral tegmental area mRNA, protein:increased expression:hippocampus, prefrontal cortex
CTD RGD
PMID:11717377 PMID:19324071 PMID:27053349 PMID:29024786 PMID:19108758 PMID:19052216 PMID:18772347 PMID:26313266 PMID:32113678 PMID:27461790 PMID:24073333 PMID:33609567 PMID:19341783 More...
RGD:401901600 , RGD:401959748 , RGD:401959607 , RGD:401959375 , RGD:401959374 , RGD:401950487 , RGD:401940184 , RGD:401940182 , RGD:401940145 , RGD:401940122 , RGD:401940121 , RGD:401940119
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Dbi
diazepam binding inhibitor
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:15950760
RGD:408361840
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Drd2
dopamine receptor D2
IEP
protein:decreased expression:hippocampus (rat)
RGD
PMID:18276072
RGD:2311587
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Fadd
Fas associated via death domain
severity
IDA
RGD
PMID:21088039
RGD:11341805
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IDA IEP IMP
RGD
PMID:27053349 PMID:12225868 PMID:10998122
RGD:401959748 , RGD:405255651 , RGD:405100721
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ameliorates treatment
IEP ISO IDA
protein:increased expression:brain (rat) associated with alcohol dependence; protein:increased expression:nucleus accumbens, caudate-putamen (rat) associated with acute stress disorder associated with pregnancy complications; protein:increased expression:brain (rat)
RGD
PMID:23185589 PMID:17331503 PMID:19324071 PMID:30632088 PMID:31442272 PMID:33592274 More...
RGD:401851068 , RGD:407571675 , RGD:401901600 , RGD:401901284 , RGD:401851072 , RGD:401901281
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gad1
glutamate decarboxylase 1
IEP
mRNA:increased expression:dentate gyrus granule cell layer
RGD
PMID:15673448
RGD:401900167
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
treatment exacerbates
ISO IEP IMP
CTD Direct Evidence: marker/mechanism protein:increased expression:shell of nucleus accumbens, cell surface (rat) protein:decreased phosphorylation:caudate-putamen, nucleus accumbens (rat) protein:altered expression:prefrontal cortex, membrane (rat) rat gene in a mouse model protein:increased phosphorylation:nucleus accumbens (rat)
CTD RGD
PMID:11404432 PMID:25746394 PMID:34390773 PMID:15287884 PMID:31209728 PMID:16775132 PMID:22072679 PMID:32717192 PMID:31863796 PMID:24201449 PMID:25716866 More...
RGD:11087075 , RGD:405818276 , RGD:405650198 , RGD:405649863 , RGD:405649739 , RGD:405101690 , RGD:405100728 , RGD:405100238 , RGD:405096668 , RGD:401976466
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
IMP
RGD
PMID:37190555
RGD:596933068
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
treatment
ISO
RGD
PMID:30632088
RGD:401901284
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12878694
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Htr1b
5-hydroxytryptamine receptor 1B
treatment
ISO
RGD
PMID:35447543
RGD:405650692
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
protein:increased expression:prefrontal cortex
RGD
PMID:28082900
RGD:401900741
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Mapk1
mitogen activated protein kinase 1
treatment
ISO IDA
protein:increased phosphorylation:central amygdaloid nucleus
RGD
PMID:33609567 PMID:29024786 PMID:19052216 PMID:18772347 PMID:27461790
RGD:401940121 , RGD:401959607 , RGD:401959374 , RGD:401950487 , RGD:401940145
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
ISO IDA
protein:increased phosphorylation:central amygdaloid nucleus
RGD
PMID:33609567 PMID:29024786 PMID:19052216 PMID:18772347 PMID:27461790
RGD:401940121 , RGD:401959607 , RGD:401959374 , RGD:401950487 , RGD:401940145
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mc4r
melanocortin 4 receptor
IEP
mRNA:altered expression:brain
RGD
PMID:8794897
RGD:1566548
NCBI chr18:62,689,798...62,691,685
Ensembl chr18:60,419,832...60,421,719
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20519536
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ncam1
neural cell adhesion molecule 1
IEP
protein:decreased expression, altered form:hippocampus (rat)
RGD
PMID:15673448
RGD:401900167
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ngf
nerve growth factor
IEP
mRNA,protein:increased expression:central amygdaloid nucleus
RGD
PMID:22871918
RGD:401965392
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17989510
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
G
Nps
neuropeptide S
IDA
RGD
PMID:23684726
RGD:9831198
NCBI chr 1:199,505,772...199,510,915
Ensembl chr 1:190,077,040...190,080,821
G
Npsr1
neuropeptide S receptor 1
IEP
RGD
PMID:23684726
RGD:9831198
NCBI chr 8:30,882,830...31,107,425
Ensembl chr 8:22,606,946...22,831,558
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IDA
RGD
PMID:27618384
RGD:408345246
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment
IMP
RGD
PMID:22304485
RGD:401965468
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IEP ISO IMP
mRNA:increased expression:hippocampus
RGD
PMID:28940732 PMID:32323150 PMID:32860885
RGD:596936232 , RGD:596936415 , RGD:596936242
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprl1
opioid related nociceptin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11027224
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3720824
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
treatment
IEP
RGD
PMID:15976090
RGD:401850590
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Pomc
proopiomelanocortin
IEP
mRNA:decreased expression:hypothalamus protein:decreased expression:brain
RGD
PMID:8883945 PMID:6268419
RGD:405878077 , RGD:408345193
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rack1
receptor for activated C kinase 1
ISO
mRNA, protein:increased expression:hippocampus, prefrontal cortex
RGD
PMID:19341783
RGD:401940119
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,169,169...33,174,975
G
Rgs11
regulator of G-protein signaling 11
treatment
ISO
RGD
PMID:15199376
RGD:597830059
NCBI chr10:15,727,279...15,735,536
Ensembl chr10:15,222,803...15,231,060
G
Rgs6
regulator of G-protein signaling 6
treatment
ISO
RGD
PMID:15199376
RGD:597830059
NCBI chr 6:107,875,883...108,527,472
Ensembl chr 6:102,264,447...102,824,753
G
Rgs7
regulator of G-protein signaling 7
treatment
ISO
RGD
PMID:15199376
RGD:597830059
NCBI chr13:89,511,492...89,941,082
Ensembl chr13:86,979,279...87,408,888
G
Arc
activity-regulated cytoskeleton-associated protein
treatment
IEP
RGD
PMID:30550948
RGD:401959617
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Avp
arginine vasopressin
ISO IEP
protein:increased expression:hippocampal formation mRNA:increased expression:hypothalamus
RGD
PMID:3556459 PMID:23805290
RGD:596933083 , RGD:407572522
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bad
BCL2-associated agonist of cell death
ISO
protein:increased expression:brain cortex, hippocampus:
RGD
PMID:16496378
RGD:407574727
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bdnf
brain-derived neurotrophic factor
IEP
mRNA:increased expression:ventral tegmental area (rat) mRNA:decreased expression:dorsal raphe nucleus mRNA, protein:increased expression:amygdala
RGD
PMID:30550948 PMID:24055683 PMID:32860885 PMID:26567727
RGD:401959617 , RGD:405866344 , RGD:596936242 , RGD:596936230
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cartpt
CART prepropeptide
IEP
mRNA, protein:increased expression:nucleus accumbens
RGD
PMID:26955782
RGD:597805883
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:31,255,098...31,290,713
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA
RGD
PMID:21171355
RGD:401959750
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Dbi
diazepam binding inhibitor
disease_progression
IEP
mRNA:increased expression:brain (rat)
RGD
PMID:15950760
RGD:408361840
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Egr1
early growth response 1
treatment
IEP
RGD
PMID:30550948
RGD:401959617
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
IEP
mRNA:increased expression:caudate putamen,nucleus accumbens protein:increased expression:central nervous system protein:increased expression:periaqueductal gray,neuron
RGD
PMID:11122358 PMID:12814374 PMID:9460759
RGD:405100959 , RGD:405101374 , RGD:405100960
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
ameliorates
ISO
RGD
PMID:28818835
RGD:597538594
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
G
Galr1
galanin receptor 1
ISO
mRNA:increased expression:brain,locus ceruleus (mouse)
RGD
PMID:10882839
RGD:407984714
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:75,772,023...75,787,577
G
Gdnf
glial cell derived neurotrophic factor
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:11798749
RGD:728679
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gfra1
GDNF family receptor alpha 1
IEP
mRNA:increased expression:frontal cortex
RGD
PMID:11798749
RGD:728679
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:257,321,742...257,551,473
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
IEP IMP
associated with Pain;protein:increased expression:central amygdaloid nucleus (rat) protein:increased phosphorylation:hippocampal formation, postsynaptic density (rat) mRNA:altered expression:cerebral cortex, hippocampus (rat)
RGD
PMID:25716866 PMID:19077125 PMID:10822164 PMID:25716866
RGD:401976466 , RGD:405101691 , RGD:405100240 , RGD:401976466
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
treatment
IMP
RGD
PMID:25308750
RGD:401965469
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IMP IEP
mRNA:decreased expression:dorsal raphe nucleus
RGD
PMID:26567727 PMID:24055683 PMID:32860885
RGD:596936230 , RGD:405866344 , RGD:596936242
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
IMP
RGD
PMID:12814374
RGD:405101374
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
IMP
RGD
PMID:12814374
RGD:405101374
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
ameliorates
IMP ISO
RGD
PMID:12814374 PMID:28818835
RGD:405101374 , RGD:597538594
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Per2
period circadian regulator 2
ameliorates
ISO
RGD
PMID:20434889
RGD:401976532
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Pomc
proopiomelanocortin
IEP
mRNA:decreased expression:hypothalamus mRNA, protein:altered expression:hypothalamus, plasma protein:increased expression:plasma
RGD
PMID:8883945 PMID:23805290 PMID:18180322
RGD:405878077 , RGD:407572522 , RGD:407572517
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
ameliorates
ISO
RGD
PMID:28818835
RGD:597538594
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Comt
catechol-O-methyltransferase
treatment ameliorates
ISO
DNA:SNPs:cds: (rs4680,rs750603) c.158A>G (human) associated with maternal opioid abuse;DNA:SNP:intron (rs740603) (human) DNA:SNP: 158A>G (rs4680) (human)
RGD
PMID:27983768 PMID:26233486 PMID:23632726
RGD:401950496 , RGD:11079504 , RGD:11097592
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
treatment
ISO
DNA:SNP: :CYP2B6*6 (516G>T,785A>G) ((human)
RGD
PMID:28320034
RGD:401901176
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ISO
mRNA:decreased expression:placenta
RGD
PMID:34352367
RGD:401938659
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Oprk1
opioid receptor, kappa 1
severity
ISO
associated with maternal opioid abuse;DNA:SNP:intron (rs702764) (human)
RGD
PMID:26233486
RGD:11079504
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
treatment ameliorates
ISO
DNA:SNP: 118A>G (rs1799971) (human) associated with maternal opioid abuse;DNA:SNP:intron (rs1799971) (human)
RGD
PMID:23632726 PMID:26233486
RGD:11097592 , RGD:11079504
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pnoc
prepronociceptin
severity
ISO
associated with maternal opioid abuse;DNA:SNP:intron (rs732636|rs351776|rs2614095 ) (human)
RGD
PMID:26233486
RGD:11079504
NCBI chr15:43,800,240...43,827,841
Ensembl chr15:39,624,641...39,651,867
G
Adra2a
adrenoceptor alpha 2A
susceptibility
ISO
DNA:SNP:promoter: C-1291G (rs1800544) (human)
RGD
PMID:17612790
RGD:401976458
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25482063
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ankk1
ankyrin repeat and kinase domain containing 1
susceptibility treatment onset
ISO
DNA:polymorphism:exon: associated with depressive disorder;DNA:SNP:exon:rs1800497(human) DNA:SNPs,haplotype:introns,exons:multiple DNA:SNP, haplotype:exon:rs1800497(human) DNA:SNP,haplotype: :rs11604671, rs4938015 (human) DNA:haplotype: :multiple DNA:SNP:exon:rs2734849(human)
RGD
PMID:28574012 PMID:21540761 PMID:17085484 PMID:22382052 PMID:21936764 PMID:25273375 PMID:18354387 More...
RGD:401959222 , RGD:401959399 , RGD:401959319 , RGD:401959315 , RGD:401959296 , RGD:401959295 , RGD:401959232
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Apbb1
amyloid beta precursor protein binding family B member 1
susceptibility
ISO
DNA:SNPs,haplotype:multiple:
RGD
PMID:18777128
RGD:10054043
NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:159,896,880...159,920,627
G
Apc2
APC regulator of WNT signaling pathway 2
ISO
DNA:hypermethylation:promoter, blood
RGD
PMID:35170441
RGD:407987268
NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:9,392,336...9,414,310
G
Arrb2
arrestin, beta 2
severity
ISO
DNA,SNPs,haplotype: : DNA:polymorphisms:cds:p.T84P, p.H281Q (human)
RGD
PMID:17579607 PMID:25450229
RGD:401901594 , RGD:11526246
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Arvcf
ARVCF, delta catenin family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38025780
NCBI chr11:96,092,451...96,150,144
Ensembl chr11:82,587,881...82,645,805
G
Bdnf
brain-derived neurotrophic factor
IEP ISO
associated with alcohol use disorder;mRNA:increased expression:shell of nucleus accumbens CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17186223 PMID:25155311
RGD:405850247
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cck
cholecystokinin
susceptibility
ISO
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:11509018
RGD:407419875
NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:121,153,500...121,160,084
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
susceptibility severity
ISO
DNA:SNP: :rs578776(human) CTD Direct Evidence: marker/mechanism DNA:missense:cds:p.R37H (human) DNA:SNPs:intron 1,3'UTR: (rs637137,rs578776) (human) DNA:SNPs:intron,CDS:rs938682,rs1051730 (human) DNA:SNP:exon: (rs1051730) (human) associated with smoking; DNA:SNP::rs1051730(human)
CTD RGD
PMID:18414406 PMID:29666375 PMID:19706762 PMID:22042774 PMID:21312287 PMID:27663783 PMID:21747048 PMID:29993116 More...
RGD:150524362 , RGD:405849405 , RGD:401959233 , RGD:401901143 , RGD:151660346 , RGD:150526806
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:55,401,702...55,415,165
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
ISO
ClinVar Annotator: match by term: CHRNA4-related condition | ClinVar Annotator: match by term: Nicotine addiction, protection against | ClinVar Annotator: match by term: Tobacco use disorder
ClinVar OMIM
PMID:15154117 PMID:19058950 PMID:19628475 PMID:21107856 PMID:21683344 PMID:22873564 PMID:24385388 PMID:25741868 PMID:26467025 PMID:26561946 PMID:28492532 PMID:31628766 PMID:32579787 More...
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:168,136,266...168,156,957
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
susceptibility severity
ISO
DNA:SNP: :rs16969968(human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs16969968, rs2036527(human) DNA:SNP, missense:CDS:rs16969968 (human) DNA:SNP:intron:rs17486278(human) associated with smoking; DNA:SNP::rs16969968 (human)
CTD RGD
PMID:18414406 PMID:18519132 PMID:28472521 PMID:19706762 PMID:21618602 PMID:29621993 PMID:27663783 PMID:20587604 PMID:29993116 More...
RGD:150524362 , RGD:596933092 , RGD:405849275 , RGD:401901143 , RGD:150527839 , RGD:150526806
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
susceptibility
ISO
DNA:SNP,haplotypes: : CTD Direct Evidence: marker/mechanism DNA:SNP: :rs2304297(human)
CTD RGD
PMID:28851948 PMID:28851948 PMID:18704094
RGD:405849281 , RGD:405849394
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24289814
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Chrnb3
cholinergic receptor nicotinic beta 3 subunit
susceptibility no_association
ISO
DNA:SNP,haplotype:: rs6474413, rs13277254 (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :rs4953, rs6474413(human) DNA:SNPs: :rs7004381, rs4950,rs13280604(human) DNA:SNPs,haplotype: : associated with Parkinson's disease;DNA:polymorphism:promoter:c.-57A>G(human)
CTD RGD
PMID:28851948 PMID:34368810 PMID:19482438 PMID:18704094 PMID:28851948 PMID:24731518 More...
RGD:405849274 , RGD:405849404 , RGD:405849394 , RGD:405849281 , RGD:405849280
NCBI chr16:71,411,847...71,454,225
Ensembl chr16:64,714,169...64,751,360
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
susceptibility
ISO
DNA:missense:cds:p.T91I, p.T375I (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29666375 PMID:22042774
RGD:405849405
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027
G
Comt
catechol-O-methyltransferase
susceptibility sexual_dimorphism onset treatment
ISO
DNA:SNP:cd: (rs4680) (human) DNA:SNPs,haplotypes:promoter,exons:mutliple DNA:SNPs,haplotype:intron 1: (rs9332377) (human) DNA:hypermethylation:promoter DNA:promoter:methylation DNA:SNP:exon 3: G1947A, p.V158M (rs4680) (human) DNA:SNPs:3'utr: (rs737865, rs165599) (human) DNA:SNPs,haplotypes:intron1,exon 4,intron 5: (rs740603,rs4680, rs174699) (human) DNA:SNP:cd: p.V158M (human)
RGD
PMID:28472995 PMID:16499480 PMID:21312287 PMID:24902721 PMID:21423427 PMID:17206495 PMID:16876132 PMID:16395295 PMID:20188797 More...
RGD:401940107 , RGD:401959300 , RGD:401959233 , RGD:401940112 , RGD:401959312 , RGD:401959230 , RGD:401940189 , RGD:401940152 , RGD:401940136
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO
mRNA:increased expression:blood, leukocytes
RGD
PMID:19212318 PMID:20047710
RGD:401940142 , RGD:401960087
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
treatment susceptibility
ISO
DNA:polymorphisms: :1459 C/T(human) DNA:SNP: :CYP2B6*6 (516G>T,785A>G) ((human) DNA:SNP: :rs2279343(human)
RGD
PMID:17654295 PMID:25489907 PMID:26153084 PMID:17223085
RGD:11096878 , RGD:401901146 , RGD:11097624 , RGD:401901145
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Dbi
diazepam binding inhibitor
ISO
mRNA:increased expression:cerebral cortex (mouse)
RGD
PMID:11750077
RGD:408356485
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Ddc
dopa decarboxylase
susceptibility
ISO
DNA:SNPs,haplotypes:: DNA:SNPs,haplotypes:multiple DNA:SNPs,haplotypes:introns:multiple (human)
RGD
PMID:17184203 PMID:15879433 PMID:16740595
RGD:401976473 , RGD:401976477 , RGD:401976474
NCBI chr14:90,592,304...90,682,830
Ensembl chr14:86,378,685...86,469,208
G
Ddr2
discoidin domain receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29216386
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:82,195,463...82,317,363
G
Dhrs7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29216386
NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:91,251,323...91,347,892
G
Drd2
dopamine receptor D2
susceptibility treatment
ISO
DNA:polymorphisms, haplotype:enhancer, promoter, intron:multiple CTD Direct Evidence: marker/mechanism DNA:SNPs, insertion/deletion:exon,introns, promoter:multiple DNA:SNP, haplotype:exon:rs6277 (957C>T)(human) DNA:polymorphisms: :(human)
CTD RGD
PMID:18579413 PMID:17108814 PMID:17085484 PMID:22382052 PMID:17654295
RGD:1600904 , RGD:401959319 , RGD:401959315 , RGD:11096878
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Drd4
dopamine receptor D4
susceptibility
ISO
DNA:repeats:exon:
RGD
PMID:31903031
RGD:401959740
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Egfr
epidermal growth factor receptor
IEP
mRNA, protein:increased expression:lung (rat)
RGD
PMID:21475988
RGD:5131452
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Fignl1
fidgetin-like 1
susceptibility
ISO
DNA:SNP,haplotype:: (rs10230343) (human)
RGD
PMID:16740595
RGD:401976474
NCBI chr14:90,573,090...90,595,342
Ensembl chr14:86,368,675...86,377,455
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP ISO
protein:increased expression:caudate-putamen protein:increased expression:brain
RGD
PMID:15026155 PMID:22048468 PMID:9789813 PMID:26169054
RGD:405100963 , RGD:405295496 , RGD:405255653 , RGD:405101700
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO IEP
protein:increased expression:nucleus accumbens, dentate gyrus of hippocampal formation (rat)
RGD
PMID:17468183 PMID:17333132
RGD:401900124 , RGD:407571683
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
susceptibility
ISO
DNA:SNPs,haplotypes:intron 6,exon 16,intron 17: (rs2267635,rs29230, rs29267)
RGD
PMID:19763258
RGD:401940104
NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
susceptibility
ISO IEP
ClinVar Annotator: match by term: Tobacco addiction, susceptibility to mRNA, protein:altered expression:brain DNA:SNPs,haplotypes:multiple
ClinVar OMIM RGD
PMID:25741868 PMID:28492532 PMID:16794563 PMID:19763258
RGD:408395148 , RGD:401940104
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:60,947,526...61,288,104
G
Galr1
galanin receptor 1
susceptibility
ISO
DNA:SNP:intron: (rs2717162) (human)
RGD
PMID:21430647
RGD:407984717
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:75,772,023...75,787,577
G
Gdnf
glial cell derived neurotrophic factor
ISO IEP
protein:decreased expression:hippocampus, striatum associated with alcohol use disorder;mRNA:decreased expression:shell of nucleus accumbens
RGD
PMID:34508846 PMID:25155311
RGD:405850211 , RGD:405850247
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
severity
ISO
DNA:SNP: :rs2268132
RGD
PMID:28900078
RGD:401900295
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
H19
H19 imprinted maternally expressed transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32739445
NCBI chr 1:207,160,175...207,162,851
Ensembl chr 1:197,730,698...197,733,134
G
Hcrt
hypocretin neuropeptide precursor
ISO
mRNA:increased expression:blood (human)
RGD
PMID:22846875
RGD:401960066
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Htr1a
5-hydroxytryptamine receptor 1A
treatment
IEP
RGD
PMID:22921986
RGD:405850243
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
sexual_dimorphism
ISO
associated with attention deficit hyperactivity disorder;DNA:SNPs: :rs11568817,rs130058 (human)
RGD
PMID:28923721
RGD:405650695
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Htr2a
5-hydroxytryptamine receptor 2A
severity treatment
ISO IMP
DNA:SNP: :rs6313 DNA:SNPs:promoter, CDS:-1438A>G (rs6311), 102T>C (rs6313)
RGD
PMID:28900078 PMID:22342986 PMID:25366721
RGD:401900295 , RGD:401901205 , RGD:401900763
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
treatment
IDA
RGD
PMID:22342986
RGD:401901205
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Htr3a
5-hydroxytryptamine receptor 3A
ISO
DNA:SNP, haplotype:enhancer: (rs897685) (human) DNA:SNP, haplotype:intron: (rs10160548) (human) DNA:SNP:intron: (rs1985242) (human) DNA:SNPs, haplotype:multiple (human)
RGD
PMID:24590108 PMID:30405098 PMID:35457612 PMID:23290502
RGD:404976878 , RGD:405096439 , RGD:405096438 , RGD:405096435
NCBI chr 8:58,138,514...58,150,960
Ensembl chr 8:49,242,020...49,254,389
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
associated with Graves Ophthalmopathy
RGD
PMID:10792346
RGD:8549806
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28864214
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Lcp1
lymphocyte cytosolic protein 1
susceptibility
ISO
DNA:SNP:: (rs1886040) (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438686 PMID:18438686
RGD:401851917
NCBI chr15:56,846,375...56,954,090
Ensembl chr15:50,488,149...50,544,680
G
Lhb
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12893845
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lysmd3
LysM domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 2:13,669,465...13,675,622
Ensembl chr 2:11,933,768...11,942,961
G
Mir218-2
microRNA 218-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28864214
NCBI chr10:20,572,523...20,572,632
Ensembl chr10:20,068,451...20,068,560
G
Ncam1
neural cell adhesion molecule 1
susceptibility
ISO
DNA:SNPs:introns:multiple
RGD
PMID:17085484
RGD:401959319
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ngf
nerve growth factor
ISO
protein:increased expression:hippocampus
RGD
PMID:34508846
RGD:405850211
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy1r
neuropeptide Y receptor Y1
ISO
DNA:SNP, haplotype:exon: (rs10033119) (human)
RGD
PMID:22309839
RGD:402463945
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
DNA:SNP : rs6198
RGD
PMID:23543128
RGD:408345225
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nrg1
neuregulin 1
sexual_dimorphism
ISO
in female;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Nrxn3
neurexin 3
ameliorates severity
ISO
DNA:SNP, haplotype: :rs1424850|rs221497|rs221473 (human) DNA:polymorphisms:cds:(rs199840331, p.Y234), p.G696, p.T99P (human) associated with schizophrenia;DNA:SNP:exon 5 (rs1004212) (human)
RGD
PMID:22716474 PMID:25450229 PMID:19658047
RGD:402528880 , RGD:11526246 , RGD:405096432
NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:107,641,780...109,272,044
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP ISO
mRNA, protein:altered expression:brain DNA:SNP: :rs150692457 (p.L140F) DNA:SNPs: :multiple DNA:SNPs, haplotypes
RGD
PMID:16794563 PMID:25450229 PMID:21618602 PMID:18534558 PMID:16713586
RGD:408395148 , RGD:11526246 , RGD:596933092 , RGD:408418728 , RGD:408395150
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Nts
neurotensin
ameliorates
IDA
RGD
PMID:18687313
RGD:597000688
NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:37,564,533...37,574,423
G
Oprm1
opioid receptor, mu 1
no_association disease_progression
ISO
DNA:SNP: :rs510769 DNA:SNPs: :multiple
RGD
PMID:26042510 PMID:19959688
RGD:401827930 , RGD:401827943
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pitrm1
pitrilysin metallopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29216386
NCBI chr17:68,705,699...68,737,350
Ensembl chr17:63,795,671...63,839,907
G
Plekhg1
pleckstrin homology and RhoGEF domain containing G1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438686
NCBI chr 1:42,612,023...42,841,727
Ensembl chr 1:40,311,221...40,434,063
G
Pomc
proopiomelanocortin
ISO
DNA:hypermethylation:promoter
RGD
PMID:29871818
RGD:405878073
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
IEP
protein:increased expression:brain
RGD
PMID:9789813
RGD:405255653
NCBI chr 1:190,433,501...190,457,241
Ensembl chr 1:181,010,305...181,026,648
G
Rad52
RAD52 homolog, DNA repair protein
susceptibility
ISO
DNA:SNP:3'utr: (rs7963551) (human)
RGD
PMID:26629180
RGD:151660337
NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:153,106,062...153,128,207
G
Rapgef3
Rap guanine nucleotide exchange factor 3
ISO
DNA:snps:introns: (rs2072115), (rs2074533) (human)
RGD
PMID:15274052
RGD:9835361
NCBI chr 7:130,754,883...130,777,303
Ensembl chr 7:128,875,773...128,898,521
G
Rptor
regulatory associated protein of MTOR, complex 1
susceptibility
ISO
DNA:SNP:: (rs1062935) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18438686
RGD:401851917
NCBI chr10:105,376,943...105,675,416
Ensembl chr10:104,878,487...105,176,983
G
Slc6a3
solute carrier family 6 member 3
severity
ISO
ClinVar Annotator: match by term: SLC6A3-related condition | ClinVar Annotator: match by term: Tobacco addiction, susceptibility to DNA:repeats: :
ClinVar OMIM RGD
PMID:25741868 PMID:28263315 PMID:28492532 PMID:27490263 PMID:25526961
RGD:401959207 , RGD:401959206
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Tlr3
toll-like receptor 3
ISO
mRNA:decreased expression:olfactory epithelial cell (human)
RGD
PMID:20935192
RGD:5129228
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tph1
tryptophan hydroxylase 1
ISO
RGD
PMID:15635702
RGD:1580461
NCBI chr 1:106,293,695...106,314,628
Ensembl chr 1:97,157,409...97,178,344
G
Ttc12
tetratricopeptide repeat domain 12
susceptibility
ISO
DNA:haplotype: :rs2282511(human) DNA:SNP: :rs2236709(human) DNA:SNPs:: DNA:SNPs,haplotype:introns,intergenics:multiple
RGD
PMID:25273375 PMID:30104163 PMID:21168125 PMID:17085484
RGD:401959295 , RGD:405866371 , RGD:405866370 , RGD:401959319
NCBI chr 8:58,696,381...58,743,857
Ensembl chr 8:49,799,920...49,847,087
G
Abcb1a
ATP binding cassette subfamily B member 1A
severity susceptibility treatment
ISO
DNA:SNP: :3435C>T (rs1045642) (human) DNA:SNP:: (rs9282564) DNA:SNPs::rs1045642, rs2032582(human) DNA:haplotype::
RGD
PMID:27061230 PMID:24950410 PMID:24086514 PMID:17178268
RGD:401959589 , RGD:401827941 , RGD:401901242 , RGD:401901190
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Akt1
AKT serine/threonine kinase 1
sexual_dimorphism
IEP
mRNA:increased expression:hippocampal formation
RGD
PMID:31071414
RGD:405866388
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Ankk1
ankyrin repeat and kinase domain containing 1
susceptibility
ISO
DNA:SNP,haplotype:exon:rs1800497(human)
RGD
PMID:19373123
RGD:401959309
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Arrb2
arrestin, beta 2
treatment
ISO
DNA:SNPs: :rs3786047, rs1045280, rs2036657(human) protein:decreased expression:pre-frontal cortex
RGD
PMID:20514076 PMID:14969742
RGD:401901595 , RGD:401901596
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,146,818...55,154,850
G
Avp
arginine vasopressin
ISO
protein:decreased expression:serum
RGD
PMID:23406607
RGD:596933090
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bdnf
brain-derived neurotrophic factor
ISO
protein:increased expression:serum
RGD
PMID:21890593
RGD:405850248
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bmper
BMP-binding endothelial regulator
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:: (rs731844) (human)
CTD RGD
PMID:18438686 PMID:18438686
RGD:401851917
NCBI chr 8:30,008,049...30,253,201
Ensembl chr 8:21,732,225...21,977,256
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:23850638
RGD:408395144
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
C9
complement C9
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:: (rs476569) (human)
CTD RGD
PMID:18438686 PMID:18438686
RGD:401851917
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:55,572,992...55,621,338
G
Ces1d
carboxylesterase 1D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12679808
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:13,796,623...13,912,035
G
Comt
catechol-O-methyltransferase
severity treatment
ISO
DNA:SNP:cd: p.V158M (rs4680) (human)
RGD
PMID:27061230 PMID:32407152
RGD:401959589 , RGD:401959744
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Crp
C-reactive protein
ISO
protein:increased expression:serum
RGD
PMID:23850638
RGD:408395144
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
treatment
ISO
RGD
PMID:10653207
RGD:401901270
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
G
Drd2
dopamine receptor D2
treatment susceptibility
ISO
DNA:SNP: :rs6275(human) DNA:SNP,haplotype: :rs1076560,rs6275(human)
RGD
PMID:19373123 PMID:19373123
RGD:401959309 , RGD:401959309
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Gal
galanin and GMAP prepropeptide
susceptibility
ISO
DNA:SNP: :rs948854(human)
RGD
PMID:24086514
RGD:401901242
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:200,650,439...200,654,959
G
Galr1
galanin receptor 1
susceptibility
ISO
DNA:SNP, haplotype:: (rs9807208) (human)
RGD
PMID:32757697
RGD:402463942
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:75,772,023...75,787,577
G
Grk2
G protein-coupled receptor kinase 2
ISO
protein:decreased expression:pre-frontal cortex
RGD
PMID:14969742
RGD:401901596
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:201,581,480...201,601,582
G
Grk6
G protein-coupled receptor kinase 6
ISO
protein:decreased expression:pre-frontal cortex
RGD
PMID:14969742
RGD:401901596
NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,177,019...9,192,644
G
Nav3
neuron navigator 3
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:: (rs770124) (human)
CTD RGD
PMID:18438686 PMID:18438686
RGD:401851917
NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:45,054,296...45,840,698
G
Ngf
nerve growth factor
ISO
DNA:hypermethylation:promoter,exon:blood protein:decreased expression:brain
RGD
PMID:29224006 PMID:26440527
RGD:401976280 , RGD:401976545
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Npy1r
neuropeptide Y receptor Y1
susceptibility
ISO
DNA:SNP, haplotype:enhancer: (rs4128839) (human) DNA:SNP, haplotype:intron: (rs4691910) (human)
RGD
PMID:31689297 PMID:32757697
RGD:402463939 , RGD:402463942
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Ntsr1
neurotensin receptor 1
susceptibility
ISO
DNA:SNP:intron:rs3915568(human)
RGD
PMID:26384852
RGD:11522680
NCBI chr 3:187,983,778...188,033,934
Ensembl chr 3:167,606,215...167,656,377
G
Oprd1
opioid receptor, delta 1
susceptibility treatment
ISO
DNA:SNP: :rs1042114 (human) DNA:SNPs, haplotype:intron 1:multiple (human) associated with neonatal abstinence syndrome in offspring;DNA:SNP:intron (rs204076) (human) associated with African American;DNA:SNP:intron (rs678849) (human) associated with methadone treatment;DNA:SNP:intron (rs204076) (human) DNA:SNP:intron (rs10753331, rs581111) (human) DNA:SNP,haplotype:multiple (multiple)(human) DNA:SNP, haplotype: (rs678849|rs2236857|rs2236855|rs760589) (human) DNA:SNP: :rs2236861(human)
RGD
PMID:28656735 PMID:24533225 PMID:26233486 PMID:23612435 PMID:37531661 PMID:22795689 PMID:17622222 PMID:28632076 PMID:24086514 More...
RGD:401850580 , RGD:402525443 , RGD:11079504 , RGD:402463973 , RGD:401977581 , RGD:401976559 , RGD:401976552 , RGD:401976541 , RGD:401901242
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
no_association
ISO
DNA:SNP: :rs702764 (human) DNA:SNP,haplotype:multiple (multiple GGCTTCT) (human)
RGD
PMID:28656735 PMID:17622222
RGD:401850580 , RGD:401976552
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprm1
opioid receptor, mu 1
susceptibility treatment no_association
ISO
ClinVar Annotator: match by term: Opioid dependence, susceptibility to, 1 protein:decreased expression:pre-frontal cortex DNA:SNP: :rs9479757(human) DNA:SNP, haplotype:3' utr:rs10485058 (human) associated with Chronic Pain;DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human) DNA:altered methylation:promoter DNA:SNPs: :multiple associated with alcohol dependence:DNA:SNP, haplotypes: :-2044C>A (human) DNA:SNPs: :172G>T (rs6912029), 1510G>A (rs12205732) (human) DNA:hypermethylation:promoter DNA:SNP:exon:17C>T (rs 1799972) (human) DNA:SNP:exon:118A>G (rs 1799971) (human)
ClinVar RGD
PMID:9193881 PMID:9689128 PMID:11134674 PMID:11773858 PMID:11773859 PMID:15037869 PMID:15086512 PMID:16046395 PMID:16387451 PMID:16682632 PMID:16906017 PMID:19528658 PMID:14969742 PMID:24086514 PMID:27958381 PMID:29781244 PMID:29564682 PMID:31853823 PMID:32492095 PMID:19429175 PMID:12815747 PMID:23226066 PMID:28121474 PMID:12960749 PMID:18181266 PMID:18181266 More...
RGD:401901596 , RGD:401901242 , RGD:401831043 , RGD:401831042 , RGD:401831040 , RGD:401827954 , RGD:401827948 , RGD:401827945 , RGD:401827942 , RGD:401827937 , RGD:401827935 , RGD:401827933 , RGD:401827929 , RGD:401827929
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
sexual_dimorphism no_association susceptibility
ISO
DNA:SNP: :rs1022563 (human) DNA:SNPs:promoter, 3' utr:rs1997794, rs102256 DNA:SNP: :rs199774, rs1022563 (human) DNA:SNP: :rs910080 (human) DNA:SNP: :rs910080, rs199774 (human)
RGD
PMID:22443215 PMID:19298317 PMID:28656735 PMID:28656735 PMID:22443215
RGD:401850569 , RGD:401850586 , RGD:401850580 , RGD:401850580 , RGD:401850569
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10321497
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:17,183,806...17,189,129
G
Pomc
proopiomelanocortin
ISO
associated with Psychological Trauma;protein:decreased expression:serum
RGD
PMID:31940647
RGD:407571691
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Ttc9
tetratricopeptide repeat domain 9
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:: (rs8688) (human)
CTD RGD
PMID:18438686 PMID:18438686
RGD:401851917
NCBI chr 6:107,064,527...107,099,361
Ensembl chr 6:101,333,141...101,368,110
G
Vegfa
vascular endothelial growth factor A
ISO
DNA:hypermethylation:exon:blood
RGD
PMID:29224006
RGD:401976280
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Avp
arginine vasopressin
IEP
mRNA:increased expression:amygdala
RGD
PMID:17443128
RGD:408364980
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Ngf
nerve growth factor
ISO
protein:increased expression:plasma
RGD
PMID:8727238
RGD:401976550
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IMP
associated with heroin dependence
RGD
PMID:24899712
RGD:596933358
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Tph2
tryptophan hydroxylase 2
treatment
ISO
associated with heroin dependence
RGD
PMID:30059533
RGD:597805899
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Ankk1
ankyrin repeat and kinase domain containing 1
susceptibility
ISO
associated with phlegm syndrome;DNA:polymorphism:exon:
RGD
PMID:26138154
RGD:11065747
NCBI chr 8:58,676,327...58,685,012
Ensembl chr 8:49,779,862...49,788,024
G
Avp
arginine vasopressin
susceptibility
ISO
DNA:SNP:intron: (rs2282018) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Creb1
cAMP responsive element binding protein 1
treatment
IEP ISO
protein:increased phosphorylation:Prefrontal Cortex, nucleus accumbens (rat)
RGD
PMID:30632799 PMID:31081159
RGD:401901180 , RGD:401940188
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crhbp
corticotropin releasing hormone binding protein
susceptibility
ISO
DNA:SNP:3'UTR: (rs1875999) (HUMAN)
RGD
PMID:24766650
RGD:401976505
NCBI chr 2:28,427,139...28,439,446
Ensembl chr 2:26,692,403...26,704,710
G
Dlg4
discs large MAGUK scaffold protein 4
treatment
ISO
RGD
PMID:31081159
RGD:401940188
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:54,739,470...54,767,153
G
Drd4
dopamine receptor D4
ISO
association with inhaler;DNA:repeats:exon:
RGD
PMID:11054768
RGD:401960062
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
IEP
protein:increased expression:Prefrontal Cortex, nucleus accumbens (rat)
RGD
PMID:30632799
RGD:401901180
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Galr1
galanin receptor 1
susceptibility
ISO
DNA:SNP:intron: (rs2717162) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr18:78,046,803...78,062,359
Ensembl chr18:75,772,023...75,787,577
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
protein:increased expression:medial prefrontal cortex,lateral prefrontal cortex,orbitofrontal cortex
RGD
PMID:29766293
RGD:401938658
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ISO
protein:increased expression:orbitofrontal cortex:
RGD
PMID:29766293
RGD:401938658
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ISO
protein:increased expression:medial prefrontal cortex,lateral prefrontal cortex,orbitofrontal cortex
RGD
PMID:29766293
RGD:401938658
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
mRNA:altered expression:striatum
RGD
PMID:30059705
RGD:401900306
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Ncam1
neural cell adhesion molecule 1
IMP
RGD
PMID:24399412
RGD:401959321
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IMP
RGD
PMID:9636221
RGD:401965473
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
susceptibility
ISO
DNA:SNP:intron: (rs1040288) (human)
RGD
PMID:24766650
RGD:401976505
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Oprd1
opioid receptor, delta 1
treatment susceptibility
ISO
mRNA:increased expression:ventral striatum associated with females, buprenorphine;DNA:SNP:intron (rs581111|rs529520) (human) mRNA:altered expression:testis, omentum (human) DNA:SNP:CDS: rs569356|rs678849 (human)
RGD
PMID:30059705 PMID:24126707 PMID:37660978 PMID:37146669
RGD:401900306 , RGD:402463962 , RGD:402463943 , RGD:401976452
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
severity
ISO
mRNA:decreased expression:peripheral blood lymphocyte DNA:SNP:CDS: rs997917|rs12548098|rs6473797|rs963549 (human)
RGD
PMID:31710992 PMID:37146669
RGD:401850570 , RGD:401976452
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
ISO
mRNA:increased expression:ventral striatum
RGD
PMID:30059705
RGD:401900306
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
treatment susceptibility
ISO
DNA:SNP:CDS: rs648893 (human) DNA:methylation:exon 1 (rs1799971) (human)
RGD
PMID:37146669 PMID:37660978
RGD:401976452 , RGD:402463943
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
ISO IEP
mRNA, protein:increased expression:peripheral blood lymphocyte protein:increased expression:nucleus accumbens
RGD
PMID:31710992 PMID:24305833
RGD:401850570 , RGD:401850592
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Pomc
proopiomelanocortin
ISO
mRNA:increased expression:ventral striatum
RGD
PMID:30059705
RGD:401900306
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Rgs10
regulator of G-protein signaling 10
IEP
RGD
PMID:22056472
RGD:13524518
NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
IEP
RGD
PMID:19664213
RGD:13524573
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
G
Rgs4
regulator of G-protein signaling 4
IEP
RGD
PMID:22056472
RGD:13524518
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:81,936,775...81,943,068
G
Apol2
apolipoprotein L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 7:111,211,944...111,219,209
Ensembl chr 7:109,331,392...109,338,558
G
Calm1
calmodulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 6:12,845,170...12,857,830
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr15:41,588,114...41,616,168
Ensembl chr15:37,412,146...37,440,287
G
Gcc1
GRIP and coiled-coil domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr 4:57,996,261...58,008,126
Ensembl chr 4:57,032,314...57,042,663
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17205118
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:31,296,156...31,362,647
G
Ager
advanced glycosylation end product-specific receptor
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Agtr1a
angiotensin II receptor, type 1a
IEP
RGD
PMID:24814703
RGD:10047100
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
G
Agtr1b
angiotensin II receptor, type 1b
IEP
RGD
PMID:24814703
RGD:10047100
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:102,844,969...102,920,232
G
App
amyloid beta precursor protein
IEP ISO
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Bdnf
brain-derived neurotrophic factor
treatment
IEP ISO
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Gdnf
glial cell derived neurotrophic factor
treatment
IEP ISO IDA
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Hmgb1
high mobility group box 1
IEP
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Igf1
insulin-like growth factor 1
IEP ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp7
insulin-like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr14:31,091,681...31,151,623
Ensembl chr14:30,737,164...30,797,314
G
Il1b
interleukin 1 beta
treatment
IDA IEP
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
treatment
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:28684969
RGD:401965467 , RGD:597538492
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ireb2
iron responsive element binding protein 2
IEP
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:55,228,085...55,311,611
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mir320a
microRNA 320a
treatment
IMP ISO
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:45,516,392...45,516,473
G
Ngf
nerve growth factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IDA IEP
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
IEP IMP
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:33390808
RGD:401965467 , RGD:401965467
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:30,715,648...31,059,885
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
IEP ISO
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Tlr2
toll-like receptor 2
treatment
IEP
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
treatment
IEP
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
treatment
IEP
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Ache
acetylcholinesterase
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Htr1a
5-hydroxytryptamine receptor 1A
IEP
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Tph2
tryptophan hydroxylase 2
IEP
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr 7:52,571,909...52,676,305
Ensembl chr 7:50,685,694...50,789,424
G
Adra2a
adrenoceptor alpha 2A
sexual_dimorphism
ISO
DNA:SNP:promoter: C-1291G (rs1800544) (human)
RGD
PMID:21140256
RGD:401976460
NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:253,060,218...253,064,365
G
Drd4
dopamine receptor D4
onset
ISO
associated with depressive disorder;DNA:repeats:exon: DNA:duplication:promoter: 120bp repeat
RGD
PMID:34828440 PMID:33544778
RGD:401959596 , RGD:401959602
NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:196,396,366...196,399,553
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
DNA:SNP:promoter:-1019G>C (rs6295)
RGD
PMID:26926882
RGD:11555812
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr1b
5-hydroxytryptamine receptor 1B
sexual_dimorphism susceptibility
ISO
associated with attention deficit hyperactivity disorder;DNA:SNP: :rs130058(human) associated with disease of mental health; DNA:SNP: :861G>C(human)
RGD
PMID:28923721 PMID:12496953
RGD:405650695 , RGD:405818271
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:82,517,360...82,534,549
G
Nrg1
neuregulin 1
susceptibility
ISO
associated with stressful life event;DNA:SNP: :rs6994992(human)
RGD
PMID:27353026
RGD:405100235
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:59,250,854...60,296,884
G
Oxtr
oxytocin receptor
ISO
DNA:promoter:methylation
RGD
PMID:30308385
RGD:597538590
NCBI chr 4:147,154,374...147,171,723
Ensembl chr 4:145,599,561...145,614,674
G
Slc6a4
solute carrier family 6 member 4
sexual_dimorphism
ISO
DNA:SNP:promoter::
RGD
PMID:21140256
RGD:401976460
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Creb1
cAMP responsive element binding protein 1
treatment
IDA
ketamine
RGD
PMID:27713001
RGD:401960089
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
protein:decreased expression: hippocampus (human)
RGD
PMID:27494187
RGD:401851061
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,853...13,333,386
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 8:116,158,810...116,171,857
Ensembl chr 8:107,280,099...107,293,146
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 5:156,579,901...156,595,147
Ensembl chr 5:151,296,662...151,311,912
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:23,037,789...23,046,759
G
Oprm1
opioid receptor, mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:80,605,251...80,618,042
G
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr 7:112,676,890...112,697,275
Ensembl chr 7:110,797,117...110,816,848
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr10:94,696,556...94,770,387
Ensembl chr10:94,197,054...94,270,892
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 1:31,537,990...31,578,962
Ensembl chr 1:29,709,443...29,750,413
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
IEP
RGD
PMID:8229066
RGD:405100718
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
mRNA, protein:increased expression:medial thalamic group, inferior colliculus, neuron
RGD
PMID:18481165
RGD:2300278
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3762968
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,723,762...5,748,698
G
Avp
arginine vasopressin
ISO
associated with alcohol dependence;protein:increased expression:plasma protein:decreased expression:cerebrospinal fluid
RGD
PMID:7662042 PMID:2425205
RGD:596933082 , RGD:596933106
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Pomc
proopiomelanocortin
ISO
protein:increased expression:mammillary body
RGD
PMID:1650797
RGD:407572523
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Adcy1
adenylate cyclase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16914643
NCBI chr14:86,125,119...86,234,459
Ensembl chr14:81,911,099...82,028,969
G
Adcy8
adenylate cyclase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16914643
NCBI chr 7:98,306,434...98,555,687
Ensembl chr 7:96,417,324...96,665,911
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16226742
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14756803 PMID:16226742 PMID:16470403
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,853...13,333,386
G
Ago2
argonaute RISC catalytic component 2
IEP
protein:increased expression:ventral tegmental area
RGD
PMID:23927484
RGD:401900655
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Arc
activity-regulated cytoskeleton-associated protein
IEP ISO
associated with morphine dependence;protein:increased expression:brain (rat) associated with morphine dependence; mRNA,protein:increased expression:brain (mouse)
RGD
PMID:19262551 PMID:27730515
RGD:401938601 , RGD:401959609
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:106,555,785...106,559,378
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21600884
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:129,810,645...129,838,608
G
Avp
arginine vasopressin
ISO IEP
CTD Direct Evidence: marker/mechanism associated with cocaine abuse;mRNA:increased expression:paraventricular nucleus of hypothalamus
CTD RGD
PMID:4040330 PMID:21677651
RGD:408418732
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:117,793,457...117,795,425
G
Bdnf
brain-derived neurotrophic factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism associated with morphine dependence;mRNA:alternative form:frontal cortex, midbrain associated with nicotine dependence
CTD RGD
PMID:12574402 PMID:25392083 PMID:24682499
RGD:401950484 , RGD:401940143
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Cacna1i
calcium voltage-gated channel subunit alpha1 I
treatment
ISO
RGD
PMID:25871318
RGD:14995950
NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:111,836,012...111,944,688
G
Camk4
calcium/calmodulin-dependent protein kinase IV
IEP
associated with alcohol use disorder;protein:decreased expression:brain
RGD
PMID:11181917
RGD:401959326
NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,585,269...24,802,487
G
Cckbr
cholecystokinin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496717 PMID:11880531
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:159,771,733...159,814,881
G
Chrm5
cholinergic receptor, muscarinic 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12154229
NCBI chr 3:119,739,229...119,791,630
Ensembl chr 3:99,284,846...99,337,252
G
Chrna5
cholinergic receptor nicotinic alpha 5 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18184829
NCBI chr 8:64,265,879...64,294,233
Ensembl chr 8:55,369,794...55,398,146
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19644040
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:64,697,741...64,704,441
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18184829
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18184829
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:175,181,402...175,189,619
G
Chrnb4
cholinergic receptor nicotinic beta 4 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15537871
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:55,418,313...55,437,027
G
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18705688
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
G
Comt
catechol-O-methyltransferase
susceptibility
ISO
associated with alcohol dependence; DNA:SNP:cd: c.158G>A (human)
RGD
PMID:11900601
RGD:401940190
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Creb1
cAMP responsive element binding protein 1
treatment sexual_dimorphism
ISO IDA IEP IMP
CTD Direct Evidence: marker/mechanism associated with heroin dependence;protein:decreased phosphorylation:nucleus accumbens associated with morphine dependence associated with alcohol use disorder;protein:altered phosphorylation:brain, nucleus associated with nicotine dependence;protein:decreased expression, decreased phosphorylation:brain, multiple associated with alcohol dependence associated with morphine dependence;protein:increased promoter binding:frontal cortex, midbrain associated with morphine dependence;protein:altered phosphorylation:ventral tegmental area associated with morphine dependence;protein:increased phosphorylation:prefrontal cortex associated with alcohol use disorder;mRNA:increased expression:cerebellum
CTD RGD
PMID:18596687 PMID:25711798 PMID:19108758 PMID:11181917 PMID:16641242 PMID:11331423 PMID:18772347 PMID:29713956 PMID:25392083 PMID:24682499 PMID:31042569 PMID:23035088 PMID:34453331 More...
RGD:401959753 , RGD:401959375 , RGD:401959326 , RGD:401959318 , RGD:401959212 , RGD:401950487 , RGD:401950486 , RGD:401950484 , RGD:401940143 , RGD:401938641 , RGD:401938640 , RGD:401938639
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crh
corticotropin releasing hormone
IEP ISO
mRNA:increased expression:amygdala (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12968131 PMID:18596687 PMID:12782395
RGD:5508177
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:102,143,055...102,144,919
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12858318
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Drd1
dopamine receptor D1
IEP
protein:increased expression:nucleus accumbens (rat)
RGD
PMID:20435100
RGD:7248622
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17189962
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
G
Faah
fatty acid amide hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18705688 PMID:19002671
NCBI chr 5:134,716,545...134,735,396
Ensembl chr 5:129,479,824...129,498,677
G
Fmr1
fragile X messenger ribonucleoprotein 1
IEP
mRNA:decreased expression:prefrontal cortex (rat)
RGD
PMID:24810662
RGD:11667955
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:147,240,301...147,278,050
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15196791 PMID:15196794 PMID:18485423
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
IEP
associated with morphine dependence;protein:increased expression:Brainstem (rat)
RGD
PMID:20438612
RGD:401900159
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
G
Gad1
glutamate decarboxylase 1
severity sexual_dimorphism
ISO IEP
associated with alcohol dependence;DNA:haplotype: : in female only, associated with alcohol dependence:protein:increased expression:cerebral cortex,hippocampus
RGD
PMID:19111404 PMID:15976529
RGD:401900129 , RGD:1643202
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:55,369,704...55,410,333
G
Gad2
glutamate decarboxylase 2
IEP
associated with alcohol dependence:protein:increased expression:cerebral cortex
RGD
PMID:15976529
RGD:1643202
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:84,763,628...84,826,155
G
Gnai1
G protein subunit alpha i1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12199159
NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:16,814,001...16,896,417
G
Gnao1
G protein subunit alpha o1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12199159
NCBI chr19:11,040,788...11,198,437
Ensembl chr19:11,035,956...11,192,493
G
Gnas
GNAS complex locus
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12199159
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ameliorates
ISO IEP IMP
CTD Direct Evidence: marker/mechanism benzodiazepine withdrawal;protein:increased expression:hippocampal formation, synapse (rat) cocaine withdrawal heroin withdrawal disorder;protein:increased phosphorylation:multiple (rat)
CTD RGD
PMID:11404432 PMID:12511956 PMID:18924138 PMID:12511956 PMID:19084907
RGD:405100713 , RGD:728494 , RGD:401976470
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,210,713...41,527,283
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12511956
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
severity
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12878694 PMID:23113297
RGD:401938657
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
severity
IEP
RGD
PMID:23113297
RGD:401938657
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:168,599,546...169,042,279
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
severity
IEP
RGD
PMID:23113297
RGD:401938657
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:167,418,640...167,481,671
G
Gucy1b1
guanylate cyclase 1 soluble subunit beta 1
severity
IEP
RGD
PMID:23113297
RGD:401938657
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:167,348,825...167,398,916
G
Hcrt
hypocretin neuropeptide precursor
severity
ISO
CTD Direct Evidence: marker/mechanism associated with alcohol dependence;mRNA:decreased expression:blood plasma (human)
CTD RGD
PMID:20738730 PMID:21621370
RGD:401960070
NCBI chr10:86,190,289...86,191,524
Ensembl chr10:85,689,465...85,691,210
G
Hcrtr1
hypocretin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20667500
NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:142,477,214...142,486,674
G
Hrh1
histamine receptor H 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8870037
NCBI chr 4:149,120,511...149,204,267
Ensembl chr 4:147,645,995...147,647,455
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8870037
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,368,298...10,407,631
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
IEP
associated with cocaine dependence;mRNA:increased expression:hippocampal formation (rat)
RGD
PMID:22860061
RGD:10445834
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
associated with alcohol dependence;DNA:SNP: :140G>C
RGD
PMID:19060480
RGD:401900293
NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:36,694,174...36,695,442
G
Htr2a
5-hydroxytryptamine receptor 2A
treatment
ISO IEP IMP
associated with alcohol dependence mRNA:decreased expression:hippocampus, ventral tegmental area associated with Cocaine-Related Disorders associated with morphine dependence;mRNA:decreased expression:peripheral blood mononuclear cell
RGD
PMID:19060480 PMID:26031442 PMID:12398913 PMID:28082900 PMID:18801381
RGD:401900293 , RGD:401901090 , RGD:401900759 , RGD:401900741 , RGD:13464135
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
G
Htr2c
5-hydroxytryptamine receptor 2C
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:decreased editing:hippocampus
CTD RGD
PMID:17105947 PMID:26031442
RGD:401901090
NCBI chr X:115,453,190...115,682,325
Ensembl chr X:110,641,153...110,870,287
G
Kdm4c
lysine demethylase 4C
susceptibility
ISO
DNA:snps:multiple (human)
RGD
PMID:22072270
RGD:9587485
NCBI chr 5:93,146,404...93,353,040
Ensembl chr 5:88,100,733...88,306,818
G
Mapk1
mitogen activated protein kinase 1
treatment
ISO IDA
CTD Direct Evidence: marker/mechanism associated with heroin dependence;protein:decreased phosphorylation:nucleus accumbens associated with morphine dependence associated with morphine dependence;protein:increased phosphorylation:prefrontal cortex
CTD RGD
PMID:17549049 PMID:25711798 PMID:18772347 PMID:23035088
RGD:401959753 , RGD:401950487 , RGD:401938640
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
ISO IDA
CTD Direct Evidence: marker/mechanism associated with heroin dependence;protein:decreased phosphorylation:nucleus accumbens associated with morphine dependence associated with morphine dependence;protein:increased phosphorylation:prefrontal cortex
CTD RGD
PMID:17549049 PMID:25711798 PMID:18772347 PMID:23035088
RGD:401959753 , RGD:401950487 , RGD:401938640
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20519536
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Ngf
nerve growth factor
ISO IEP
associated with alcohol dependence;DNA,protein:hypermethylation,decreased expression:promoter,serum associated with alcohol dependence;protein:altered expression:brain associated with alcohol dependence;protein:decreased expression:plasma
RGD
PMID:21392176 PMID:16252071 PMID:18639986
RGD:401965410 , RGD:401976435 , RGD:401965411
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19751225
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nptx2
neuronal pentraxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19084905
NCBI chr12:15,151,136...15,162,045
Ensembl chr12:10,037,435...10,048,345
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16952158
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Npy2r
neuropeptide Y receptor Y2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18828811
NCBI chr 2:170,200,027...170,210,286
Ensembl chr 2:167,903,879...167,905,024
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
associated with cocaine dependence;DNA:SNP:intron:rs41423247
RGD
PMID:27397864
RGD:401976507
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
ISO
associated with alcohol use disorder;protein:increased tyrosine phosphorylation:suprachiasmatic nucleus
RGD
PMID:29139560
RGD:408418729
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Oprd1
opioid receptor, delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2415332
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
G
Oprk1
opioid receptor, kappa 1
treatment
IMP IEP ISO
mRNA:increased expression:bed nucleus of stria terminalis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9463367 PMID:20232057 PMID:22515275 PMID:30075159
RGD:9834942 , RGD:401850573
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
G
Oprl1
opioid related nociceptin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11027224
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:168,834,003...168,839,920
G
Oprm1
opioid receptor, mu 1
severity
ISO
associated with heroin dependence; DNA:SNP:CDS (rs6848893) (human)
RGD
PMID:26692286
RGD:11532896
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
G
Pdyn
prodynorphin
IEP
associated with cocaine abuse;mRNA:altered expression:hippocampal formation, nucleus accumbens associated with opioid abuse
RGD
PMID:30818133 PMID:9045086
RGD:401851051 , RGD:401851908
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
G
Per1
period circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20738730
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
G
Per2
period circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20434889 PMID:20738730
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20738730
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607
G
Pnoc
prepronociceptin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:10680585
NCBI chr15:43,800,240...43,827,841
Ensembl chr15:39,624,641...39,651,867
G
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:225122 PMID:15689546 PMID:15714323 PMID:20738730
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:26,939,837...26,945,664
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
treatment
IDA
associated with Morphine Dependence
RGD
PMID:25604667
RGD:13514096
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,347,731...83,356,775
G
Prkg2
protein kinase cGMP-dependent 2
severity
IEP
RGD
PMID:23113297
RGD:401938657
NCBI chr14:10,864,020...10,972,617
Ensembl chr14:10,559,882...10,666,888
G
Prl
prolactin
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with opiate dependence
CTD RGD
PMID:9037573 PMID:6932063
RGD:401959329
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Ptger3
prostaglandin E receptor 3
treatment
IMP
RGD
PMID:10708732
RGD:10043351
NCBI chr 2:249,264,985...249,409,966
Ensembl chr 2:246,606,183...246,684,434
G
Ren
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28415
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Rhoa
ras homolog family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:108,991,954...109,025,746
G
Runx2
RUNX family transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
G
Slc6a1
solute carrier family 6 member 1
IEP ISO
protein:increased expression:cerebral cortex CTD Direct Evidence: therapeutic
CTD RGD
PMID:14598306 PMID:15976529
RGD:1643202
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:147,466,965...147,482,293
G
Slc6a4
solute carrier family 6 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17000009
NCBI chr10:62,322,688...62,357,060
Ensembl chr10:61,826,123...61,858,384
G
Smad1
SMAD family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr19:45,417,430...45,477,962
Ensembl chr19:28,513,131...28,573,651
G
Smad5
SMAD family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,864,720...7,891,634
G
Smurf1
SMAD specific E3 ubiquitin protein ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30158054
NCBI chr12:14,748,717...14,840,273
Ensembl chr12:9,635,025...9,726,519
G
Tacr1
tachykinin receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7692360
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733
G
Th
tyrosine hydroxylase
IEP
protein:increased serine phosphorylation:brainstem (rat)
RGD
PMID:20973778
RGD:5128830
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all